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Melanization (prophenoloxidase activation) is a major innate immune response in 
insects, which produces highly toxic and reactive compounds around the wounding or 
infection. It involves an extracellular serine proteinase pathway which rapidly amplifies 
responses to infection and stimulate killing of pathogens. Inhibitory regulation of the 
proteinases by serine proteinase inhibitors (serpins) is important for ensuring a localized 
defense response.  
One immune responsive serpin and one clip domain hemolymph proteinase (HP) 
from M. sexta were investigated. RT-PCR was used to examine gene expression. Proteins 
were expressed using baculovirus/insect cell system, and purified with various types of 
columns. Western immunoblotting was performed to analyze protein levels and protein-
protein interactions in vitro and in vivo.  
M. sexta serpin-8 mRNA and protein levels increased significantly after immune 
challenge. Similar to Drosophila serpin Necrotic, serpin-8 has an N-terminal extension 
and a Leu at the predicted P1 site. The serpin-8 core domain (serpin-8-ΔN) was expressed 
and purified. Serpin-8-ΔN has a specificity being able to inhibit elastase- and 
chymotrypsin-like proteinases and formed inhibitory complexes with chymotrypsin, 
Cathepsin G, and elastase. Addition of recombinant serpin-8-ΔN to M. sexta plasma 
suppressed proPO activation. M. sexta hemolymph proteinase, HP19 and HP14 are highly 
possible physiological targets of serpin-8.  
Two isoforms of hemolymph proteinase-1 (HP1) are present in M. sexta 
hemolymph. The two proteins share 90% amino acid sequence similarity. Recombinant 
HP1 zymogens and catalytic domains were expressed and purified. Addition of zymogens 
or catalytic domains of HP1 into plasma resulted in proPO activation. Proteolytic 
cleavage of proHP6 was observed, when catHP1a alone was added into plasma. ProHP6 
cleavage occurred within the catalytic domain when proHP6 was incubated with proHP1a 
in the presence of detergent. Some hemolymph factor(s) may contribute to the cleavage 
of proHP6 at its correct activation site, although the identity of such factor(s) is not yet 
known. HP1 was found to be regulated by M. sexta serpin-4 and serpin-5, and the serpin-
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Insects are one of the most successful groups of living organisms, accounting for nearly 
one million species (Hoffmann 1995). During evolution, insects developed a complex and 
effective innate immune system different from the adaptive immune system of vertebrates to cope 
with a large variety of pathogens. It has been established that the innate immune system provides 
an essential first line defense and plays a key role in stimulating and orienting the following 
adaptive immune responses (Vilmos et al., 1998). It is proven that the innate immune 
mechanisms of insects share many fundamental characteristics with the innate immune system of 
vertebrates (Hoffmann et al., 1996). 
The innate immune responses of insects have three tightly interconnected reactions 
(Hoffmann et al., 1996). The first is the proteolytic cascades triggered by wounding or pathogen 
infection. This is the case of the coagulation cascade leading to blood clotting, and of the 
prophenoloxidase activating cascade. The second is the cellular immune responses, which mainly 
consist of phagocytosis and encapsulation of invading microorganisms (Hoffmann 1995). The 
third is the synthesis of a variety of antimicrobial peptides by fat body and other tissues. 
Melanization (prophenoloxidase activation) is an important innate immune defense in 
many invertebrates. This immune reaction produces toxic quinone substances involved in 
formation of melanin that physically encapsulates invading pathogens (Cerenius et al., 2008). A 
complex extracellular serine proteinase cascade is involved in the proteolytic activation of 
prophenoloxidase (proPO), which is activated by host proteins recognizing conserved surface 
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components of microorganisms. More than 25 serine proteinase cDNAs have been isolated from M. 
sexta fat body and hemocytes in our laboratory (Jiang et al., 1999; Jiang et al., 2005). Identification of 
these hemolymph proteinases (HPs) is important to elucidate the roles of serine proteinases in insect 
innate immune responses. Prophenoloxidase-activating proteinases (PAPs) are among the few serine 
proteinases with known functions (Wang et al., 2001; Jiang et al., 2003). Two separate pathways 
leading to proPO activation have been proposed in M. sexta, which involves a few key HPs (Wang et 
al., 2006; An et al., 2009). Other than these HPs with clear functions, most of HPs are not well 
studied in M. sexta. cDNA of M. sexta HP1 was isolated earlier and it is reported that HP1 is highly 
expressed in hemocytes, but not in fat body. No significant change in HP1 mRNA level occurs after 
immune challenge (Jiang et al., 1999). Little is known about the activation, biochemical activity and 
biological functions of HP1. 
ProPO activation is negatively regulated by serine proteinase inhibitors (serpins) of serpin 
superfamily. Serpins, identified in nearly all species, adopt a conserved tertiary structure and act as 
suicide substrates by binding covalently to their target proteinases. They regulate a variety of 
physiological processes and defense mechanisms, such as blood coagulation, inflammation and 
complement activation. Insect hemolymph contains high concentrations of serpins. They regulate 
endogenous proteinases generated during immune responses (Kanost, 1999). Several serpins have 
been well characterized in M. sexta. They either directly inhibit PAPs (Jiang et al., 1996; Zhu et al., 
2003) or inhibit serine proteinases upstream of PAPs (Zou et al., 2005; Tong et al., 2005) to 
effectively limit the production of quinones and ensure a localized defense response. M. sexta serpin-
8 is a newly discovered immune responsive serpin with an N-terminal extension. Its inhibitory 
specificity and biological function have not been investigated. 
My research aims to: (1) express, purify and functionally characterize M. sexta serpin-8; (2) 







REVIEW OF LITERATURE 
Insect immune system 
The immune system provides organisms protection from invasion of a wide range of 
pathogens. In vertebrates, one component of immunity, the innate immune system fights 
infections from the very first moment when pathogens invade host organisms and it is considered 
as the fundamental defense weapon of hosts (Hoffmann 1995). The other component, acquired 
immunity, which is mediated by white blood cells, takes days to develop an enormous array of 
antibodies that are able to recognize pathogens that the host may never have encountered before 
(Kaufmann, 2008). Although innate and acquired immune systems were discovered at around the 
same time, the knowledge of mechanisms used by acquired immunity quickly outpaced the 
understanding of innate immunity. The measurement, chemical analysis, purification and 
structural determination of antibodies became available in the early 1980’s (Kimbrell et al., 
2001). Understanding of innate immunity requires different methods and perspectives and 
involves both invertebrates and vertebrates. Innate immunity evolved before the separation of 
vertebrates and invertebrates (Janeway, 1989), and some organisms exclusively depend on it.  
Although they lack acquired immunity, insects are the most evolutionarily successful 
organisms and account for nearly 90% of all extant animal species. Insects are able to efficiently 
defend against an extremely large variety of potentially harmful microorganisms (Hoffman, 
1995). Many innate immune mechanisms are conserved throughout the animal kingdom
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(Kanost et al., 2004). The insect host defense system has many similarities to the basic 
characteristics of mammalian acute phase response. Consequently, insect innate immunity attracts 
substantial interests in recent years and studies have led to the discovery of several major 
interconnected reactions in the immune system.  
The insect innate defense begins with the initiation of two proteolytic cascades. One of 
them leads to localized blood clotting (Iwanaga, 1993b), the other leads to melanization at the 
wounding site or around invading microorganisms (Söderhäll et al., 1996). Phagocytosis of 
bacteria by specialized cells and encapsulation of larger organisms by blood cells occur next. 
Concomitantly, a variety of antimicrobial peptides which are synthesized in the fat body and 
secreted into hemolymph, act synergistically to kill the invading microorganisms (Osaki et al., 
1999).  
Genetic study of Drosophila provides an opportunity to dissect the development and 
differentiation of this immune system at the level of transtriptional control (Hoffman, 2003). At 
the same time, innate immune responses of lepidopteran larvae have been studied for more than 
40 years and used as models for biochemical research (Kanost et al., 2004). Manduca sexta is 
used to investigate hemocytes and hemolymph proteins, as the last instar larva reaches 10-12 g, 
and 1-2 ml of hemolymph can be collected from each individual. It is an ideal subject for protein 
purification or study of protein interactions that occur in hemolymph. 
 
Recognition of invasive microorganisms 
All types of invasive microbes need to be recognized and killed. How does an insect host 
recognize and destroy all of them? A multilayer defense is involved: the first line is a physical 
barrier, the exoskeleton or cuticle (Brey et al., 1993). Once this layer is breached, insects use the 
second layer of defense for recognition of infection. Microorganisms have various surface 
features that distinguish them from multicellular organisms, which are known as “microbial 
patterns” and their detectors are thus called “pattern recognition receptors or proteins” (Kang et 
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al., 1998). Those microbial patterns include β-1,3-glucan of fungi, peptidoglycans (PG), 
lipopolysaccharide (LPS), and lipoteichoic acid (LTA) of bacteria. Thus, some of the pattern 
recognition proteins are named as β-1,3-glucan recognition protein (βGRP), peptidoglycan 
recognition protein (PGRP), Gram-negative bacteria-binding protein (GNBP), hemolin, and 
lectins (e.g. mannose-binding protein) (Gillespie et al., 1997). Upon binding to their target 
“microbial patterns”, pattern recognition proteins undergo a conformational change required for 
recruiting other plasma factors or hemocytes to eliminate microorganisms (Liu et al., 2001). 
However, little is known about how such structural changes activate the signaling pathways 
which result in blood clotting or melanization. 
Hemolin is a member of the immunoglobulin superfamily and participates in protein 
complex formation with bacterial surfaces and is used to initiate phagocytosis (Su et al., 1998). 
Only lepidopteran hemolin has been identified (Rasmuson et al., 1979; Ladendorff et al., 1990; 
Lee et al., 2002). No ortholog has been discovered in the Drosophila melanogaster or Anopheles 
gambiae genomes. M. sexta hemolin is able to bind hemocytes and surface components of 
bacteria, such as LPS and LTA. Hemolin’s ability to bind both hemocytes and bacteria helps to 
trap bacteria in hemocyte nodules and further clear bacteria from circulation in hemolymph 
(Ladendorff et al., 1990). 
C-type lectins are calcium-dependent carbohydrate-binding proteins. They function as 
pattern recognition proteins in the vertebrate and invertebrate innate immune systems (Weis et al., 
1998). M. sexta has at least four immunelectins (IML), immulectin1-4, all of which contain two 
tandem carbohydrate recognition domains and are highly similar in sequence to such domains in 
other C-type lectins from insects to mammals. In vitro encapsulation assays showed that M. sexta 
IML-1 and IML-3 enhance cellular encapsulation but not melanization. IML-2 and IML-4 
enhance both encapsulation and melanization (Yu et al., 1999; Yu et al., 2000; Yu et al., 2002). 
The βGRP family of recognition proteins include a β-1,3-glucanase-like domain in the 
carboxyl terminus. They bind to β-1,3-glucan but lack the amidase activity, due to amino acid 
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substitutions in the catalytic center (Ochiai et al., 1999). Up till now, two β-1,3-glucan 
recognition proteins (βGRPs) have been purified and cloned from M. sexta (Ma et al., 2000; 
Jiang, et al., 2004). They are similar in sequence to B. mori βGRP. The M. sexta βGRPs 
aggregate yeasts and bacteria through β-1,3-glucan and LTA (but not LPS). βGRPs have been 
demonstrated to stimulate the prophenoloxidase activation cascade in several arthropod species. 
Gram-negative bacteria-binding proteins (GNBPs), first identified in the silkworm (Lee et al., 
2003) are other members of the family. M. sexta GNBP specifically binds to LTA, LPS, 
diaminopimelic acid-type peptidoglycans (DAP-PGs) from E. coli and B. subtilis (Wang et al., 
2011). 
PGRPs were first characterized in larger insect species, like silkworm through their ability 
to bind either to intact bacteria or to surface components of bacteria (Yoshida et al., 1996). They 
are similar in sequence to T7 lysozyme but lack a hydrolytic activity. The differences in 
structures of the PGRP domains may account for the discrimination between classes of 
microorganisms. Drosophila genome encodes 13 PGRP genes which have been classified to three 
groups according to its length, short-form, transmembrane long-form and cytoplasmic long-form 
(Gottar et al., 2002). In short PGRPs, a signal peptide is followed by the PGRP domain. 
Drosophila PGRP-SA and -SD are short secretory proteins binding to Gram-positive bacteria 
through Lys-type PG (Michel et al., 2001). The long PGRPs contain an N-terminal 
transmembrane region with a C-terminal PGRP domain. Drosophila PGRP-LC is a long form 
with a transmembrane domain. It recognizes DAP-type PG from Gram-negative bacteria (Ramet 
et al., 2002). Drosophila cytoplasmic PGRP-LE activates the immune deficiency (Imd) pathway 
when it is overexpressed. It was discovered that mice and humans have four genes encoding 
PGRP family members (Takehana 2002). 
 
Insect cellular immune responses 
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The insect immune system consists of cellular and humoral components which work 
together to protect hosts from a variety of invaders. Cellular immunity refers to immune 
responses that do not involve antibodies or complement, but rather involve the activation of 
different types of immune cells. The cellular responses to infection in insects include 
phagocytosis, nodulation and encapsulation. Hemocytes exhibit changes in morphology from 
freely circulating cells to aggregates of adherent cells. They are believed to play signaling 
functions between distant immune responsive tissues via the production of cytokines (Evans et 
al., 2003). 
Insect hemocytes are originated from lymph lobes (Jung et al., 2005). Proliferation and 
differentiation of Drosophila blood cells are under the control of several signaling pathways. The 
transcription factors involved in these pathways are highly similar to those in the regulation of 
mammalian hematopoiesis (Evans et al., 2003). Insect hemocytes are classified into a few groups 
according to their morphology and biological functions (Meister 2005). In Drosophila, there are 
three: plasmatocytes, lamellocytes and crystal cells. Plasmatocytes are phagocytic macrophage-
like cells which consist of 90%-95% of the blood cells (Vilmos et al., 1998). They are primarily 
responsible for phagocytic removal of dead cells and microbial pathogens and tissue remodeling 
during insect metamorphosis. Unlike the mechanism of phagocytosis in vertebrates, little data is 
available about the molecular aspects of phagocytosis in insects. A small peptide named 
plasmatocyte-spreading peptide has been identified in several lepidopteran species (Wang et al., 
1999; Skinner et al., 1991). It is present in plasma as an inactive precursor. Once it is activated 
upon wounding, it stimulates the adhesion of plasmatocytes to the body wall and reduces 
bleeding. Lamellocytes have a flattened shape and are capable of encapsulation of larger invaders 
(Rizki et al., 1894). Encapsulation is a multicellular defense mechanism in which a capsule of 
overlapping layers of hemocytes is formed around protozoans, nemotodes, and eggs or larvae of 
parasitic insects. Encapsulation may associate with melanization to kill invaders (Strand et al., 
1995). Crystal cells constitute 5% of hemocytes. They are nonphagocytic cells involved in 
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melanizaion. Mature crystal cells express prophenoloxidase (proPO) which mediates the 
melanization process. They are fragile, ready to disrupt, and release their content into hemolymph 
upon activation (Rizki et al., 1994). Therefore, they function as storage cells for the large amount 
of proPO in their cytoplasm in crystallized form.  
 
Insect humoral immune responses 
The insect humoral responses parallel the mammalian acute phase responses which are 
stimulated by injury or bacterial challenge and characterized by the synthesis of acute phase 
proteins mainly in the liver and blood cells (Vilmos et al., 1998). In insects, humoral responses 
are also triggered by wound or pathogen infection. The proteolytic cascade leads to three 
immediate reactions: hemolymph clotting, melanization, and antimicrobial peptides synthesis.  
 
Hemolymph clotting 
Hemolymph clotting is an essential mechanism to limit the loss of hemolymph and heal 
wounds. In arthropods, two types of clotting mechanism have been studied. One was investigated 
in cockroach (Leucophaea maderae) (Bohn et al., 1984) and locust (Locusta migratoria) (Dushay 
2009). The polymerization of clottable proteins such as lipophorin and vitellogenin-like proteins 
is catalyzed by a Ca2+ dependent transglutaminase released from hemocytes. The other type is 
well studied in the horseshoe crab (Lymulus polyphemus) (Iwanaga et al., 2005). The LPS or β-
1,3-glucan mediated clotting is activated by a three-step serine protease cascade, where four 
serine proteases and one clottable protein (Factors C, G, B, proclotting enzyme and coagulogen) 
are involved. The last reaction in the cascade is to convert coagulogen to insoluble coagulin gel, 
resulting in gelation or cell agglutination. A structural homology occurs between the hemolymph 
clotting enzymes, the complement system and blood clotting of mammals. It is possible that the 




Melanization and prophenoloxidase (proPO) activation system 
Melanization reaction in insects is associated with multiple host defense mechanisms 
leading to the sequestration and killing of invading microorganisms (Hultmark 1993). It is 
controlled by a cascade of serine proteinases that ultimately activates the inactive proPO to active 
PO which, in turn, catalyzes the formation of quinones. Quinines are precursors for cuticle 
sclerotization and melanin synthesis. Quinone compounds may also be involved in wound healing 
and encapsulation of parasites (Jiang et al., 2003).  
The key enzyme in the melanization process is phenoloxidase (PO), which is present as a 
precursor form, prophenoloxidase (proPO), in the hemocytes or in the plasma. POs are probably 
necessary for insect survival and all insect genomes contain genes for POs (Cerenius et al., 2008). 
The number of PO genes ranges from 10 in the mosquito Aedes aegypti (Waterhouse et al., 2007) 
to a single PO gene in the honeybee Apis mellifera (Zou et al., 2006). POs are primarily produced 
by specific hemocytes such as crystal cells of Drosophila, and oenocytoids in many other insects 
and the granular hemocyte types in crustaceans (Rizki et al., 1985; Shrestha et al., 2008; 
Söderhäll et al., 1983). After release, it is either actively transported to cuticle (Ashida et al., 
1997) or deposited around wounds and encapsulated parasites (Bidochka et al., 1997). All 
arthropod POs lack a signal peptide (Ling et al., 2005). It is thus unclear how POs are released 
from the cells. PO belongs to a class of metalloproteins with type-3 copper centers (Decker, 
2007). Arthropod POs are more similar in amino sequence to arthropod hemocyanins which also 
belong to metalloproteins, than to fungal or mammalian tyrosinases, especially in their copper 
binding sites (Jiang et al., 1997). 
PO is synthesized as an inactive zymogen, proPO which can be activated by proteolytic 
cleavage at a specific site near the amino terminus (Jiang et al., 2003). It is reported that proPO 
can also be activated by certain detergent (e.g. cetylpyridinium chloride) that do not cleave 
peptide bonds, perhaps by inducing a conformational change at the active site (Hall et al., 1995). 
Two proPOs have been cloned in M. sexta, proPO-1 and proPO-2 (Hall et al., 1995; Jiang et al., 
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1997). They share 50% sequence similarity and form predominantly heterodimers in M. sexta 
plasma (Jiang et al., 1997). The crystal structure of M. sexta proPOs leads to a model for 
localized proPO activation in insects (Li et al., 2009). 
Wounding or exposure to certain pathogens leads to the activation of proPO by a 
proteinase, named proPO-activating proteinase (PAP) in M. sexta (also known as proPO-
activating factors or enzyme (PPAF/PPAE) in other insects. Three PAPs have been cloned and 
studied in M. sexta. PAP-1 was isolated from a cuticular extract of M. sexta (Wang et al., 2001). 
PAP-2 and PAP-3 were purified from M. sexta hemolymph (Jiang et al., 2003). PAP-2 and PAP-3 
contain two amino-terminal regulatory clip domains followed by a carboxyl-terminal catalytic 
domain, whereas PAP-1 consists of one clip domain at its amino-terminus (Jiang et al., 2003). 
The solution structure of PAP-2 dual clip domain shows that it includes a probable substrate-
binding site, a bacterial-interacting region and a remarkable charged surface for specific 
association with activator/cofactor (Huang et al., 2007). The three PAPs effectively activate 
proPO to PO only when in the presence of serine proteinase homologs (SPHs) which are 
considered as cofactors (Yu et al., 2003). SPHs are similar in amino acid sequence to serine 
proteinases, but they lack proteolytic activity because their active site serine residues are changed 
to glycine. Three PPAFs have been identified in the beetle, Tenebrio. molitor, and two of them 
have been crystallized providing details about the activation mechanism (Kan et al., 2008; Park et 
al., 2007; Lee et al., 2004). Structural evidence of PPAFs has shown that upon activation, PPAF-
II (a SPH) oligomerises and its clip-domain is responsible for binding of PO. This interaction 
ensures that active PO is under tight control and that the active PO is not spread through the 
hemolymph in an uncontrolled manner, but stays in the local area of activation cascade (Piao et 
al., 2007). 
Although PO-generated compounds are powerful weapons to fight against pathogens, 
they can also be harmful to host tissues and cells (Zhao et al., 2007). The need for a tight 
temporal and spatial control of its activity is obvious. Several critical steps in the proPO 
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activation pathway are carried out by specific serine proteinases and serine proteinase inhibitors 
(serpin) prevent premature and excessive activation. These inhibitors are present at high 
concentrations in insect hemolymph.  
 
Synthesis of antimicrobial peptides 
The hallmark of the humoral immune response is the systematic antimicrobial response. 
It corresponds to the challenge-induced synthesis of a variety of antimicrobial peptides (AMPs) 
by the fat body (Sondergaard, 1993) and release into the hemolymph where they readily reach 
their effective concentrations. Fat body, a functional equivalent of mammalian liver and adipose 
tissues, synthesizes most of AMPs, due to its large size and its location inside the open circulatory 
system. Other tissues, such as hemocytes, cuticular epithelial cells, gut, and salivary glands also 
produce AMPs (Boman, 1991; Brey et al., 1993). Injection of bacteria into the hemocoel induces 
the production of AMPs in the hemolymph of Drosophila. Some AMPs are very stable due to the 
presence of intramolecular disulfide bonds and are detectable in the hemolymph several weeks 
after the challenge. The number of insect AMPs is large: over 100 have been reported so far. 
Many AMPs have low molecular weights. Although they are diverse in structure, many AMPs are 
amphipatic, acting at membranes to kill microbes by lysis. According to their structures, AMPs 
are divided into a least two major classes: the cyclic peptides containing disulfide bonds, and the 
linear peptides lacking cysteines (Hoffman et al., 1996). 
The most prominent peptides in the cyclic group are the 4 kDa anti-Gram-positive 
bacterial insect defensins and the 5 kDa antifungal peptide drosomycin. Insect defensins are 
cationic peptides containing six conserved cysteins engaged in three disulfide bridges (Cornet et 
al., 1995). About 30 defensins have been characterized in various insect species, such as Aedes, 
Anopheles and Drosophila (Lowenberger et al., 1995; Dimarcq et al., 1994). The sequence 
similarity is high among these insect defensins and the overall structure is strictly conserved. 
Insect defensins are not homologous to mammalian and plant defensins. Drosomycin contains 8 
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cysteines engaged in intramolecular disulfide bridges. It exhibits potent antifungal activity but is 
inactive against bacteria. Drosomycin, shows a significant homology with a family of 5 kDa 
cysteine-rich plant antifungal peptides isolated from seeds of Brassicaceae, indicating that plants 
and insects can rely on similar molecules in their innate host defense (Fehlbaum et al., 1994). 
There are mainly three families in the linear group: cecropins, proline-rich peptides, and 
glycine-rich peptides. Cecropins (4 kDa) are strongly cationic, amphipatic and cause 
instantaneous lysis of bacterial cells through disintegration of their cytoplasmic membranes. 
Thus, cecropins have antibacterial activity against both Gram-positive and Gram-negative 
bacteria (Boman, 1994). Proline-rich peptides are those with molecular mass of 2-4 kDa, lacking 
cystein and containing at least 25% proline. They are primarily active against Gram-negative 
bacteria by increasing the membrane permeability (Hetru et al., 1994). The glycine-rich family 
includes several 9-30 kDa polypeptides, all of which have a high percentage of glycine residues 
(10-22%). They are mainly active against Gram-negative bacteria (Lee et al., 1995). 
The identification of AMPs was followed by analysis of the challenge-induced control of 
their expression in the early 1990s. By the mid-to-late 1990s, it was discovered that the 
expression of AMP genes depends on two members of the nuclear factor-κB (NF-κB) family in 
D. melanogaster, DIF (dorsal-related immunity factor) and Relish. DIF and Relish are responsive 
to fungal and bacterial infection respectively through two distinct signaling pathways, known as 
the Toll and immune deficiency (Imd) pathways (Lemaitre et al., 2007). 
The Toll pathway activation accounts primarily for response to fungi and Gram-positive 
bacteria. It involves several factors that were initially discovered in the control of dorsoventral 
patterning in the embryo and it is parallel to the mammalian signaling cascades downstream of 
the interleukin-1 receptor (IL-1R) and the Toll-like receptors (TLRs) (Hoffman, 2003). 
Drosophila Toll is a transmembrane receptor, consisting of an extracellular leucine-rich repeat 
and intracellular signaling domain. The key player in the activation of Toll pathway is a cysteine-
knotted cytokine-growth factor-like polypeptide, spätzle which is activated at the end of a 
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proteolytic cascade (Lemaitre et al., 1996). The binding of spätzle to Toll activates the signaling 
pathway which leads to the dissociation of NF-κB-like protein, Dorsal, and Dif from their 
inhibitory protein, the IκB-like protein, Cactus.  
The Imd pathway is similar to the tumor-necrosis factor-receptor (TNF-R) pathway in 
mammals (Hoffmann et al., 2002). It is primarily, although not exclusively, involved in defense 
against Gram-negative bacteria, and most AMPs controlled by this pathway are predominantly 
active against Gram-negative bacteria, such as cecropins, attacins, drosocin, diptericins. Initiation 
of the Imd pathway requires a transmembrane PGRP, PGRP-LC. However, the mechanisms by 
which PGRP-LC activates the Imd pathway remain unclear. Relish, the NF-κB-like protein 
involved in this pathway is not inhibited by Cactus, but has its own inhibitory domain in its 
carboxy-terminal region (Dushay et al., 1996). Activation of Relish requires a signal-induced 
proteolytic cleavage that dissociates the Rel-homology domain from its inhibitory domain and 
allows its nuclear translocation. 
Although some immune-induced genes are clearly dependent on one pathway only, others 
can be induced by both cascades. Drosomycin gene is such an example. It is easily induced by the 
Toll pathway, but it also can be induced by the Imd pathway in the systemic response and is only 
activated by the Imd pathway in the local response (Tzou et al., 2000). Therefore, a question is 
whether the two pathways can synergistically increase the expresion of some immune-response 
genes. It is partially supported by a bioinformatics analysis which shows that κB binding sites are 
specific for either Toll or Imd pathway activation (Leulier et al., 2000).  
 
Serine proteinases and serine proteinase pathways 
Fat body and hemocytes produce and secrete a variety of plasma proteins with direct 
antimicrobial activity or with indirect functions in insect immune responses. One group of 
proteins plays an important role in signal transduction by forming a network of extracellular 
serine proteinase. Components of this network have a Ser residue in their active site. 
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Among them, M. sexta PAP-1, PAP-2 and PAP-3 belong to a subfamily of arthropod 
serine proteinases that contain at least one amino-terminal clip domain and a carboxyl-terminal 
proteinase domain. The clip domain was first identified in proclotting enzyme from the horseshoe 
crab (Tachypleus tridentatus) (Jiang et al., 2000). Typical clip-domain proteinases consist of an 
amino-terminal regulatory clip domain, a catalytic serine proteinase domain and a linker 
connecting the two domains. Clip domains are 37-55 amino acid residue sequences which are 
tethered together by three pairs of disulfide bonds to form a compact “paper clip-like” structure. 
The function of a clip domain is largely unclear, but it might play an important role in protein-
protein interactions, since most of the clip-domain serine proteinases are involved in signal-
amplifying cascade reactions (Jang et al., 2008). The clip-domain serine proteinases are 
synthesized as zymogens and need to be activated by a specific proteolytic cleavage between the 
clip domain and the catalytic domain. After cleavage, a pair of cysteine residues still links the two 
domains such that when the proteinase is activated, the catalytic heavy chain remains covalently 
attached by the disulfide bond to the light chain which includes the clip domain (Fig.1). The clip-
domain serine proteinases have been found in different insect species and participate extensively 
in the immune reactions. In addition to clip-domain serine proteinases, other serine proteinases 
have also been identified as member of the cascade.  
Sequential activation of extracellular serine proteinase cascades regulates important 
innate immune reactions, hemolymph clotting, melanization, and AMP synthesis as mentioned 
above. These proteolytic cascades have a functional core consisting of several serine proteinases 
that undergo zymogen activation, upon cleavage by an upstream proteinase. Biochemical studies 
performed in T. molitor and M. sexta, and genetic analysis in D. melanogaster, reveal striking 
similarities in the mechanisms underlying serine proteinase activation by microbial invaders (Fig. 
2). All involve the sequential activation of an apical modular serine proteinase (that displays a 
certain level of autoactivation) and clip-domain proteinases (Buchon et al., 2009). 
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In M. sexta, HP14 is converted to the active form in the presence of β-1,3-glucan and 
βGRP1 or βGRP2 (Wang et al., 2006). Binding of β-1,3-glucan and recognition proteins triggers 
the autoactivation of proHP14 into HP14, which then processes proHP21 (Wang et al., 2007). In 
turn, HP21 cleaves proPAP-2 (or proPAP3) into PAP2 (or PAP3) that finally activates proPO in 
the presence of SPHs (Gorman et al., 2007). In T. molitor, binding of PG to the PGRP-
SA/GNBP1 complex induces autoactivation of a Tm-modular serine proteinase zymogen (Tm-
MSP) (Fig. 2). Tm-MSP in turn generates another serine proteinase Tm-SAE (SPE activating 
enzyme). Active Tm-SAE cleaves precursor of Tm-SPE (spätzle-processing enzyme), which 
results in the activation of spätzle and proPO (Kan et al., 2008). 
The Drosophila Toll pathway establishes the dorsoventral axis during embyronic 
development (Fig. 2). A large mosaic protein named Nudel autoactivates and activates the 
zymogen form of Gastrulation defective (Gd), the upstream activating proteinase of Snake. The 
active Snake, a clip-domain serine proteinase cleaves to activate a downstream clip-domain 
protein, Easter. Easter is a serine proteinase which processes spätzle to become a functional Toll 
ligand that ventralizes the embryo (Lemaitre et al., 2007). A similar proteinase cascade occurs in 
Drosophila as in T. molitor such that, upon microbe challenge, binding of PG to the PGRP-
SA/GNBP1 complex induces activation of a modular serine proteinase zymogen. Dm-MSP in 
turn activates another serine proteinase Grass to cleave Dm-SPE. Dm-SPE generates active 
spätzle and turns on the Toll-AMP intracellular pathway. 
 
 
Figure 1. Domain organization of clip-domain proteinases. The proteinases contain at least 
one amino-terminal clip domain followed by a linker region of variable length and a carboxyl-
terminal serine proteinase domain. A disulfide bond connects the linker region to the proteinase 
domain. When the proteinase zymogen is activated by a specific proteolysis, the clip domain and 




Figure 2. Extracellular cascades of serine proteinases in insects. Biochemical studies 





similarities in the mechanisms underlying serine proteinase activation by pattern recognition 
proteins (Buchon et al., 2009). 
 
Regulation of serine proteinases by serpins 
Serpins are 50 kDa serine proteinase inhibitors present in nearly all species. They are 
suicidal inhibitors that form covalent acyl complex with their target proteinases. Serpins were 
first identified in humans and the most intensively-studied ones are human plasma proteins 
named antitrypsin and antithrombin. Serpins regulate a variety of physiological processes and 
defense mechanisms, such as blood coagulation, inflammation and complement activation. In 
humans, several serpin mutations are linked to diseases, for example emphysema and blood-
coagulation disorders (Reichhart 2005). 
Serpins, about 350-400 amino acids long, contain a single domain. Some serpins have an 
N-terminal or C-terminal extension, such as Drosophila serpin, Necrotic and M. sexta serpin-3. 
The serpin tertiary structure consists of three beta-sheets (A, B and C), and 7-9 alpha-helices. 
There is an exposed C-terminal reactive center loop (RCL) which acts as bait for the target 
proteinase (Gettins, 2002). The P1 residue located in the RCL determines primary specificity of 
inhibition. When a serpin binds to its target proteinase, the proteinase cleaves a scissile bond 
between residues P1 and P1’ within the RCL and is trapped into the backbone carbonyl of the P1 
residue via a covalent ester linkage with the active site Ser. The RCL then inserts into beta-sheet 
A in the serpin core structure and displaces the proteinase (Ye et al., 2001). The proteinase is 
dragged to the other side of the serpin with its active site distorted, while the RCL is completely 
inserted into beta-sheet A. Serpins are identified as inhibitory based on several specific residues 
in the hinge and RCL regions. Counting down toward P1 site, there is a consensus inhibitory 
pattern: P17 (E), P16 (E/K/R), P15 (G), P14 (T/S), P12-P9 (A/G/S), which is required for 
efficient insertion of the RCL into beta-sheet A in the serpin core structure (Reichhart 2005). 
Non-inhibitory serpins have divergent and shorter sequences in this region. 
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Insect hemolymph contains a high concentration of serpins. They may regulate 
endogenous proteinases generated during immune responses (Kanost, 1999). The proPO 
activation pathway, an effective way for wound healing and microbe killing, produces quinones 
that polymerize to form melanin. But quionones are toxic to hosts (Zhao et al., 2007) and should 
be highly regulated as a local, transient reaction against invaders. Several serpins have been 
identified in M. sexta. M. sexta serpin-1 is a mixture of 12 proteins resulting from mutually 
exclusive alternative splicing. These proteins differ in inhibitory selectivity because each of them 
contains a different reactive center loop (Jiang et al., 1996). Two of the 12 serpin-1 isoforms have 
been found to form complex with M. sexta serine proteinases. Serpin-1J can inhibit activation of 
proPO and form SDS-stable complex with PAP-3 in vitro (Jiang et al., 2003). Serpin-1I 
contributes to inhibition of HP14 (Wang et al., 2006). M. sexta serpin-2 is expressed in 
hemocytes and is located in the cytoplasma. The target proteinase of serpin-2 is unknown. M. 
sexta serpin-3 has been demonstrated to block proPO activation by inhibition of PAP-3 (Zhu et 
al., 2003). M. sexta serpin-6 also strongly inhibits PAP-3. There are other serpins which inhibit 
upstream proteases of the cascade (Zou et al., 2005). M. sexta sepin-4 is found to inhibit HP1, 
HP6 and HP21, and M. sexta serpin-5 is an inhibitor of HP1, HP6 and two other unknown 
proteinases (Tong et al., 2005). 
In the Drosophila genome, there are 29 serpin genes (Irving et al., 2000). Analysis shows 
that 17 out of 29 have hinge and RCL regions that correspond to active, inhibitory serpins, and 19 
out of 29 have a signal peptide. Among the 17 active inhibitors, 12 are secreted and five 
intracellular. Seven and five of the non-inhibitory serpins are extra- and intracellular respectively. 
Only a few Drosophila serpins have been studied in detail. Drosophila serpin43Ac (Necrotic) is 
reported to be responsible for the control of serine proteinases in the Toll pathway (Levashina et 
al., 2003). It negatively regulates one or more serine proteinases that participate in spätzle 
activation after infection. The serpin43Ac is located in a cluster of four serpin genes in 
chromosome 43A. Deletion of the three other transcripts, serpin43Aa, serpin43Ab and 
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serpin43Ad has no effect on the Toll pathway. The activation of the melanization process is 
regulated by Drosophila serpin27A, orthologous to M. sexta serpin-3. Loss-of function mutations 
in serpin27A lead to a high rate of spontaneous melanization and constitutively increased PO 
activity in the blood (Ligoxygakis et al., 2002). In addition to its function in immunity, serpin27A 
also plays a role during early embryogenesis. It directs dorso-ventral axis formation in early 
development by restricting the activation of a proteolytic cascade to the ventral part of the 
embryo. Similar to M. sexta serpin-1 and Drosophila serpin42Da encodes at least 10 isoforms 
that differ at both the N-terminus and C-terminus (Kruger et al., 2002). One isoform, 
serpin42DaA forms an SDS-stable complex with human furin and with its Drosophila homolog, 
subtilisin-like PC2. The existence of non-inhibitory serpins strengthens the possibility of 
divergent functions. Drosophila serpin76A, one of the non-inhibitory serpins, may function in 













Table 1. List of abbreviations 
AS ammonium sulfate NF-κB nuclear factor-κB 
AMP antimicrobial peptide PG peptidoglycans 
CPC cetylpyridinium chloride PGRP peptidoglycan recognition 
protein 
CH control hemolymph PO phenoloxidase 
clip-SP clip domain serine proteinase proPO prophenoloxidase 
DAP-PG diaminopimelic acid-type 
peptidoglycan 
PAP PO-activating proteinase 
DS dextran sulfate POI phenoloxidase inhibitor 
DIF dorsal-related immunity factor PPAF proPO-activating factor 
βGRP β-1,3-glucan recognition protein RCL reactive center loop 
GNBP Gram-negative bacteria-binding 
protein 
rpS3 ribosomal protein S3 
HP hemolymph proteinase SP serine proteinase 
Imd immune deficiency SPH serine proteinase homolog 
IML immunelectins SERPIN serine proteinase inhibitor 
IH induced hemolymph SPE   spätzle-processing enzyme 
IL-1R interleukin-1 receptor SAE SPE activating enzyme 
LPS lipopolysaccharide TNF-R tumor-necrosis factor-receptor 
LTA lipoteichoic acid TLR Toll-like receptor 







EXPRESSION, CHARACTERIZATION AND FUNCTIONAL STUDY OF MANDUCA SEXTA 
SERPIN-8 
Introduction 
Phenoloxidase (PO) is important in defense against pathogens and parasites in insects. PO 
catalyzes the hydroxylation of a monophenol to an o-diphenol, and the oxidation of o-diphenol to 
o-quinone. The toxic quinone intermediates and o-quinones polymerize to form melanin at the 
injury spot or around invading microorganisms (Hultmark 1993). The melanization process 
involves prophenoloxidase (proPO) activation, in which the inactive form of proPO is converted 
to the active enzyme PO (Kim et al., 2005). ProPO activation in insects is mediated by a serine 
proteinase cascade, similar to the blood clotting system and complement system in vertebrates 
(Ashida et al., 1997). In the presence of pathogens, components of this cascade become activated 
sequentially via limited proteolytic cleavage. 
Due to the toxic nature of products of the melanization process (Zhao et al., 2007), plasma 
serpins regulate the proPO activation pathway. Serpins are serine proteinase inhibitors about 50 
kDa with an exposed reactive center loop (RCL) near their carboxyl terminus. The P1 residue 
located in RCL determines the primary specificity of inhibition (Gettins, 2002). Several serpins 
from M. sexta have been characterized previously. M. sexta serpin-1 is a mixture of 12 proteins 
resulting from mutually exclusive alternative splicing (Jiang et al., 1996). Nine out of 12 isoforms 
of M. sexta serpin-1 have been separated
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and identified in plasma using two-dimensional PAGE and MALDI-TOF/TOF analysis (Ragan et 
al., 2010). M. sexta serpin-3 was recently found to inhibit HP8 (Christen et al., 2012) besides 
PAP-3 (Zhu et al., 2003). A. gambia serpin-6 (AgSRPN6) controls melanization by forming a 
complex with M. sexta PAP-1, PAP-3 and HP6 (An et al., 2012). 
Necrotic (Nec or Spn43Ac) is a Drosophila serpin that regulates the extracellular 
activation of the Drosophila Toll-mediated antifungal response (Levashina et al., 1999). Nec has 
a predicted P1-P1’ Leu-Ser active site, suggesting that it has an antichymotrypsin inhibitory 
specificity (Robertson et al., 2006). Nec has an 88-100 residue N-terminal extension which is 
unusual among serpins. The extension contains regions rich in glutamines and prolines, including 
a 24-residue polyglutamine repeat (Robertson et al., 2003). A few other inhibitory serpins contain 
an N-terminal extension. The extension in antithrombin is involved in forming a heparin binding 
site, whereas the extension in heparin provides an additional proteinase binding site (Robertson et 
al., 2003). The N-terminus of Nec has little sequence homology with either of these proteins, 
which makes it difficult to investigate its function. However, it is established that the N-terminus 
is not required for inhibitory activity (Pelte et al., 2006). Persephone, a thrombin-like serine 
proteinase in Drosophila, may be inhibited by Nec in vivo (Ligoxygakis et al., 2002). 
M. sexta serpin-8 is a newly discovered serpin with an N-terminal extension. More than 
20 hemolymph proteinases are known in M. sexta (Jiang et al., 2005) and some of these are likely 
endogenous proteinase targets of serpin-8. The purpose of this study is to define the inhibitory 
selectivity of serpin-8, examine its regulatory role in the proPO activation pathway, and identify 
its target proteinase(s). To achieve this, we have expressed and purified the recombinant protein. 
Using this material we have been able to show serpin-8 acts as an inhibitor of some commercial 
proteinases and two proteinases in the M. sexta proPO activation system. 
 




M. sexta eggs were originally purchased from Carolina Biological Supply, and the larvae 
were reared as described by Dunn and Drake (Dunn et al., 1983). 
 
Collection of hemolymph, hemocytes, and fat body from M. sexta larvae 
Control hemolymph was collected from cut prolegs of day 2, 5th instar larvae. Day 2, 5th 
instar larvae were injected with a mixture of formaldehyde-killed E. coli (1×108 cells/larvae) and 
100 μg of Micrococcus luteus (Sigma) suspended in 100 μl of saline (0.9% w/v of NaCl). 
Hemolymph from three larvae was combined as one biological sample. Hemolymph was 
collected into microcentrifuge tubes at 0, 6, 12, and 24 h. A few crystals of 
diethyldithiocarbamate and phenylthiourea were added to the tubes before collection to prevent 
melanization of hemolymph. Hemocytes were collected and removed from hemolymph by 
centrifugation at 5,000×g for 15 min at 4°C. Hemolymph from the naïve and injected larvae were 
aliquoted and stored at -80°C. 
 
RNA extraction and reverse transcription-PCR analysis 
Total RNA samples were isolated from fat body and hemocytes of naïve and induced M. 
sexta larvae and different tissues (cuticle, midgut, salivary gland, muscle, nerve, trachea, 
Malpighian tubules) using the Micro-to Midi total RNA purification system (Invitrogen). Tissues 
from three larvae were combined to form one biological sample, except for salivary gland and 
nerve, which were from six larvae. 2-4 μg RNA sample, 10 pmol oligo(dT), and dNTPs (1 μl, 10 
mM each) were mixed with diethylpyrocarbonate-treated H2O in a final volume of 12 μl, 
denatured at 65°C for 5 min, and quickly chilled on ice for 3 min. Moloney murine leukemia 
virus reverse transcriptase (1 μl, 200 U/μl, Invitrogen), 5×buffer (4 μl), 0.1 M dithiothreitol (2 μl), 
and RNase OUT (1 μl, 40U/μl, Invitrogen) were added to the denatured RNA sample (12 μl) for 
first strand cDNA synthesis at 37°C for 50 min. M. sexta ribosomal protein S3 (rpS3) mRNA was 
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used as an internal control to normalize the cDNA samples using specific primers j037 (5’-CAT 
GAT CCA CTC CGG TGA CC-3’) and j038 (5’-CGG GAG CAT GAT TTT GAC CTT AA-3’). 
Primers j117 (5’-CGA GCA ATC TGG GAA TCT CGC T-3’) and j119 (5’-TGG AAG CAA 
TCC AGC TGT TGA-3’) were used to amplify M. sexta serpin-8 cDNA, and primers j640 (5’-
CAA TTG GTG GAA CTC CAA CAT-3’) and j641 (5’-CTC GAG GTC ATA AAT GGA CTG-
3’) were used to amplify M. sexta HP19 cDNA under thermal cycling conditions empirically 
chosen to avoid saturation: 27 cycles of 94°C, 30s, 55°C, 30s, 72°C, 45s. After separation by 1% 
agarose gel electrophoresis, intensities of the PCR products were quantified and compared using 
Kodak Digital Science 1D Gel Analysis Software. 
 
Expression and purification of M. sexta serpin-8 core region (serpin-8-ΔN) and HP19 
catalytic domain (catHP19) from insect cells 
The entire coding region for serpin-8-ΔN was amplified by PCR using forward primer 
j137 (5’-CCA TGG GAA TTC ATT CGG GGC CTG CAT C-3’, EcoRI site underlined) and 
reverse primer j143 (5’-TCA AGC ATG CTC GAG TGT AGG ATC CAT TAT TCT TGC-3’, 
XhoI site underlined). The amplified fragment was purified with Wizard PCR Preps DNA 
Purification System (Promega) and ligated into pGEM-T vector (Promega) to verify sequence. 
From the correct plasmid, the EcoRI-XhoI fragment was retrieved by restriction digestion and 
directionally inserted to the same sites of pMFH
6
 (Lu et al., 2008) a plasmid vector modified from 
pFastBac1, to generate recombinant baculovirus according to the manufacture’s instruction.  
We have a project to express the catalytic domains of hemolymph proteinases in M. sexta 
(see appendices) and HP19 is one of those hemolymph proteinases. HP19 catalytic domain 
(catHP19) was amplified using forward primer j640 (5’-CAA TTG GTG GAA CTC CAA CAT-
3’, MfeI site underlined) and reverse primer j641 (5’-CTC GAG GTC ATA AAT GGA CTG-3’, 







transformed into E. coli strain DH10Bac, which contains a bacmid and a helper plasmid. The 





plasmid was isolated. The insertion of serpin-8-ΔN or catHP19 frangment in the recombinant 
bacmid was confirmed by PCR using a serpin-8-ΔN or catHP19 gene-specific forward primer and 
a reverse primer located downstream of the transposition site on the bacmid. 
For serpin-8 expression, the initial viral stock (V
0
) was obtained by transfected 
Spodoptera frugiperda Sf9 cells with a bacmid-cellFECTIN mixture, and its titer was improved 
through serial infections. Sf9 cells (at 2.0×10
6
cells/ml) in 100 ml of Sf-900 II serum-free medium 
(Invitrogen) were infected with the baculovirus stocks at a multiplicity of infection of 10 and 
grown at 27°C for 96 h with gentle agitation (100 rpm). The expression of catHP19 was the same. 
Serpin-8-ΔN purification was carried out using 500 ml of the cell culture medium. The 
cells were removed by centrifugation at 5,000×g for 15 min. The supernatant was mixed with an 
equal volume of distilled water (500 ml) with 1mM benzamidine at 4°C for 30 min. After 
centrifugation at 12,000×g for 30 min, the cleared supernatant (1000 ml) was applied to a dextran 
sulfate (DS)-Sepharose column (40 ml) (Nakamura et al., 1985) equilibrated with buffer A (10 
mM potassium phosphate, pH 6.4, 1 mM benzamidine) and washed with 200 ml of buffer A, 
bound proteins were eluted with a linear gradient of 0-1.0 M NaCl in buffer A (100 ml).  
The fractions (4 ml/tube) were collected and aliquots of the franctions (7 μl) were 
subjected to SDS-PAGE and immunoblot analysis using anti-His5 antibody (BioRad). Fractions 
containing serpin-8-ΔN were pooled and applied onto nickel-nitrilotriacetic-acid-agarose column 
(2 ml), equilibrated with buffer B (50 mM potassium phosphate, pH 8.0, 300 mM NaCl, 10 mM 
imidazole, 0.005% Tween-20) and washed with 10 ml of buffer B and bound proteins were eluted 
from the column with a linear gradient of 10-100 mM imidazole in buffer B (10 ml). Finally, 
tightly bound proteins were eluted with 5 ml of buffer B containing 250 mM imidazole. The 
fractions (1 ml/tube) were collected and aliquots of the franctions (7 μl) were subjected to SDS-
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PAGE and immunoblot analysis using anti-His5 antibody (BioRad). Fractions containing serpin-
8-ΔN were pooled and concentrated using Amicon ultracentrifugal 30K MWCO filter device 
(Millipore). Buffer of the concentrated protein was exchanged with 20 mM Tris-HCl, pH 7.5, 50 
mM NaCl using the same filter and stored at -80°C in aliquots. About 600μg of serpin-8-ΔN was 
used as antigen for preparing a rabbit polyclonal antiserum. CatHP19 was purified from the 
conditioned medium (1 liter) by the same protocol. 
 
Inhibitory activity assay and complex formation assay 
Recombinant serpin-8-ΔN (200 ng/μl, 1 μl) was incubated with various commercial 
proteinases (100 ng/μl, 1 μl) in the buffer (8 μl, 20mM Tris-HCl, pH 8.0) at room temperature for 
10 min. For the control, serpin-8-ΔN was replaced by the buffer. Then 150 μl of a suitable 
substrate was added, and the residual proteinase activity was measured by monitoring A405 in the 
kinetic mode on a plate-reader (Molecular Device). One unit activity is defined as 
ΔA405/min=0.001. The proteinases and their substrates were diluted immediately before use in 
buffer (20 mM Tris-HCl, pH 8.0, 50 mM NaCl). The proteinases and their artificial substrates 
used in the assay were bovine pancreatic trypsin (Sigma) and N-acetyl-Ile-Glu-Ala-Arg-p-
nitroanilide (IEARpNa, 50 μM, Sigma); bovine α－chymotrypsin (Sigma) and N-succinyl-Ala-
Ala-Pro-Phe-p-nitroanilide (100 μM Sigma); human neutrophil Cathepsin G (Sigma) and N-
succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (AAPFpNa, 100 μM, Sigma); porcine pancreatic 
elastase (Sigma) and N-succinyl-Ala-Ala-Pro-Leu-p-nitroanilide (AAPLpNa, 100 μM, Sigma); 
proteinase K (Sigma) and N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (AAPFpNa, 100 μM, 
Sigma). For complex formation assay, the reactions were stopped by adding SDS-PAGE loading 
buffer and boiling for 5 min. The samples were separated by 10% SDS-PAGE and visualized by 




Serpin-proteinase association rate constant (ka) 
Various concentrations of purified serpin-8-ΔN (1 μl) was mixed with bovine α－
chymotrypsin (2 μM, 1 μl), porcine pancreatic elastase (6 μM, 1 μl) and human neutrophil 
Cathepsin G (50 μM, 1 μl) in the buffer (8 μl, 20 mM Tris-HCl, pH 7.5) at a serpin/proteinase 
molar ratio of 20, incubated at room temperature for 15, 30, 45, 60, 75, 90 and 120 sec, and then 
the residual amidase activities of proteinases were measured using substrates, N-succinyl-Ala-
Ala-Pro-Phe-p-nitroanilide (AAPFpNa, 100 μM, 150 μl, Sigma) and N-succinyl-Ala-Ala-Pro-
Leu-p-nitroanilide (AAPLpNa, 100 μM, 150 μl, Sigma). With excessive serpin, the reactions are 
pseudo-first order. From the linear regression curve of ln(residue amidase activity) vs. incubation 
time (t), the half-life time (t0.5) for inhibition was calculated. Association rate constants (ka) were 
calculated using equation ka=0.693/(t0.5*I0), I0 is the initial concentration of the serpin) (Beatty et 
al., 1979). 
 
Assay of catHP19 residual amidase activity 
Purified recombinant catHP19 (150 ng/μl, 2 μl,) was incubated with 6 mM 
cetylpyridinium chloride (CPC, 1 μl) in the buffer (7 μl, 20 mM Tris-HCl, pH 7.5, 50 mM NaCl) 
at room temperature for 5 min. The residual amidase activity was then measured using an 
artificial substrate, N-succinyl-Ala-Ala-Pro-Leu-p-nitroanilide (AAPLpNa, 100 μM, 150μl, 
Sigma) by monitoring A405 in kinetic mode on a plate-reader (Molecular Device). One unit 
activity is defined as ΔA405/min=0.001. An average activity data were plotted as mean ± S.D. (n = 
3) in the bar graph. CPC or catHP19 alone was used as controls. 
 
ProPO activation and inhibition 
One μl of hemolymph was incubated for 30 min at room temperature with M. luteus (1 
μg/μl in saline, 1 μl) in the buffer (8 μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-
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20). PO activity was measured by adding 150μl of 2 mM dopamine (in 100 mM sodium 
phosphate buffer, pH 7.5) as a substrate and monitoring A470 for 10 min on a microplate reader 
(Jiang et al., 2003a). Hemolymph samples which have low basal PO activity were selected for the 
assay. 
To dertermine the role of catHP19 in proPO activation, naïve hemolymph (1 μl), M. luteus 
(1 μg/μl, 1 μl), and catHP19 (100 ng/μl, 1 μl) were incubated in the buffer (7 μl, 20 mM Tris-HCl 
pH 8.0, 1 mM CaCl2, 0.001% Tween-20) at room temperature for 30 min. PO activity  was 
measured using dopamine as described above. Activity data were plotted as mean ± S.D. (n = 3) 
in the bar graph. Control reactions were plasma only and M. luteus with plasma. 
For inhibition assay, 1 μl of induced hemolymph was incubated for 5 min at room 
temperature with purified recombinant serpin-8-ΔN (1 μl) at varying concentrations in the buffer 
(7 μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-20). Then 1 μl of M. luteus (1 μg/μl) 
was added and incubated for another 10 min at room temperature before the PO activity (mean ± 
S.D., n = 3) assay as described above. 
 
Determination of the cleavage site in M. sexta serpin-8 
To determine the position of the scissile bond in the serpin-8, purified serpin-8-ΔN (150 
ng/μl, 2 μl) was incubated with catHP19 (100 ng/μl, 2 μl) in the buffer (26 μl, 20 mM Tris-HCl, 
pH 7.5, 50 mM NaCl) at room temperature for 30 min. Half of the reaction mixture (15 μl) was 
subjected to 10% SDS-PAGE for detection of the serpin-proteinase complex, and half of the 
mixture was subjected to MALDI-TOF mass spectrometry (Jiang et al., 2003). The molecular 
mass of a newly appeared peak that was absent in the control spectra of serpin-8-ΔN and catHP19 
alone was compared with calculated values of the carboxyl-terminal peptides to deduce the 





Cell-free hemolymph samples were collected as described above, and these plasma 
samples (10 μl) were mixed with 100% saturated ammonium sulfate (8.2 μl, pH 7.0) on a 
vortexer. The ammonium sulfate (A.S.) was adjusted to 45% saturation, and centrifuged to 
separate precipitate from the supernatant which contains storage protein. The pellet was saved 
and re-dissolved into the buffer (10 μl, 20 mM Tris-HCl, pH 7.5). Different microbial surface 
components (1 μl) were incubated with the 45% ammonium sulfate fraction of hemolymph at 
room temperature for 15 min. Half of the reaction mixtures were separated by 10% SDS-PAGE 
and immunoblot analysis was performed using serpin-8 antibody as the primary antibody (diluted 
1: 2000), and goat anti-rabbit IgG-alkaline phosphatase conjugate (BioRad, diluted 1: 1000) as 
the secondary antibody. 
Purified serpin-8-ΔN (150 ng/μl, 1 μl) was incubated with Anopheles gambiae HP14 
catalytic domain (AgHP14cat) (100 ng/μl, 2 μl) in the buffer (7 μl, 20 mM Tris-HCl, pH 7.5, 50 
mM NaCl) at room temperature for 30 min. AgHP14cat was purified by Wang Yang in the 
laboratory. The reaction mixture (10 μl) was subjected to 10% SDS-PAGE and immunoblot 
analysis for detection of the serpin-proteinase complex using His5 antibody (BioRad) as the 
primary antibody (diluted 1: 2000), and goat anti-mouse IgG-alkaline phosphatase conjugate 
(BioRad, diluted 1: 1000) as the secondary antibody. 
 
Results 
cDNA sequence of M. sexta serpin-8 
The serpin-8 cDNA, isolated by my labmate Subrahmanyam Rayaprolu, contains 2673 
nucleotides, with a 121-bp 5’-noncoding region, a 1458-bp open reading frame, and a 1094-bp 3’-
noncoding region, including a 9-bp poly (A) tail (Fig. 3). The 3’-noncoding region contains five 
putative polyadenylation signals (AATAAA or ATTAAA). The open reading frame encodes a 
protein of 485 amino acid residues, with a predicted 18-residue signal peptide for secretion. The 
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open reading frame of serpin-8 is longer than other M. sexta serpins, because it has a 95 residue 
N-terminal extension. There are two potential N-linked glycosylation sites at Asn275 and Asn451. 
There are seven putative O-linked glycosylation sites at Thr74, Thr78, Thr81, Thr92, Thr93, Ser85 and 
Ser87, all of which are located in the N-terminal extension region. The calculated molecular mass 
of mature serpin-8 is 51,487Da and its calculated isoelectric point is 8.51.  
 
Sequence comparison of M. sexta serpin-8 with other insect serpins 
BLAST search and sequence alignment indicated that M. sexta serpin-8 is most similar in 
amino acid sequence to B. mori serpin-12 (NP_001036857), with 55% identity and 77% 
similarity. They have a similar reactive center loop sequence, as 6 out 10 residues are the same 
from P5 to P5’ region (Fig. 4). Among the nine serpins, M. sexta serpin-8, B. mori serpin-12 and 
Drosophila Nec have two distinctive features. First, they have a Leu residue at the predicted P1 
site, indicating that they are inhibitors of elastase- and chymotrypsin-like proteases, and second, 
they have an N-terminal extension. Necrotic was reported to negatively regulate the extracellular 
activation of the Drosophila Toll-mediated antifungal signaling pathway (Levashina et al., 1999; 
Ligoxygakis et al., 2002; Robertson et al., 2002).  B. mori serpin-12 has not been characterized 
further than genome sequencing. 
 
Expression and purification of M. sexta serpin-8-ΔN 
To explore the biochemical function of M. sexta serpin-8, we expressed the serpin-8 core 
region (serpin-8-ΔN) using the baculovirus system, because it is reported that both full-length and 
the core serpin (serpin-ΔN) are active inhibitors (Pelte et al., 2006). The fragment of the serpin-8-
ΔN was inserted into the EcoRI-XhoI restriction site of the expression vector, pMFH6 which has a 
honeybee mellitin signal peptide and C-terminal (His)6-affinity tag (Lu et al., 2008). The 
recombinant serpin-8-ΔN was soluble and secreted into the cell culture medium. After removing 
cells from the culture, the protein was first enriched by ion exchange chromatography and eluted 
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from the dextran sulfate (DS) column with a linear gradient of NaCl. The fractions containing 
serpin-8-ΔN were pooled and loaded onto the nickel-affinity column. The protein was eluted with 
a linear gradient of imidazole. Serpin-8-ΔN migrated as a 41 kDa single band on 10% SDS-
PAGE under reducing condition (Fig. 5). The molecular mass of serpin domain (serpin-ΔN) in 
which N-terminal extension is not included is 40,919Da and its calculated isoelectric point is 
8.55.  
 
M. sexta serpin-8 mRNA and protein levels after bacterial challenge 
In order to examine the transcriptional regulation of serpin-8 gene in response to bacterial 
challenge, the serpin-8 mRNA level was analyzed by RT-PCR. Serpin-8 mRNA was 
constitutively expressed at a low level in hemocytes and increased dramatically 24 h after bacteria 
challenge. The amount of mRNA in fat body slightly increased after immune challenge (Fig. 6A). 
The induction pattern of serpin-8 protein in hemolymph was also examined by 
immunoblot analysis using serpin-8 antibody. A low level of serpin-8 was present in naïve 
hemolymph. After injecting the larvae with killed E.coli, a small decrease of the 50 kDa band 
protein was detected at 12 h. Serpin-8 protein level increased continuously and significantly 
around 24 h after the immune challenge and remained high up to 32 h (Fig. 6B). The increase in 
serpin-8 concentration at 6 h and decrease at 12 h may reflect the individual variations. 
 
M. sexta serpin-8 mRNA levels in different tissues and developmental stages 
The mRNA level of serpin-8 was examined in the following tissues: cuticle, midgut, 
salivary gland, muscle, nerve, trachea, Malpighian tubules by RT-PCR (Fig. 7A). Serpin-8 gene 
was not expressed in midgut. A low level of serpin-8 mRNA was detected in salivary gland and 
muscle. Serpin-8 transcript levels were moderate in cuticle and Malpighian tubules and much 
higher in nerve and trachea.  
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We examined the levels of sepin-8 mRNA in fat body of different developmental stages 
(Fig. 7B). A slight decrease in serpin-8 mRNA level occurred in day 4 and day 5 of 4th instar 
larval stage. The mRNA slightly increased in 5th instar larval stage, compared to 4th instar larval 
stage. There was no substantial change in mRNA level during 5th instar larval stage and 
wandering stage. The serpin-8 mRNA level dramatically decreased during pupal and adult stage. 
 
Inhibitory activity of M. sexta serpin-8-ΔN 
In order to determine the inhibitory specificity of serpin-8, recombinant serpin-8-ΔN was 
used to test its inhibition of commercial proteinases (Fig. 8A). Among these proteinases, serpin-8-
ΔN showed strong inhibitory activity against chymotrypsin, cathepsin G and elastase, but no 
inhibitory activity against trypsin or proteinase K. Serpin-8-ΔN inhibited chymotrypsin by 70%, 
cathepsin G by 94%, and elastase by 85% at the molar ratio (proteinase:serpin-8 = 1:1.3), 
indicating that serpin-8-ΔN is a potent inhibitor of cathepsin G and elastase and less effective in 
inhibiting chymotrypsin.  
In the inhibition reaction between a serpin and a susceptible proteinase, an SDS-stable 
inhibitor-enzyme complex formed. Such complexes were detected when we incubated serpin-8-
ΔN with chymotrypsin, cathepsin G and elastase (Fig. 8B). The combined apparent molecular 
mass of serpin-8-ΔN (41 kDa) and the proteinases (~30 kDa) is close to the size of the complex 
(~70kDa). 
To further characterize the serpin-proteinase reaction, the association rate constants (ka) 
were determined. The inhibition reactions between serpin-8-ΔN and elastase, and between serpin-
8-ΔN and cathepsin G had the similar ka, which were two times higher than between serpin-8-ΔN 
and chymotyrpsin (Table 1). 
 
Inhibition of M. sexta prophenoloxidase activation by serpin-8-ΔN 
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To investigate the physiological function of serpin-8, we tested its effect on proPO 
activation. Different amounts of recombinant serpin-8-ΔN were incubated with plasma for 5 min 
before adding M. luteus into the reaction. The reaction mixture was then incubated for another 10 
min at room temperature before measurement of PO activity. Serpin-8-ΔN at 200ng/μl inhibited 
proPO activation by 50% (Fig. 9). Since PAPs are not supposed to be inhibited by serpin-8 due to 
inappropriate substrate specificity, serpin-8 must inhibit at least one proteinase upstream of PAPs 
in the proPO activation cascade. 
 
cDNA sequence and structural features of M. sexta HP19 
The HP19 cDNA (Jiang et al., 2005) contains 2480 nucleotides, with an 83-bp 5’-
noncoding region, a 1647-bp open reading frame, and a 750-bp 3’-noncoding region, including a 
26-bp poly (A) tail (Fig. 10). The 3’-noncoding region contains four putative polyadenylation 
signals (AATAAA or ATTAAA). The open reading frame encodes a protein of 548 amino acid 
residues, with a predicted 19-residue signal peptide. There are two potential N-linked 
glycosylation sites at Asn368 and Asn403. The calculated molecular mass of mature HP19 is 
58,938Da and its calculated isoelectric point is 7.66. HP19 has a C-terminal catalytic domain and 
an N-terminal region with unknown function. The molecular mass of HP19 catalytic domain is 
28,499Da and its calculated isoelectric point is 6.64.  
The predicted proteolytic cleavage site is located between Leu276 and Val277 (Jiang et al., 
2005). Therefore, the activating enzyme for proHP19 may be a serine proteinase with 
chymotrypsin-like specificity. The catalytic domain is similar in sequence to serine proteinases 
with elastase specificity, including the catalytic triad of His321, Asp375, and Ser474. The primary 
substrate-specificity pocket (Perona et al., 1995) is likely composed of Ser468, Ser495, and Val510, 
suggesting that HP19 has a specificity for cleavage after the C-terminus of Ala, Val, or Leu. 
BLAST search and sequence alignment indicated that M. sexta HP19 is most similar in amino 
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acid sequence to T. castaneum HP19 (XP_970870.2), with 38% identity and 54% similarity. T. 
castaneum HP19 has not been characterized. 
 
Expression and purification of M. sexta HP19 catalytic domain (catHP19) 
The fragment of the HP19 catalytic domain was amplified using PCR from HP19 cDNA 
(Jiang et al., 2005) and cloned into the expression vector, pMFH6 which has a honeybee mellitin 
signal peptide and C-terminal (His)6-affinity tag (Lu et al., 2008), using MfeI and XhoI restriction 
sites. The N-terminal residues “Val-Val-Asp-Gly” of HP19 catalytic domain was replaced by 
“Gly-Ile-Gly-Gly” in order to fit into the expression vector and have the least changes in amino 
acid residues. The recombinant catHP19 was soluble and secreted into the cell culture medium. 
The cell culture medium was clarified by centrifugation, and the supernatant was applied to ion 
exchange column and eluted from the column with a linear gradient of NaCl. The elution 
fractions containing catHP19 were combined and loaded onto the nickel-affinity column. The 
bound protein was eluted with imidazole. The catHP19 migrated as a 30kDa single band on 10% 
SDS-PAGE under reducing condition (Fig. 11).  
 
M. sexta HP19 mRNA and protein levels after bacterial challenge 
In order to investigate the transcriptional regulation of HP19 gene in response to bacterial 
challenge, the HP19 mRNA level was analyzed by RT-PCR (Fig. 12A). HP19 mRNA was 
constitutively expressed at a moderate level in fat body with no significant increase 24 h after 
bacterial challenge. The HP19 mRNA level was a little higher in hemocytes than in fat body, and 
the amount of mRNA slightly increased after immune challenge. 
The induction pattern of HP19 protein in hemolymph was also examined by immunoblot 
analysis using HP19 antibody (Fig. 12B). A low level of HP19 was present in naïve larval 
hemolymph. After injecting the larvae with killed E.coli, the protein level remained at low until 
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24 h of after bacterial injection. The amount of HP19 protein level increased dramatically around 
24 h after immune challenge and remained high up to 32 h.  
 
M. sexta catHP19 amidase activity 
To investigate whether the recombinant catHP19 had amidase activity, it was incubated 
with an artificial substrate, AAPLpNa and A405 was monitored in the kinetic mode. CatHP19 had 
low AAPLase activity (~0.2U) and correlation coefficient of 0.689. Since catHP19 has an 
elastase-like specificity which may cleave after the C-terminus of Phe, Val, or Leu, AAPVpNa 
and AAPFpNa were also used as substrates to observe amidase activity of catHP19. We did not 
detect catHP19’s activity (results not shown). It is reported that insect proPO can be activated by 
detergent besides proteolytic cleavage (Hall et al., 1995). Cetylpyridinium chloride (CPC), a 
cationic detergent, was used to test if it can enhance catHP19 activity. A great increase of 
AAPLase activity was observed (with the value above 0.6 and correlation coefficient of 0.912) 
when catHP19 was incubated with CPC prior to activity measurement (Fig. 13). 
 
Role of catHP19 in M. sexta proPO activation 
To investigate the role of catHP19 in M. sexta proPO activation cascade, control 
hemolymph was incubated with microbial elicitor, M. luteus and recombinant catHP19 (Fig. 14). 
The control hemolymph sample had low basal PO activity and could be activated dramatically by 
M. luteus, which indicated that the proPO activation system was functional in the hemolymph. 
There was a great increase of PO activity when catHP19 was added to the control hemolymph in 
the absence of microbial elicitor. When catHP19, M. luteus, and control hemolymph were 
incubated together, a high PO activity was observed, but this PO activity was not higher than the 
one when hemolymph was incubated with catHP19 only, which implied that there was no 




Inhibition of HP19 by M. sexta serpin-8-ΔN 
A characteristic feature of the inhibition of serine proteinases by serpins is the formation 
of a serpin-proteinase complex that is stable in SDS. Such a complex formed between serpin-8-
ΔN and catHP19 as indicated by immunoblot analysis (Fig. 15), when serpin-8-ΔN and catHP19 
were incubated at room temperature for 30 min. In the controls of HP19 or serpin-8-ΔN only, 
HP19 antibody recognized the proteinase, but not serpin-8-ΔN, and serpin-8 antibody recognized 
the inhibitor, but not the proteinase. A new immunoreactive band was detected by both serpin-8 
and HP19 antibodies at 70 kDa, but was absent in the controls. The apparent molecular size of 
this band is close to that predicted for the complex formed between recombinant serpin-8-ΔN and 
catHP19. However, there was no complex detected when serpin-8-ΔN was incubated with 
catHP19 in the presence of CPC (result not shown), indicating that CPC may affect the activity of 
serpin-8-ΔN. 
To further characterize the inhibition reaction, we determined the cleavage site of serpin-
8-ΔN upon reaction with catHP19 by MALDI mass spectrometry. A major peak of 5,441 Da was 
detected in the serpin-8-ΔN and catHP19 mixture and the intensity of this 5,441 Da peak was 
about 8800, which probably represents the carboxyl-terminal peptide released from proteolytic 
cleavage of serpin-8-ΔN by catHP19 (Fig. 16C). In the control spectrum of catHP19 only, there 
was no major mass peak in the range of 2000-7000 Da (Fig. 16A). In the other spectrum of 
serpin-8-ΔN only, there was no mass peak at 5,441 Da, but a mass peak of 5,442 Da was detected 
with a low intensity of about 3600 (Fig. 14B). Based on the sequence alignment (Fig. 4), the 
predicted scissile bond in serpin-8-ΔN was after Leu447. Mass of the resulting serpin-8-ΔN C-
terminal peptide (S448YDEPSLYFRANKPFLAILWDNRSSIPLFMARIMDPT-LEHHHHHH) is 
5442.1 Da. The one Da difference was within the experimental error and detection of the 5,442 
Da peak in the control spectrum of serpin-8-ΔN only may be due to the cleavage of serpin-8-ΔN 
during purification as shown in Fig. 15. Other small peaks within the mass range of 5000 to 6000 
Da represented the peptides released from non-specific cleavage near Leu447: the 5,355 Da peak 
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for Y449DE…H6 (calculated mass: 5,355.1 Da), the 5,555 Da peak for L447SY…H6 (calculated: 
5,555.3 Da), the 5,725 Da peak for V445AL…H6 (calculated: 5,725.5 Da), and the 5,796 Da peak 
for A444VA…H6 (calculated: 5,796.6 Da), and the 5,867 Da peak for A443AV…H6 (calculated: 
5,867.7 Da). Taken together, the mass analysis indicated that the scissile bond of serpin-8 is 
between Leu447 and Ser448, consistent with the substrate specificity of HP19.  
 
Cleavage of M. sexta serpin-8 N-terminus upon peptidoglycan stimulus from Gram-positive 
bacteria 
A previous study found that Drosophila Nec was cleaved off at the N-terminal end by 
either fungal or Gram-positive bacterial infection (Pelte et al., 2006). Such cleavage was blocked 
by mutations in Persephone which is required in Toll Pathway activation (Ligoxygakis et al., 
2002). It is unclear if Nec is directly cleaved by Persephone or if Persephone activates a 
downstream proteinase that is responsible for the N-terminal cleavage of Nec (Pelte et al., 2006). 
In order to test if the N-terminus of M. sexta serpin-8 can be cleaved by immune challenge, 45% 
ammonium sulfate precipitated fraction of induced hemolymph was incubated with various 
microbial components from Gram-positive and Gram-negative bacteria, and fungi. According to 
protein size, the serpin-8-ΔN in the hemolymph is about 10 kDa smaller than the intact serpin-8, 
similar to the size of the recombinant serpin-8-ΔN. The result suggested that only surface 
components from Gram-positive bacteria induced the N-terminal cleavage of serpin-8 (Fig. 17A). 
There was a clear band corresponding to serpin-8-ΔN in the reaction mixture containing 
hemolymph and insoluble PG from S. aureus (Fig. 17A, lane 7) and a faint band detected when 
hemolymph was incubated with M. luteus (Fig. 17A, lane 2). No cleavage was observed when 
Gram-negative surface component (LPS) or fungal PG (laminarin or zymosan) was added into 
hemolymph. To rule out the possibility of the cross reaction between serpin-8 antibody and 
insoluble PG from S. aureus, the PG was included in Fig. 15B to react with serpin-8 antibody. 
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The result of Fig. 17B indicated that PG did not react with serpin-8 antibody and the cleavage 
occurred when hemolymph was stimulated with PG. 
 
Detection of M. sexta serpin-8-proteinase complex in hemolymph 
While recombinant serpin-8-ΔN formed a complex with HP19 catalytic domain in vitro 
(Fig. 15), is the same complex present in hemolymph also? The 0-45% AS fraction of induced 
hemolymph was incubated with S. aureus insoluble PG. Then the reaction mixtures were 
separated by 10% SDS-PAGE and immunoblot analysis was performed using serpin-8 antibody. 
A new band was detected by serpin-8 antibody around 70 kDa (Fig. 18A). This band was absent 
in the hemolymph alone sample. The apparent molecular size of this band is close to that 
predicted for the complex formed between serpin-8-ΔN and an unknown proteinase. Surprisingly, 
when HP19 antibody was used to react with the same sample, no complex band was detected 
(data not shown). Since the scissile bond of serpin-8 is between Leu447 and Ser448, also consistent 
with the substrate specificity of HP14 (Wang et al., 2006), HP14 antibody was used to test if the 
complex is formed by HP14 catalytic domain and serpin-8. The result showed that a band was 
detected by HP14 antibody around 70 kDa, and a band around 30 kDa which corresponded to 
HP14 catalytic domain, appeared as well (Fig. 18B, lane 2). To test the hypothesis that serpin-8-
ΔN can form complex with HP14 in vitro, we made use of the A. gambiae HP14 catalytic domain 
(AgHP14cat), as M. sexta HP14 catalytic domain is not available. AgHP14cat was expressed in 
Baculovirus expression system and used as material for our mosquito project. AgHP14 
(AgCP12488) and M. sexta HP14 are orthologs (Ji et al., 2004). The result showed that a complex 
band appeared when serpin-8-ΔN was incubated with AgHP14cat (Fig. 18C). Since serpin-8-ΔN 
and AgHP14cat are recombinant proteins with His-tag at C-terminus, the antibody against His-tag 
recognized both proteins and the complex. The His5 antibody did not recognize the cleaved 
serpin-8-ΔN shown in Fig. 15C suggesting that the cleaved serpin-8-ΔN lost the C-terminus. 
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Upon infection or injury, an extracellular serine proteinase cascade is activated leading to 
the converstion of inactive proPO to active PO which catalyzes melanin formation (Ashida et al., 
1997). The proPO activation pathway is regulated by serpins to prevent unnecessary activation 
and limit melanization as a transcient and local reaction (Kanost et al., 2004). 
In this study, I have expressed and purified a new immune responsive serpin, serpin-8 
from M. sexta. Its mRNA is constitutively expressed at a low level in hemocytes and at a 
moderate level in fat body. After bacterial injection, serpin-8 mRNA level increased both in 
hemocytes and fat body (Fig. 6A). Serpin-8 protein is constitutively present in larval plasma at a 
low concentration, which increased significantly at 24 h after immune challenge (Fig. 6B). 
M. sexta serpin-8 is most similar in amino acid sequence to B. mori serpin-12 of unknown 
function including very similar reactive center loop sequences (Fig. 4). According to sequence 
alignment, M. sexta serpin-8, B. mori serpin-12 and Nec have a Leu at their predicted P1 site (Fig. 
4), indicating that they are inhibitors of elastase- and chymotrypsin-like proteinases. Furthermore, 
the three serpins have an N-terminal extension which is unusual among other serpins. Although 
the function of the extension is unclear, Nec extension contains stretches of glutamines and 
prolines, including a 9-residue polyglutamine repeat (Pelte et al., 2006). However, M. sexta 
serpin-8 and B. mori serpin-12 do not have any structural features or repeats within the N-
terminal extension. A previous study found that the expression of full-length Nec was not 
successful in E. coli, resulting in a shortened protein that contained only the common serpin core 
(serpin-ΔN) and they showed that the N terminus is not required for inhibitory activity 
(Robertson et al., 2003).  Another study also found that both full-length Nec and the core serpin 
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are active inibitors of a range of serine proteinases (Pelte et al., 2006). Furthernore, M. sexta 
serpin-8 has seven putative O-linked glycosylation sites in the N-terminal extension, which may 
affect protein expression. Therefore, we expressed the serpin-8 core domain (serpin-8-ΔN) using 
the baculovirus/insect cell system. 
RT-PCR analysis showed that serpin-8 mRNA level is high in larvae, and low in pupae 
and adults in unchallenged tobacco hornworm (Fig. 7B). Serpin-8 transcript was not present in 
midgut, but in cuticle and Malpighian tubules. The amount of transcript was most abundant in 
nerve and trachea (Fig. 7A). These results are not consistent with Nec expression pattern. Soukup 
et al. (2009) found that Nec mRNA level is moderate in larvae and adults, and higher in pupal 
stages. They also reported that nec transcript was detected in mid- and hind-gut, but not in 
Malpighian tubules or brain tissue. The comparison may suggest that the spatial distribution of 
specific serpins is important to their function in the immune response and also in other processes 
such as insect development. 
To examine the inhibitory profile of serpin-8, a panel of proteinases was chosen by virtue 
of each being an easily available, well characterized proteinase. Results from this study showed 
that serpin-8-ΔN has a specificity being able to inhibit elastase- and chymotrypsin-like enzymes 
(Fig. 8A and Table 1). We have shown that serpin-8-ΔN successfully forms inhibitory complexes 
with chymotrypsin, Cathepsin G, and elastase (Fig. 8B). Therefore, serpin-8 may act in vivo on a 
number of serine proteinases with certain specificity, performing a role as a broad-spectrum 
proteinase inhibitor. 
Addition of recombinant serpin-8-ΔN to plasma suppressed proPO activation (Fig 9). 
According to their specificity, PAPs, HP6, HP8 and HP21 are not supposed to be inhibited by 
serpin-8, serpin-8 inhibits at least one upstream proteinase in the proPO activation cascade. M. 
sexta HP19 is an immune responsive serine proteinase with elastase specificity, suggesting that 
HP19 has the specificity for cleavage after the C-terminus of Ala, Val, or Leu. The mRNA and 
protein levels of HP19 increased after immune challenge (Fig. 12). It is difficult to purify active 
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proteinases from hemolymph, because they are present in plasma at low concentration and 
regulated tightly by serpins. We thus tried to express the catalytic domain of HP19 (catHP19). 
Although the amidase activity of catHP19 was low (Fig. 13), addition of catHP19 increased PO 
activity in plasma (Fig. 14), and catHP19 formed inhibitory complexes with serpin-8-ΔN (Fig. 
15), suggesting HP19 may be a physiological target proteinase of serpin-8 in M. sexta. The 
cleavage site of serpin-8-ΔN upon reacting with catHP19 was determined by mass spectrometry 
(Fig. 16). The result indicates that the scissile bond of serpin-8 is between Leu447 and Ser448, 
consistent with the substrate specificity of HP19. 
Serpin-8 N-terminal extension was cleaved upon encountering peptidoglycan from Gram-
positive bacteria (Fig. 17). N-terminal cleavage of Nec was induced by either fungal or Gram-
positive bacterial infection (Pelte et al., 2006) and they found Drosophila Persephone, required 
for fungal response in Toll pathway (Ligoxygakis et al., 2002) is related to this cleavage, but they 
are not sure if the interaction is direct or indirect. So far, no specific proteinase was identified to 
be responsive for the cleavage of the N-terminal extension of serpin-8. However, it is supposed to 
function in the immune pathway mediated by Gram-positive bacteria. 
Serpin-8 complex was detected in hemolymph by serpin-8 antibody and HP14 antibody, 
but not by HP19 antibody (Fig 19A and B), which may be due to the low reactivity of HP19 
antibody. HP14 is a chymotrypsin-like serine proteinase preferring to cleave after Leu, which 
matches the P1 site of serpin-8 (Wang et al., 2006). Upon peptidoglycan challenge, the complex 
band was detected around 70 kDa by serpin-8 antibody and HP14 antibody, and the catalytic 
domain of HP14 was detected as well, which is consistent with the previous study (Wang et al., 
2006). It suggests a possible regulatory mechanism for the pathway initiation. AgHP14cat was 
made use to test if serpin-8-ΔN forms complex with HP14 in vitro. Similar assay was applied to A. 
gambiae serpin-6 which formed complex with M. sexta PAP-1, PAP-3 and HP6 (An et al., 2012). 
These results suggest that serpin-8 may regulate more than one serine proteinases in M. sexta 
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proPO activation cascade. Similar cases can be found in M. sexta serpin-3, serpin-4, serpin-5 and 
serpin-6 (Christen et al., 2012; Tong et al., 2005; Zou et al., 2005). 
Several considerations should be taken in understanding the results of this study. First, it 
is possible that serpin-8-ΔN may lack some of the specificity-determining regions that could be 
present in the N-terminal extension. Alternatively, the N-terminal extension may change the rate 
of serpin-8 association of inhibition with its target proteinase by influencing the stability of the 
native serpin. To further study the function of the full-length protein could be useful to solve this 
problem. In addition, the data of the association rate constant between serpin-8-ΔN and catHP19 
is unavailable, due to the low activity of catHP19. CPC may affect the ability of serpin-8-ΔN to 
form complex with proteinaes, as no complex was detected when serpin-8-ΔN was incubated 
with catHP19 in the presence of CPC (data not shown). More assays to test if CPC affects the 
inhibitory activity of serpin-8-ΔN are useful to address the problem. The availability of M. sexta 
active HP14 will allow us to further confirm that M. sexta HP14 is a physiological target of 
serpin-8. 
Overall, this study has shown conclusively that serpin-8-ΔN is a serine proteinase 
inhibitor, with the specificity to inhibit elastase- and chymotrypsin-like proteinases. Prediction of 
physiological targets of serpin-8 is based on analysis of the specificity pocket architecture of M. 











1    GCCGACACAACAACGTGTGGAGTGTCTTGGCGAAAATAATATTTGCAAAATCAAGAAAGTGGTTATTAAGAATATTTAGTGACTCATCGA 
91   TGTATCATTGGACATACATAAATTTGCAAATATGAAGATATTAATAAGCATATTTTTTTGTTACTTCTCTTTAGGAGTACACTCACAATT 
                               -18  M  K  I  L  I  S  I  F  F  C  Y  F  S  L  G  V  H  S  Q  L 
181  GAATGTAATACCATTGAACAATGACGCTGACCCCAACAGCATTTACTTCGCGGATAACATGAGGCCTTTTGTTAGGAGTTCTGGATTTAA 
3      N  V  I  P  L  N  N  D  A  D  P  N  S  I  Y  F  A  D  N  M  R  P  F  V  R  S  S  G  F  N 
271  TCAAAATATGCAAACCAATACTAGAGGACCCTTTGAATCGCAGTTCGATATACAAGCATCCCTACAAACTACGAAATCCCAAAGAGAACA 
33     Q  N  M  Q  T  N  T  R  G  P  F  E  S  Q  F  D  I  Q  A  S  L  Q  T  T  K  S  Q  R  E  Q 
361  ACAGCCACAGATAAATGGTGGAGTACACAGTCCGACTAGATCACCAACGCAGGACACTCCTTTCAAATCCTTATCACCAATGATACCTAC 
63     Q  P  Q  I  N  G  G  V  H  S  P  T& R  S  P  T& Q  D  T& P  F  K  S& L  S& P  M  I  P T& 
451  AACAAGCTCTTTTCATTCGGGGCCTGCATCTACAAGCTTTGGTGTTAACGTGTTTAAGCAAATGGCCACCGAGCAATCTGGGAATCTCGC 
93     T& S  S║ F  H  S  G  P  A  S  T  S  F  G  V  N  V  F  K  Q  M  A  T  E  Q  S  G  N  L  A 
541  TGCGTCGCCTTTCTCCATCACGATTTTACTGGCAATGCTGCAGCAAGGTGCAGCTGGTAACACCTTAGACGAGATAACAAGAGCATTGCA 
123    A  S  P  F  S  I  T  I  L  L  A  M  L  Q  Q  G  A  A  G  N  T  L  D  E  I  T  R  A  L  Q 
631  GATGACTCCAGAGAAATCAGCAGAGATTTTTAAGAAAGTCAATGAAGAAATACAGAAACGCAATTCAAGAAACATTTTAAAAACGGCCAA 
153    M  T  P  E  K  S  A  E  I  F  K  K  V  N  E  E  I  Q  K  R  N  S  R  N  I  L  K  T  A  N 
721  CAACGTGTTCTTAAGCGAAAATTTCAACTTAAACCCGCAGTTCAAAAGGATAGCCGTTAACAACTTTGATAGTGATTTGACACCGACTTA 
183    N  V  F  L  S  E  N  F  N  L  N  P  Q  F  K  R  I  A  V  N  N  F  D  S  D  L  T  P  T  Y 
811  TTTTGGAAAACCAGCTCTGGCCGCCCAAAATATCAACAGCTGGATTGCTTCCAAGACTAATGATAAAATTGACAAACTTGTTAGCCCCGA 
213    F  G  K  P  A  L  A  A  Q  N  I  N  S  W  I  A  S  K  T  N  D  K  I  D  K  L  V  S  P  D 
901  TGATCTCAGTGGAAATACGCAGATGGTGATGGTGAATGCTGTATACTTCAAGGGGTTGTGGGAGATTCCGTTTAGGGAACAAGCCACACA 
243    D  L  S  G  N  T  Q  M  V  M  V  N  A  V  Y  F  K  G  L  W  E  I  P  F  R  E  Q  A  T  Q 
991  AAAACGCAATTTCACCTTAAACGGGGGTGAAAAGAAGGTGGCATCGTTTATGCAAACACGTCGTTATTTCAAAGCTGGAACTCACAAGCC 
273    K  R  N# F  T  L  N  G  G  E  K  K  V  A  S  F  M  Q  T  R  R  Y  F  K  A  G  T  H  K  P 
1081 TGCCATGGCGAAAGTGGTTGTTTTACCCTTCGAGTACAACGAATACTCTCTTATCGTCGTCTTACCGCTTAAATCATCTAATGTTGACGC 
303    A  M  A  K  V  V  V  L  P  F  E  Y  N  E  Y  S  L  I  V  V  L  P  L  K  S  S  N  V  D  A 
1171 ACTTCTTTCATCACTTTCCATGGAAGATGTGGCCAGTTTCTTGGATTTACCACCCAAAGACGTGGCGCTGGAATTACCTAAGTTTTCTAT 
333    L  L  S  S  L  S  M  E  D  V  A  S  F  L  D  L  P  P  K  D  V  A  L  E  L  P  K  F  S  I 
1261 CAAAGCCGATATTAATTTGGAACCAGTTTTGAATAAGATGGGTGTATCCAGCATTTTTACCCAACAAGCGGAACTTTATAATCTTGGATC 
363    K  A  D  I  N  L  E  P  V  L  N  K  M  G  V  S  S  I  F  T  Q  Q  A  E  L  Y  N  L  G  S 
1351 ACATGGCTCGCTGTCTCCTCAAGTTTCATCAGCTTTGCACTCAGCTGTTCTAACAATCGATGAGAGAGGAGGCTCGGCGGCCGCCGCTAC 
393    H  G  S  L  S  P  Q  V  S  S  A  L  H  S  A  V  L  T  I  D  E  R  G  G  S  A  A  A  A  T 
1441 ATCTTTCGCAGCTGTAGCATTATCTTATGATGAGCCTTCATTATATTTCAGAGCTAACAAGCCTTTCCTGGCTATATTATGGGATAATAG 
423    S  F  A  A  V  A  L  S  Y  D  E  P  S  L  Y  F  R  A  N  K  P  F  L  A  I  L  W  D  N# R 
                         P1 P1’ 
1531 ATCATCTATTCCGCTGTTTATGGCAAGAATAATGGATCCTACAATATAGATCTTTGGTAATTCATTGTCAATAACATTAATGTAGTAAAA 












2611 GCCCGCGATGTCTATGTGCATAATTTTTTATATAAATATACATGTTCTTACGTTAAAAAAAAA 2673 
 
Figure 3. Nucleotide and deduced amino acid sequence of M. sexta serpin-8. The one-letter 
code for amino acid residue is shown below the nucleotide sequence and aligned with the second 
nucleotide of the corresponding codon. Numbers on the left are assigned to nucleotide residues 
and amino acid residues, including negative numbers for residues in the secretion signal peptide 
which is underlined. Two putative N-linked glycosylation sites are marked with # after the Asn 
residues. Seven putative O-linked glycosylation sites are marked with & after the Thr and Ser 
residues. The predicted P1 and P1’ sites are shaded and marked. The putative polyadenylation 





Ms serpin-8        -----MKILISIFFCYFSLGVHSQLNVIPLNNDADPNSIYFADNMRPFVRSSGFNQNMQT 
Bm serpin-12       -----MKVFISLTVCCFVLSADSQSSFRTQNQYPKYDSTINSDQIYFDDNRPSGSINIQK 
Ms serpin-4        ------MKCVLVIVLCIVSCYCDDLPAKVRNGLTEKIGNFSIELLYHTSKSQPENQ---- 
Ms serpin-5        -----MMMKCAIFVLFFGACYCDVD-------FYERPRNFSIELLYHTQLQTGG------ 
Ms serpin-1J       ---------MKIIMCIFGLAALAMAGETDLQKILRESNDQFTAQMFSEVVKANPGQ---- 
Dm Necrotic        -----MASKVSILLLLTVHLLAAQTFAQELIAWQRQQQQQQQQQLQLQQQLLLQQQQHQR 
Ms serpin-6        ------MLKSAALVLLVATCVSSQCFSKDDSSKKLDPGARTSLYSGQLAFTLNLFQTINS 
Ms serpin-3        -----MTSTIYFAFFVAPLLLCSLADDVDPNTLRAVFGYSALDQAALVGAESNKQAATVT 
Dm serpin-27A      MTKMGGNLAVMLLSLFLSALATGNGNSIPTTTTPQGVFETRTDKLPGGAASVPSGAGIYD 
                                                                              
 
Ms serpin-8        NTRGPFESQFDIQASLQTTKSQREQQPQING------GVHSPTRSPTQDTPFKSLSPMIP 
Bm serpin-12       ELSNLNGLTIGTKIPIINPNFGAPQYSPYANNVIIQPSIQTYNQETTKIVPQKSGTPAKK 
Ms serpin-4        ------------------------------------------------------------ 
Ms serpin-5        ------------------------------------------------------------ 
Ms serpin-1J       ------------------------------------------------------------ 
Dm Necrotic        NPRPELGLRSLPGNPWTQNNQEAISDVVAVDLTKREPVTPPPNRPPPVFSYMDRFSSELF 
Ms serpin-6        AVPDD------------------------------------------------------- 
Ms serpin-3        PDNGTLVDPDYWDTEEFQPSTADYDIFDWVLTKR-------------------------- 
Dm serpin-27A      DIDTFVPFRSDSHDPFSWHLLKTVLQN--------------------------------- 
                                                                              
 
Ms serpin-8        TTSSFHSGPAS-----------TSFGVNVFKQMATEQSGNLAASPFSITILLAMLQQGAA 
Bm serpin-12       MTDTFFQAQATRPEIDSIDYPITHFGINIFKQITSSQSGNMVVSPFSITTLLALLQQGAT 
Ms serpin-4        ---------------------------------------NLVLSPITVWTALAVISEGAT 
Ms serpin-5        ---------------------------------------HVVISPFGIWTLMTGIALGAT 
Ms serpin-1J       ---------------------------------------NVVLSAFSVLPPLGQLALASV 
Dm Necrotic        KEIIKSQSQQ-----------------------------NVVFSPFSVHALLALIYGASD 
Ms serpin-6        ---------------------------------------NIFFSPFSVYQSLLLAYFSTG 
Ms serpin-3        --------------------------------VASTSNANFLLSPLGLKLALAILTEAAT 
Dm serpin-27A      ----------------------------------ETADKNVIISPFSVKLVLALLAEAAG 
                                                          :.  *.: :   :     .:  
 
Ms serpin-8        G--NTLDEITRALQMTPEK---SAEIFKKVNEEIQKRNSRNILKTANNVFLSENFNLNPQ 
Bm serpin-12       G--STLDQISAALHLAPLK---TSEVFRNVMENVQKRQSQNILKTLNNIFVAETFNLNRD 
Ms serpin-4        G--NTRREINHALRITNRNKNVTRANYREISNWLVVKTKTVELAKINAIFVDQQRLPQED 
Ms serpin-5        G--NSYKQLSRAFILPKNPDTLTEGYKSLTNVVLDPSSNAVALTSKNFVFLDNDFNVYPD 
Ms serpin-1J       G--ESHDELLRALALPNDN--VTKDVFADLNRGVRAVKG-VDLKMASKIYVAKGLELNDD 
Dm Necrotic        G--KTFRELQKAGEFSKNAMAVAQDFESVIKYKKHLEGADLTLATKVYYNRELG-GVNHS 
Ms serpin-6        G--RTEESLKKSLEIEDNMDKMNLMTAYKVDKRSRMTNNNSDSYEFTTANKLFVANELQV 
Ms serpin-3        G--STRSELASALGFGLDR-TEVRRKFSTIIESLKRESPDYILNLGSRIYMGEGVQPRQR 
Dm serpin-27A      AGTQTQVELANTQTDIRSQNNVREFYRKTLNSFKKENQLHETLSVRTKLFTDSFIETQQK 
                   .   :  .:  :                                                 
 
Ms serpin-8        FKRIAVNNFDSDLTPTYFGKPALAAQNINSWIASKTNDKIDKLVSPDDLSGNTQMVMVNA 
Bm serpin-12       FERIAKSGFGSGVTLMNFGRPDVAIQRINNWVGAMTNGKIENLLSQDAISQSSQLVLVNV 
Ms serpin-4        FIAIAKEIYDTNMVPLKFEESDVAADVINRQISNVTHGRIKNIVNSESFKE-SKMILTSA 
Ms serpin-5        FRLRLQKDFSAAIKVLDFGDPNSAR--IANTYIEKSGGRVSNVLQSDDFQE-SRMLLTNV 
Ms serpin-1J       FAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNA 
Dm Necrotic        YDEYAKFYFSAGTEAVDMQNAKDTAAKINAWVMDTTRNKIRDLVTPTDVDPQTQALLVNA 
Ms serpin-6        RQCMFDLFGEEIEALNFRENPEVSREYINNWVERITKNHIKKLLPADGVSEFTKLVLANA 
Ms serpin-3        FAAIAQEFYKTELKTTNFFKPEVAAREINNWVSNATQGKIPNLVEADDVADVILLILN-T 
Dm serpin-27A      FTATLKHFYDSEVEALDFTNPEAAADAINAWAANITQGRLQQLVAPDNVRS-SVMLLTNL 
                                       .  :   *       : .:: .::    .      ::    
 
Ms serpin-8        VYFKGLWEIPFREQATQKRNFTLNGGEKK-VASFMQTRRYFKAGTHKPAMAKVVVLPFE- 
Bm serpin-12       VYFKGLWQIPFRTESTVPQPFLLKGGIQK-TAPFMRTRRYFRTGLDPITNAKVISLPFE- 
Ms serpin-4        LYFKAQWTVPFNASSTTKMPFHDSHGKKIGEVNMMYNRQTYPFANMRQLQARVIELPYGS 
Ms serpin-5        ISFKGLWATPFNKSDTVLEPFYNENKEVIGSVNMMYQKAQIPFSNIRDLKAFAIELPYGD 
Ms serpin-1J       IYFKGSWKDKFVKERTMDRDFHVS-KDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYE- 
Dm Necrotic        VYFQGRWEHEFATMDTSPYDFQHTNGRIS-KVAMMFNDDVYGLAELPELGATALELAYK- 
Ms serpin-6        AYFKGVWASKFSPERTKKEPFFVSETRQT-LVPFMKQKGTFHYGVSEELGAQVLELPYK- 
Ms serpin-3        LYFKGTWRHQFAPNATKPGPFYVSPQLQK-TVPFMNVKDNFYYVDSSRFDAKILRLPYR- 
45 
 
Dm serpin-27A      IYFNGLWRRQFAT--TFQGSFFRSKDDQS-RAEFMEQTDYFYYTTSEKLKAQILRLPYK- 
                     *:. *   *    *    *          .  *               *  : :.:   
 
Ms serpin-8        YNEYSLIVVLPLKSSNVDALLS--------SLSMEDVASFLDLPPKDVALELPKFSIKAD 
Bm serpin-12       KDQYSLLVVLPHEQSDIDTLIS--------RLTVEQLIAYQNFTAMDVELELPKFTVKGD 
Ms serpin-4        ENRLSMIIMLPNPGVSVEDMFLNFKTFTLDNFFEEMRLSSEEFGDDEIDCFLPRFKIEAD 
Ms serpin-5        TKKYSMLIFLPHPNTKIDDMYKNLAVISLKDVFKKLQTDAEYFGLEDIDVKIPRFHISTN 
Ms serpin-1J       GDQASMIIILPNQVDGITALEQKLK------DPKALSRAEERLYNTEVEIYLPKFKIETT 
Dm Necrotic        DSATSMLILLPNETTGLGKMLQQLS-----RPEFDLNRVAHRLRRQSVAVRLPKFQFEFE 
Ms serpin-6        GNDISMFILLPPYSMKEGVTNIIAN----LNTERLAAVMEESYMSREVIVEIPKFTIERT 
Ms serpin-3        GNKYAMYIVVPNSLTGLPRVLNNLS---------ELRTEMIYLQERLVDVILPKFQFEYM 
Dm serpin-27A      -GKNSLFVLLPYALNGIHDLVKNLE-------NDELKSAQWAMEEVKVKVTLPKFHFDYQ 
                       :: :.:*                                    :   :*:* ..   
 
Ms serpin-8        INLEPVLN-KMGVSSIFTQQA--ELYNLGSHGSLSPQVSSALHSAVLTIDERGGSAAAAT 
Bm serpin-12       TDLVPVFN-RMGISNMFSNRA--ELFGLGTFREFSPQVSSAVHSAVLSIDEKGGSAAAAT 
Ms serpin-4        LDMSEVLQNAMGIQALFDQNK--AMLPYMAR--TPMYVSKVLHKAEIEVTEEGTVASGVT 
Ms serpin-5        LVLNKPLN-DMGVYDIFQPDL--ASFQRVSK--DNIFVSAIVHKADIEVTEAGTVASAAT 
Ms serpin-1J       TDLKEVLS-NMNIKKLFTPGA--ARLENLLKTKESLYVDAAIQKAFIEVNEEGAEAAAAN 
Dm Necrotic        QDMTEPLK-NLGVHQMFTPNS--QVTKLMDQP---VRVSKILQKAYINVGEAGTEASAAS 
Ms serpin-6        LSLRPILD-RLGVGDLFNVSA--DFSTLTEDS--GIRFDDAVHKAKIQIDEEGTVAAAAT 
Ms serpin-3        SRLEGVLR-EMGVREAFEDTASFPGIARGQLLYQRLRVSKVFQRTGIEVNELGSVAFSAT 
Dm serpin-27A      QNLKETLR-SLGVREIFEDSASLPGLTRGADVAGKVKVSNILQKAGINVNEKGTEAYAAT 
                     :   :   :.:   *                    ..  .: : : : * *       
 
                        P1P1’ 
Ms serpin-8        SFAAVAL║SYDEP--SLYFRANKPFLAILWDNRSSIPLFMARIMDPTI------- 
Bm serpin-12       SFGVVAL║SFDDP--AVVFKANRPFLAVLWDTALSLPLFMAKIEDPTE------- 
Ms serpin-4        IAEFSNR║IG-----IIRYEVNRPFSYIIVEKVTNTIVFGGIYKQPFLY------ 
Ms serpin-5        TASFADR║IS-----TPSFHANRPFLYFIMEKTTYSVIFSGIYSKPTVY------ 
Ms serpin-1J       AFILTDR║CCSDY--DDNIEFDVNRPFYLNLRTNEHLLFSGICIQPEI------- 
Dm Necrotic        YAKFVPL║SLPPK--PTEFVANRPFVFAVRTPASVLFIGHVEYPTPMSV------ 
Ms serpin-6        ALFGF-R║SSRPAE-PTRFIANFPFVYLIYERPTNSILFFGVYRDPKK------- 
Ms serpin-3        QIGIQNK║FGEDSDINYEVVANKPFMFFIQEESTRQTLFTGRVSDPALVDGAFKA 
Dm serpin-27A      VVEIENK║FGGST-AIEEFNVNRPFVFFIEEESTGNILFAGKVHSPTTQN----- 
                                        :      :        :       *          
 
Figure 4. Sequence alignment of nine insect serpins. The amino acid sequences of M. sexta 
serpin-1J, serpin3-6, serpin-8, D. melanogaster serpin-27A, D. melanogaster Necrotic and B. 
mori serpin-12 are aligned. The secretion signal peptide sequences are underlined. The predicted 
scissile bonds are indicated by “║” between P1 (shaded) and P1’ residues. “*” indicates positions 
which have an identical residue. “:” indicates positions which have strongly conserved residues. 
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Figure 5. Purification of M. sexta serpin-8-ΔN from the baculovirus-infected insect cells. 
Purified serpin-8-ΔN (50 ng/μl, 10 μl) was analyzed by 10% SDS-PAGE and Coomassie blue 
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Figure 6. Changes in M. sexta serpin-8 mRNA and protein levels upon bacterial challenge. 
A, Total RNA samples from control (C) and induced (I) larvae fat body (F) and hemocyes (H) 
were analyzed by RT-PCR using gene specific primers. The M. sexta ribosomal protein S3 
mRNA was used as an internal standard. CF and CH: fat body and hemocytes from the naïve 
larvae; IF and IH: hemocytes and fat body from the larvae after 24 h after injection of a mixure of 
M. luteus and E. coli. B, cell-free hemolymph samples (2 μl) collected at 0, 1, 6, 12, 24, and 32 h 
(Lane 1-6) after fifth instar day 2 larvae had been injected with 1×108 killed E.coli cells were 
subjected to 10% SDS-PAGE analysis under reducing condition. Immunoblotting was performed 
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Figure 7. M. sexta serpin-8 mRNA levels in different tissues and different developmental 
stages. A, Total RNA samples of various tissues collected from day 3, 5th instar naïve larvae were 
analyzed. C: cuticle; M: midgut; SG: salivary gland; MS: muscle; N: nerve; T: trachea; MT: 
Malpighian tubules. B, Total RNA samples were collected from fat body of day 0-6 of 4th instar 
naïve larvae, day 1-6 of 5th instar naïve larvae, day1-6 of wandering larvae, and early, middle, late 
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Figure 8. Inhibitory activity of M. sexta serpin-8-ΔN. A, Inhibition of enzymatic activity of 
various proteinases by M. sexta serpin-8-ΔN. Purified recombinant serpin-8-ΔN (200 ng/μl, 1 μl) 
was incubated with various proteinases (100 ng/μl, 1 μl) in the buffer (8 μl, 20mM Tris-HCl, pH 
8.0) at room temperature for 10 min. The residual amidase activity (mean ± S.D., n = 3) was then 
measured using 150 μl different artificial substrates. Chymo: bovine α － chymotrypsin, 
AAPFpNa (100 μM) was used as its substrate; Trypsin: bovine pancreatic trypsin, IEARpNa (50 
μM) was used as its substrate; Pro K: proteinase K, AAPFpNa (100 μM) was used as its 
substrate; Cath G: human neutrophil Cathepsin G, AAPFpNa (100 μM) was used as its substrate; 
Elastase: porcine pancreatic elastase, AAPLpNa (100 μM) was used as its substrate. B, Detection 
of SDS-stable serpin-proteinase complexes by immunoblot analysis. Tracks contain a mixture of 
50 
 
serpin-8-ΔN (200 ng/μl, 1 μl) and three proteinases (100 ng/μl, 1 μl). Tested proteinases are 
bovine α－chymotrypsin (Lane 1), porcine pancreatic elastase (Lane 2), and human neutrophil 










Concentration of proteinases Concentration 
of serpin-8-ΔN 
ka (M-1s-1) 
20:1 chymotrypsin  
2 μM 
40 μM 1.1×104
20:1 porcine pancreatic elastase  
6 μM 
120 μM 2.3×104




Bovine α-chymotrypsin (2 μM, 1 μl), porcine pancreatic elastase (6 μM, 1 μl), and human 
neutrophil Cathepsin G (50 μM, 1 μl) were incubated for varying time at room temperature with 
excessive moles of serpin-8-ΔN (1 μl) in the buffer (8 μl, 20 mM Tris-HCl, pH 7.5). The residual 
amidase activities of three proteinaes were measured using sustrates as described in Materials and 
Methods. Half-life time (t0.5) was calculated by linear regression curves plotting ln(residue 
amidase activity) vs. incubation time (t). Association rate constants (ka) were calculated using 
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Figure 9. Inhibition of M. sexta proPO activation by serpin-8-ΔN. Induce plasma sample (1 
μl) was incubated for 5 min at room temperature with different concentrations of recombinant 
serpin-8-ΔN (1 μl) in the buffer (7 μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-20). 
Then 1 μl of M. luteus (1 μg/μl) was added and incubated at room temperature for 10 min prior to 



















1     GCTTACGCTCAGCAAATTTTTGTGTCAACAAATAGTTGTTTAATCGTTTATAATATTGGACCAGGAAATTTATTTATTAAAAAATGATCA 
                                                                                      -19 M  I
91    GAACTATCACCGCCCTCGCTATTCTGGCCATAACTGTTCCCACACACGAACAAAGCACGCCAGTATCTCCATGTCCAAACGTCTTCGAGT 
-17   R  T  I  T  A  L  A  I  L  A  I  T  V  P  T  H  E  Q  S  T  P  V  S  P  C  P  N  V  F  E 
181   ACGAACCCCCAGGAACAGAAGCCGGGCGGTGGTACGGCGTAGTGCATCTCTCCACAGATAGCACACTGCATTCCTTATGGCTGAACATAG 
14    Y  E  P  P  G  T  E  A  G  R  W  Y  G  V  V  H  L  S  T  D  S  T  L  H  S  L  W  L  N  I 
271   TACTGGATGGAAAGGCTGATATACTGGGTAACTGGGTAGGCGACGTGACCACACAAGACAACATAGACTTCAAAATAGAAAATACTCAAA 
44    V  L  D  G  K  A  D  I  L  G  N  W  V  G  D  V  T  T  Q  D  N  I  D  F  K  I  E  N  T  Q 
361   TGAAGATCAGTCCTGGCCCAGCGGTGGCTGTTAGATTCTTCGTCCAATACAACACTCTAACTAAGGCACCTCTGCTACAAGCTATAAGAC 
74    M  K  I  S  P  G  P  A  V  A  V  R  F  F  V  Q  Y  N  T  L  T  K  A  P  L  L  Q  A  I  R 
451   TCAACGGTCGAGAAATCTGCAACGCCAACGCACCCCAACCAGCTGTAGAAAGACCTGTTATCACTCAGAGGCCAGTCAGAGTTGACTCAA 
104   L  N  G  R  E  I  C  N  A  N  A  P  Q  P  A  V  E  R  P  V  I  T  Q  R  P  V  R  V  D  S 
541   CCTCGTCGAGACCACAGACAGTCAAGCCTCAGTCAACGAATTCGAGAAAGGAATCGATTCCAGAGCTTCCGCTGAACACAAGGCCTATAC
134   T  S  S  R  P  Q  T  V  K  P  Q  S  T  N  S  R  K  E  S  I  P  E  L  P  L  N  T  R  P  I 
631   AGGGCCGTCCGTCCAGCGAAGGGCCGGTCTACGTGAAGCCGGCGAACGTGCCCAGCCCTTCCAGCATAAGCGATGTCTCGACACAAACTT 
164   Q  G  R  P  S  S  E  G  P  V  Y  V  K  P  A  N  V  P  S  P  S  S  I  S  D  V  S  T  Q  T 
721   ACAATGCAAACACGAGGCCAACGAACACAAGACTGACGCCAGCGCCACCCACACGGACTACTACCAGGAGGCAAGAAGTCTTGGACTTCG 
194   Y  N  A  N  T  R  P  T  N  T  R  L  T  P  A  P  P  T  R  T  T  T  R  R  Q  E  V  L  D  F 
811   ATGATAATGCAAGTAATGCAGAAGAACCTGAATACTTCAGTGGCGGTCAACCCACATTCATTATTCCCAACAAAAACGACAACTCTCACT 
224   D  D  N# A  S  N  A  E  E  P  E  Y  F  S  G  G  Q  P  T  F  I  I  P  N  K  N  D  N  S  H 
901   CTAACAGCAACAAGAGGCAACAACAGAACCATTGCGGTAGAGTGTTGCTGAACAATCCTATACCACTGGTGGTAAATGGAACTCCAACAT 
254   S  N  S  N  K  R  Q  Q  Q  N  H  C  G  R  V  L  L  N  N  P  I  P  L ║V  V  N  G  T  P  T 
991   TGGAAGGGCAGTGGCCATGGCAGATAGCTGTCTACCAAACTCAGACGGTGGACAACAAGTACATTTGCGGTGGTACTCTGATATCACACA 
284   L  E  G  Q  W  P  W  Q  I  A  V  Y  Q  T  Q  T  V  D  N  K  Y  I  C  G  G  T  L  I  S  H 
1081  AGCATATCATCACGGCAGCGCATTGTGTCACCCGCAAAGGGTCCCGGCGGGTTGTGAATAAGAATACGCTCACTGTATATTTGGGTAAAC 
314   K  H  I  I  T  A  A  H※C  V  T  R  K  G  S  R  R  V  V  N  K  N  T  L  T  V  Y  L  G  K 
1171  ACAATTTGAGGACTTCAGTGGACGGAGTACAGATCAAATTCGTGGAGAAGATTATATTACACCCGATGTACAATGCGTCGACGTTTACCA
344   H  N  L  R  T  S  V  D  G  V  Q  I  K  F  V  E  K  I  I  L  H  P  M  Y  N# A  S  T  F  T 
1261  GCGACCTGGCCATCCTGGAGCTACGCGAGTCTGTCACGTATTCGAACTGGGTACAGCCCGCGTGTCTCTGGCCCGACAATGCGATCAACC 
374   S  D※L  A  I  L  E  L  R  E  S  V  T  Y  S  N  W  V  Q  P  A  C  L  W  P  D  N  A  I  N#
1351  TCAGCAACGTTATCGGAAAAAAGGGATCGGTTGTAGGCTGGGGCTTTGACGAGACAGGCGTGGCTACCGAAGAGCTAAGCTTGGTCGAGA 
404   L  S  N  V  I  G  K  K  G  S  V  V  G  W  G  F  D  E  T  G  V  A  T  E  E  L  S  L  V  E 
1441  TGCCTGTAGTAGACACTGAGACTTGCATCAGGTCCTATAGCGAATTCTTCATCAGATTCACTTCGGAATACACCTACTGCGCTGGTTATA 
434   M  P  V  V  D  T  E  T  C  I  R  S  Y  S  E  F  F  I  R  F  T  S  E  Y  T  Y  C  A  G  Y 
1531  GAGATGGTACCTCCGTCTGCAACGGCGACAGTGGTGGTGGTATGGTGTTCAAGATTGGTGACTACTGGTACCTCAGAGGGCTGGTCTCCC 
464   R  D  G  T  S@ V  C  N  G  D  S※ G  G  G  M  V  F  K  I  G  D  Y  W  Y  L  R  G  L  V  S 
1621  TCTCAGTTGCTAGGCAGAATGAATTCCGCTGCGACCCCTCCCACTACGTAGTGTTTACGGACTTAGCGAAATTCTTACCCTGGATCAAGC 
494   L  S@ V  A  R  Q  N  E  F  R  C  D  P  S  H  Y   V@ V  F  T  D  L  A  K  F  L  P  W  I  K 
1711  AGTCCATTTATGACTATTAACTGTAGCGGTTTTTGATAGATTTTGTAAGCTATTGCGAATAGTTTGGTTTAAGATGAGCGATGTAGATAT 








2431 AGCAATAAATTTAATAATTGCCTTAAAAAAAAAAAAAAAAAAAAAAAAAA 2480 
 
 
Figure 10. Nucleotide and deduced amino acid sequence of M. sexta HP19. The one-letter 
code for amino acid residue is shown below the nucleotide sequence and aligned with the second 
nucleotide of the corresponding codon. Numbers on the left are assigned to nucleotide residues 
and amino acid residues, including negative numbers for residues in the secretion signal peptides 
which are underlined. Putative N-linked glycosylation sites are marked with # after the Asn 
residues. The predicted proteolytic cleavage site is marked by ║. The catalytic triad residues are 
marked by ※. The residues that make the primary substrate-specificity pocket are marked by @. 


































Figure 11. Purification of M. sexta catHP19 from the baculovirus-infected insect cells. 
Purified catHP19 (50 ng/μl, 10 μl) were analyzed on 10% SDS-PAGE and Coomassie blue 












































Figure 12. Changes in M. sexta HP19 mRNA and protein levels upon bacterial challenge. A, 
Total RNA samples from fat body (F) and hemocyes (H) of control and induced larvae were 
analyzed by RT-PCR using gene specific primers. The M. sexta ribosomal protein S3 mRNA was 
used as an internal standard. CF and CH: fat body and hemocytes from the naïve larvae; IF and 
IH: hemocytes and fat body from the larvae after 24h after injection of a mixure of M. luteus and 
E. coli. B, cell-free hemolymph samples (2 μl) collected at 0, 1, 6, 12, 24, and 32 h (Lane1-6) 
after fifth instar day 2 larvae had been injected with 1×108 killed E.coli cells were subjected to 
10% SDS-PAGE analysis under reducing condition. Immunoblotting was performed using 1: 



























catHP19                            +             + 
CPC                     +                           + 
 
Figure 13. CPC-induced M. sexta catHP19 activity using substrate AAPLpNa. Purified 
recombinant catHP19 (150 ng/μl, 2 μl) was incubated with 6 mM CPC (1 μl) in the buffer (7 μl, 
20 mM Tris-HCl, pH 7.5, 50 mM NaCl) at room temperature for 5 min. The residual amidase 
activity (mean ± S.D., n = 3) was then measured using an artificial substrate, AAPLpNa (100 μM, 













plasma      +         +          +          +                 
M.luteus               +                      +                 
catHP19                            +         +                 
 
Figure 14. Role of catHP19 in M. sexta proPO activation. Naïve hemolymph (1 μl), M. luteus 
(1 μg/μl, 1 μl), and catHP19 (100 ng/μl, 1 μl) were incubated in the buffer (7 μl, 20 mM Tris-HCl 
pH 8.0, 1 mM CaCl2, 0.001% Tween-20) at room temperature for 30 min. PO activity (mean ± 
S.D., n = 3) was measured using dopamine as a substrate. Controls reactions were plasma only 
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Figure 15. Detection of SDS-stable M. sexta serpin-8-ΔN-catHP19 complex by immunoblot 
analysis. Purified serpin-8-ΔN (150 ng/μl, 1 μl) was incubated with catHP19 (100 ng/μl, 1 μl) in 
the buffer (13 μl, 20 mM Tris-HCl, pH 7.5, 50 mM NaCl) at room temperature for 30 min. The 
reaction mixture (15μl) was subjected to immunoblot analysis for detection of the complex. Lane 
1: catHP19 only; Lane 2: serpin-8-ΔN only; Lane 3: serpin-8-ΔN and catHP19. Sizes and 


































Figure 16. Cleavage site determination of M. sexta serpin-8. Purified serpin-8-ΔN (150 ng/μl, 
1 μl) was incubated with catHP19 (100 ng/μl, 1 μl) in the buffer (13 μl, 20 mM Tris-HCl, pH 7.5, 
50 mM NaCl) at room temperature for 30 min. The reaction mixture was directly analyzed by 
MALDI-TOF mass spectrometry. Representative strong spectra were presented with the mass 
value on top of the peaks. The spectrum was subjected to noise removal and calibrated with an 
external standard of horse apomyoglobulin. A, the control spectrum of catHP19. B, the control 





















IH (45% A. S.)  +    +    +    +     +     +    + 
                                    M. luteus           + 
                                          LPS                 + 
                                   Laminarin                       + 
                                     Zymosan                                + 
S. aureus secreted PGN                                     + 

















































IH (45% A.S.)                +       + 
S. aureus insoluble PGN      +                + 
 
Figure 17. Cleavage of M. sexta serpin-8 N-terminus upon peptidoglycan stimulus from 
Gram-positive bacteria. 10 μl of induced hemolymph were mixed with 100% saturated 
ammonium sulfate (8.2 μl, pH 7.0). The ammonium sulfate (A.S.) was adjusted to 45% 
saturation, and centrifuged to separate precipitate from the supernatant. The pellet was saved and 
re-dissolved into the buffer (10 μl, 20 mM Tris-HCl, pH 7.5). Various microbial surface 
components (1 μg/μl, 1 μl) were incubated with the 45% ammonium sulfate fraction of 
hemolymph at room temperature for 15 min. M. luteus (Sigma); LPS (Invitrogen); Laminarin 
(Sigma); Zymosan (Sigma); S. aureus secreted PGN (Sigma): Staphylococcus aureus secreted 
peptidoglycan; S. aureus insoluble PGN (Sigma): Staphylococcus aureus insoluble peptidoglycan. 
The reaction mixtures were separated by 10% SDS-PAGE and immunoblot analysis was 
performed using serpin-8 antibody. The sizes and positions of molecular weight standards are 
indicated on the left. Bands representing serpin-8, serpin-8 cleaved products and serpin-8-ΔN are 
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                                          AgHP14cat                  +       + 
 
Figure 18. Detection of M. sexta serpin-8-proteinase complex in hemolymph. 10 μl of induced 
hemolumph were mixed with 100% saturated ammonium sulfate (8.2 μl, pH 7.0) to 45% 
saturation. The suspension was centrifuged to separate precipitate from the supernatant. The 
pellet was saved and re-dissolved into the buffer (20 μl, 20 mM Tris-HCl, pH 7.5). S. aureus 
insoluble PGN (1 μg/μl, 1 μl) was incubated with the 0-45% AS fraction of induced hemolymph 
at room temperature for 30 min. Half of the reaction mixtures (10.5 μl) were separated by 10% 
SDS-PAGE and immunoblot analysis was performed using serpin-8 antibody (A) and the other 
half of the reaction mixtures (10.5 μl) were treated the same way except for using HP14 antibody 
(Wang et al., 2006) (B). C, Detection of SDS-stable M. sexta serpin-8-ΔN-AgHP14cat complex 
by immunoblot analysis. Purified serpin-8-ΔN (150 ng/μl, 1 μl) was incubated with AgHP14cat 
(100 ng/μl, 2 μl) in the buffer (7 μl, 20 mM Tris-HCl, pH 7.5, 50 mM NaCl) at room temperature 
for 30 min. The reaction mixture (10 μl) was subjected to 10% SDS-PAGE and immunoblot 
analysis using His5 antibody. The sizes and positions of molecular weight standards are indicated 
on the left. Bands representing serpin-8, cleaved serpin-8, serpin-8-ΔN, complex, proHP14, HP14 






EXPRESSION, PURIFICATION AND FUNCTIONAL STUDY OF MANDUCA SEXTA CLIP-
DOMAIN HEMOLYMPH PROTEINASE-1 
Introduction 
Extracellular serine proteinase cascades are involved in some biological processes in 
vertebrates and invertebrates, such as blood coagulation and complement system in mammals, 
development and immune responses in invertebrates (Ashida, et al., 1997). Melanization, an 
insect defense response to wounding and infection, involves such a serine proteinase network. 
Insect PO is synthesized as inactive zymogen proPO. The proteolytic cleavage of proPO occurs 
as the final step in a serine proteinase cascade activated by tissue damage or microorganism 
invasion (Cerenius et al., 2008). The final step of proPO activation has been well studied in many 
insects. Three M. sexta PAPs effectively activate proPO to PO in the presence of cofactors, serine 
proteinase homologs (SPHs) (Yu et al., 2003). Three T. molitor PPAFs have been identified and 
two of them have been crystallized providing insights into the activation mechanism (Kan et al., 
2008; Park et al., 2007; Lee et al., 2004). 
To elucidate the complex pathway components, cDNA cloning and functional study of 
HPs are essential. HP1-HP4 were the first four serine proteinases isolated in M. sexta by 
designing degenerate primers coding for the conserved sequences around the catalytic residues 
(Jiang et al., 1999). After successfully isolated the four HP cDNAs, 20 additional HP cDNAs 
have been cloned (Jiang et al., 2005). It is reported that mRNA and protein levels of many HPs 
increase after the immune challenge. Polyclonal antibodies were generated against recombinant  
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HPs, which allows us to detect proteolytic cleavages occurred in plasma after bacterial injection.  
The initiation of M. sexta proPO activation is via HP14 autoactivation upon recognition of 
fungal surface components, which sequentially activate HP21, PAP-2 and -3, and eventually 
convert proPO to PO (Wang et al., 2007). Another clip-domain serine proteinase of M. sexta, HP6 
was identified. It was shown to occupy a position as the penultimate proteinase in two different 
immune pathways, one led to activation of proPO and the melanization response and the other 
triggered the activation of spätzle and synthesis of AMPs (An et al., 2009). Drosophia serine 
proteinase, Persephone, an ortholog to M. sexta HP6 is found to be involved in a fungal-specific 
branch of Toll receptor activation (Levashina et al., 1999; Ligoxygakis et al., 2002). Persephone 
can be activated either by the secreted fungal virulence factor PR1 or by endogenous proteolytic 
activity in hemolymph downstream of GNBP3 (Gottar et al., 2006). However, the activators of 
both M. sexta HP6 and Drosophila Persephone are not yet identified. 
As mentioned above, HP1 is one of the first four serine proteinases isolated in M. sexta. 
Based on sequence alignment, the proteolytic activation site of HP1 is predicted between residues 
Arg140 and Val141, which indicates that HP1 has trypsin-like specificity (Jiang et al., 1999). HP1 is 
most similar in sequence to the proclotting enzyme from horseshoe crab, T. tridentatus. HP1 
mRNA is expressed highly in hemocytes, but not in fat body. The amount of HP1 mRNA does 
not change significantly after E. coli injection (Jiang et al., 1999). No further study has been 
reported to investigate the biological functions of HP1. Recently, we found one HP1 clone whose 
sequence is slightly different from the one published. To distinguish them, we designate the 
published HP1 as HP1a and the new one as HP1b. Most of serine proteinases including HP1 are 
synthesized as zymogens in plasma. Their active forms are difficult to purify from hemolymph 
due to low concentrations and regulation by serpins. Expression catalytic domains of serine 
proteinase may provide a good way to obtain active proteinases and study their functions. 
Availability of recombinant zymogens and active forms of HPs may facilitate us to use them as 
substrates in pathway perturbation assays. 
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Here we report the expression and functional characterization of M. sexta, HP1. HP1 
zymogen forms, proHP1a and proHP1b, and the catalytic domains catHP1a and catHP1b were 
produced. These purified proteins were used as reagents to examine their proteolytic activity in 
vitro and in vivo. The role of HP1 in M. sexta proPO activation pathway was examined. We also 
analyzed the complex formed by HP1 and serpins in plasma. 
 
Materials and Methods 
Insects and hemolymph collection 
M. sexta eggs were originally purchased from Carolina Biological Supply, and the larvae 
were reared as described by Dunn and Drake. Control hemolymph was collected from cut prolegs 
of day 2, 5th instar larvae. Day 2, 5th instar larvae were injected with a mixture of formaldehyde-
killed E. coli (1×108 cells/larvae) and 100 μg of Micrococcus luteus (Sigma) suspended in 100 μl 
of saline (0.9% w/v of NaCl). Induce hemolymph was collected 24 h after injection. A few 
crystals of diethyldithiocarbamate and phenylthiourea were added to the tubes before collection to 
prevent melanization of hemolymph. Hemolymph from the naïve and induced insects were 
aliquoted and stored at -80°C. 
 
Expression and purification of M. sexta proHP1a, proHP1b, and catalytic domains of HP1, 
catHP1a and catHP1b 
ProHP1a was amplified by PCR using forward primer j1351 (5’-GAA TTC GAG ATT 
ACT CCG AAC TGC A-3’, EcoRI site underlined) and reverse primer j587 (5’-CTC GAG CCG 
TGC ATT CTC CAT G-3’, XhoI site underlined) from HP1a cDNA clone. ProHP1b was 
amplified by PCR using the same pair of primers (forward primer j1351 and reverse primer j587) 
from HP1b cDNA clone. CatHP1a was amplified by PCR using forward primer j586 (5’-CAA 
TTG GCG GCC GCC CAG CAA-3’, MfeI site underlined) and reverse primer j587 (5’-CTC 
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GAG CCG TGC ATT CTC CAT G-3’, XhoI site underlined) from HP1a cDNA clone. CatHP1b 
was amplified by PCR using the same pair of primers (forward primer j586 and reverse primer 
j587) from HP1b cDNA clone. 
The amplified fragment was purified with Wizard PCR Preps DNA Purification System 
(Promega) and ligated into pGEM-T vector (Promega). From the resulting plasmid, the EcoRI-
XhoI fragment for proHP1a/b and MfeI-XhoI fragment for catHP1/b were retrieved by restriction 
digestion and directionally inserted to the same sites of pMFH
6
 (Lu et al., 2008) a plasmid vector 
modified from pFastBac1, to generate recombinant baculovirus according to the manufacture’s 




-catHP1a/b was transformed 
into E. coli strain DH10Bac, which contains a bacmid and a helper plasmid. The recombinant 




-catHP1a/b donor plasmid was 
isolated. The insertion of proHP1a/b or catHP1a/b sequence in the recombinant bacmid was 
confirmed by PCR using a proHP1a/b or catHP1a/b gene-specific forward primer and a reverse 
primer located downstream of the transposition site on the bacmid.  
For protein expression, the initial viral stock (V
0
) was obtained by transfected Spodoptera 
frugiperda Sf9 cells with a bacmid-cellFECTIN mixture, and its titer was improved through serial 
infections. Sf9 cells (at 2.0×10
6
cells/ml) in 100 ml of Sf-900 II serum-free medium (Invitrogen) 
were infected with the baculovirus stocks at a multiplicity of infection of 10 and grown at 27°C 
for 96 h with gentle agitation (100 rpm). 
ProHP1a and proHP1b purifications were carried out using 500 ml of the cell culture 
medium. The cells were removed by centrifugation at 5,000×g for 15 min. The supernatant was 
mixed with an equal volume of distilled water (500 ml) with 1mM benzamidine at 4°C for 30 
min. After centrifugation at 12,000×g for 30 min, the cleared supernatant (1000 ml) was applied 
to a dextran sulfate (DS)-Sepharose column (40 ml) (Nakamura et al., 1985) equilibrated with 
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buffer A (10 mM potassium phosphate, pH 6.4, 1 mM benzamidine) and washed with 200 ml of 
buffer A, bound proteins were eluted with a linear gradient of 0-1.0 M NaCl in buffer A (100 ml). 
The fractions (4 ml/tube) were collected and aliquots of the fraction (7 μl) were subjected 
to SDS-PAGE and immunoblot analysis using HP1 antibody (Jiang et al., 1999). Fractions 
containing M. sexta proHP1a/b were pooled and applied onto nickel-nitrilotriacetic-acid-agarose 
column (2 ml), equilibrated with buffer B (50 mM potassium phosphate, pH 8.0, 300 mM NaCl, 
10 mM imidazole, 0.005% Tween-20) and washed with 10 ml of buffer B, bound proteins were 
eluted from the column with a linear gradient of 10-100 mM imidazole in buffer B (10 ml). 
Finally, tightly bound proteins were eluted with 5 ml of buffer B containing 250 mM imidazole. 
The fractions (1 ml/tube) were collected and subjected to SDS-PAGE and immunoblot analysis 
using HP1 antibody. Fractions containing proHP1a/b were pooled and concentrated using 
Amicon ultracentrifugal 30K MWCO filter device (Millipore). Buffer of the concentrated protein 
was exchanged with 20 mM Tris-HCl, pH 7.5, 50 mM NaCl using the same filter and stored at -
80°C in aliquots. CatHP1a/b was purified from the conditioned medium (1 liter) by the same 
protocol except for using Amicon ultracentrifugal 10K MWCO filter device (Millipore) to 
concentrate proteins. 
 
ProPO activation assay 
One μl of hemolymph was incubated for 30 min at room temperature with M. luteus (1 
μg/μl in saline, 1 μl) in the buffer (8 μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-
20). PO activity was measured by adding 150μl of 2 mM dopamine (in 100 mM sodium 
phosphate buffer, pH 7.5) as a substrate and monitoring A470 for 10 min on a microplate reader 
(Jiang et al., 2003a). Hemolymph samples which have low basal PO activity were selected for the 
assay. 
To dertermine the role of proHP1a/b or catHP1a/b in proPO activation, naïve hemolymph 
(1 μl), M. luteus (1 μg/μl, 1 μl), and proHP1a/b (100 ng/μl, 1 μl) or catHP1a/b (50 ng/μl, 1 μl) 
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were incubated in the buffer (7 μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-20) at 
room temperature for 30 min. PO activity  was measured using dopamine as described above. An 
average activity data were plotted as mean ± S.D. (n = 3) in the bar graph. Control reactions were 
plasma only and M. luteus with plasma. 
To test possible additive effect of proHP1- or catHP1-elicitor interaction on proPO 
activation, four samples were used as decribed above: naïve plama (1 μl in 9 μl buffer) (#1), 
elicitor (1 μg/μl, 1 μl) + plasma (1 μl in 8 μl buffer) (#2), enzyme (1 μl) + plasma (1 μl in 8 μl 
buffer) (#3) and elicitor (1 μg/μl, 1 μl) + enzyme (1 μl) + plasma (1 μl in 7 μl buffer) (#4). PO 




Cell-free hemolymph samples were collected as described above, and these plasma 
samples or purified proteins were separated by 10% SDS-PAGE. Immunoblot analysis was 
performed using rabbit polyclonal antiserum against HP6 as the primary antibody (diluted 1: 
2000) and goat anti-rabbit IgG-alkaline phosphatase conjugate (BioRad, diluted 1: 1000) as the 
secondary antibody. Amounts of hemolymph and each protein for a particular experiment are 
provided in the legends to Fig. 24, 27-29. 
 
Cleavage of M. sexta proHP6 by HP1 in the presence of CPC 
Purified recombinant proHP6 (An et al., 2009) was incubated with proHP1a in the 
presence of CPC, or various types of detergents in the buffer (20 mM Tris-HCl pH 7.0, 20 mM 
NaCl) at 37°C for 4 h. Amounts of each protein for a particular experiment are provided in the 
legends to Fig. 24, 26-29. 
 
Determination of amino-terminal sequences 
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Purified recombinant proHP6 (150 ng/μl, 2 μl) (An et al., 2009) was incubated with 
proHP1a (300 ng/μl, 2 μl) and 6 mM CPC (1 μl) in the buffer (10 μl, 20 mM Tris-HCl pH 7.0, 20 
mM NaCl) at 37°C for 4 h. The reaction mixture was treated with SDS-loading buffer containing 
DTT and separated on 10% SDS-PAGE. The protein was then transferred to a polyvinylidene 
difluoride (PVDF) membrane and stained with Coomassie Blue. The 30 kDa polypeptide 
corresponding to the cleaved HP6 was cut out and subjected to automated Edman degradation in 
Nevada Proteomics Center. 
 
Assay of amidase activity 
Purified recombinant proHP1a (250 ng/μl, 2 μl) or catHP1a (150 ng/μl, 2 μl) was 
incubated with various concentrations of cetylpyridinium chloride (CPC, 1 μl) in the buffer (7 μl, 
20 mM Tris-HCl pH 7.0, 20 mM NaCl) at room temperature for 5 min. The residual amidase 
activity was then measured using the artificial substrates, N-acetyl-Ile-Glu-Ala-Arg-p-nitroanilide 
(IEARpNa, 50 μM, 150 μl, Sigma) or N-acetyl-Leu-Asn-Leu-His-p-nitroanilide (LDLHpNa, 
100μM, 150 μl, KSU) by monitoring A405 in the kinetic mode on a plate-reader (Molecular 
Device). One unit activity is defined as ΔA405/min=0.001. Activity data were plotted as mean ± 
S.D. (n = 3) in the bar graph. 
 
Immuno-affinity purification of M. sexta HP1-serpin complex 
HP1 antibody-coupled Protein-A Sepharose CL-4B beads were prepared (Harlowet al., 
1988). Briefly, Protein-A Sepharose CL-4B beads (Sigma) were hydrated in PBS and washed 
three times with PBS. About 2 ml of the beads were resuspended in 10 ml of PBS and mixed by 
rotation for 2 h at room temperature with 2 ml of HP1 rabbit antiserum. Then the beads were 
washed three times with 10 volumes of PBS and twice with 10 volumes of 0.2 M sodium borate, 
pH 9.0. Solid dimethylpimelimidate was added to a final concentration of 20 mM to the beads 
resuspended in 10 volumes of 0.2 M sodium borate, pH 9.0 and mixed overnight at room 
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temperature. The coupling was terminated by washing the beads with 0.2 M ethanolamine-HCl, 
pH 8.0 and reacted with it for 2 h at room temperature. Finally, the beads were washed with PBS 
and stored in PBS at 4°C. 
To purify HP1-serpin complex from hemolymph, 15-20 ml of naïve hemolymph was 
collected from day 3 fifth instar larvae. The plasma was mixed with a protease inhibitor cocktail 
(Sigma, P-8849, 1 ml to 20 ml of plasma) and incubated for 10 min to inactivate proteases. The 
plasma was centrifuged at 5000×g for 15 min at 4°C to remove any precipitate. The supernatant 
was mixed overnight at 4°C with 2 ml of HP1-antibody-coupled Protein-A Sepharose CL-4B 
beads, and the mixture was packed into a column. The column (2 ml of bed volume) was washed 
with 20 volumes of 1 M NaCl and then 10 volumes of 10 mM sodium phosphate buffer, pH 6.5. 
Finally the column was eluted with 10 volumes of 100 mM glycine-HCl, pH 2.5, 10% ethylene 
glycol. Fractions (1 ml each) were collected into 0.1 ml of 1 M sodium phosphate, pH 8.0. The 
fractions were analyzed by 10%SDS-PAGE and immunoblotting analysis. 
 
Orbitrap MS analysis of M. sexta HP1-serpin complexes 
To identify HP1-serpin complexes after separation by SDS-PAGE, the complex bands 
were cut out, and Orbitrap mass spectrometry (MS) of tryptic fragments was performed by the 
Recombinant DNA/Protein Core Facility at Oklahoma State University. The protein bands were 
reduced with DTT and alkylated with iodoacetamide, and then subjected to in-gel trypsin 
digestion. The peptide masses were compared with the predicted masses of tryptic peptides 
derived from M. sexta hemolymph proteases in M. sexta database which includes the protein 
sequences from NCBI, and contig sequences from the pyrosequencing project (Zhang et al., 





cDNA sequence and structural features of M. sexta HP1b 
The cDNA sequence of HP1 was published previously (Jiang et al., 1999).  The open 
reading frame encodes a protein of 388 amino acid residues, with a predicted 14-residue secreted 
signal peptide. The calculated molecular mass of mature HP1 is 41,934Da and its calculated 
isoelectric point is 5.67. Recently we found one HP1 clone whose sequence is slightly different 
from the reported one. Thus, we designate the published one as HP1a and the new one as HP1b. 
The HP1b cDNA contains 1349 nucleotides, with a 10-bp 5’-noncoding region, a 1167-bp 
open reading frame, and a 172-bp 3’-noncoding region, including a 18-bp poly (A) tail. The 3’-
noncoding region contains one putative polyadenylation signals (AATAAA) (Fig. 19). The open 
reading frame encodes a protein of 388 amino acid residues, with a predicted 14-residue secreted 
signal peptide. There are two potential N-linked glycosylation sites at Asn205 and Asn261. The 
calculated molecular mass of mature HP1b is 41,843Da and its calculated isoelectric point is 
5.38. 
Based on sequence alignment, HP1a and HP1b are 89% identical and 95% similar in 
amino acid sequence (Fig. 20). The predicted proteolytic cleavage sites of HP1a and HP1b are 
located between Arg140 and Val141 indicating that the activating enzyme for proHP1 may be a 
serine proteinase with trypsin-like specificity. Both proHP1a and proHP1b are clip domain serine 
proteinases composing of an amino-terminal clip domain connected by a linker region to a 
carboxyl-terminal serine proteinase domain. Their catalytic domains include a catalytic triad of 
His182, Asp231, and Ser324. Their primary substrate-specificity pocket is likely composed of Asp318, 
Gly346, and Gly356, suggesting that HP1a and HP1b have the specificity for cleavage after 
positively charged amino acid residues, Lys or Arg. A new BLAST search indicated that M. sexta 
HP1 is most similar in amino acid sequence to B. mori hemocyte proteinase-1 (BAG70409.1), 




Expression and purification of M. sexta proHP1a, proHP1b, and catalytic domains catHP1a 
and catHP1b 
The fragment of proHP1a/b was inserted into the EcoRI-XhoI restriction site of the 
expression vector, pMFH6 which has a honeybee mellitin signal peptide and C-terminal (His)6-
affinity tag (Lu et al., 2008), and the fragment of catHP1a/b was inserted into the MfeI-XhoI 
restriction site of the same vector. The N-terminal residues “Val-Phe-Gly-Ser” of HP1a catalytic 
domain and the N-terminal residues “Val-Phe-Asp-Ser” of HP1b catalytic domain were replaced 
by “Gly-Ile-Gly-Gly” in order to fit into the expression vector and have the least changes in 
amino acid residues. All the recombinant proteins were soluble and secreted into the cell culture 
medium. After removing the cells from the culture, the protein was purified by ion exchange 
column and eluted from the dextran sulfate (DS) column with a linear gradient of NaCl. The 
elution fractions which contained the target proteins were pooled and loaded onto the nickel-
affinity column. The protein was eluted with a linear gradient of imidazole. The proHP1a and 
proHP1b migrated as a 50kDa single band (Fig. 21A and C) on 10% SDS-PAGE under reducing 
condition. The apparent molecular masses of proHP1a and proHP1b were greater than the 
predicted masses for the mature proenzyme. This may indicate that proHP1 is post-translationally 
modified by glycosylation. CatHP1a and catHP1b migrated as a 30kDa band (Fig. 21B and D) on 
10% SDS-PAGE under reducing condition.  
 
Roles of proHP1a and proHP1b in M. sexta proPO activation 
To study the roles of proHP1a and proHP1b in M. sexta proPO activation cascade, control 
hemolymph was incubated with microbial elicitor, M. luteus and recombinant proHP1a and 
proHP1b. The control hemolymph sample had low basal PO activity and could be activated 
substantially by M. luteus, which indicated that the proPO activation system was functional in the 
hemolymph. As shown in Fig. 22, there was an increase of PO activity when proHP1a or 
proHP1b was added to the control hemolymph in the absence of microbial elicitor. When 
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proHP1a or proHP1b, M. luteus, and control hemolymph were incubated together, a greater 
enhancement of PO activity was observed than the one when hemolymph was incubated with 
proHP1a or proHP1b only. But the statistical analysis indicated that there was no additive effect 
of proHP1a and M. luteus , or proHP1b and M. luteus on increase of PO activity. 
 
Roles of catHP1a and catHP1b in M. sexta proPO activation 
The roles of catHP1a and catHP1b in M. sexta proPO activation cascade were also 
investigated (Fig. 23). The control hemolymph with low basal PO activity and high sensitiviry to 
M. luteus was incubated with microbial elicitor and catHP1a or catHP1b prior to PO activity 
measurement. A dramatic increase of PO activity was observed when catHP1a alone was added 
into hemolymph, and a moderate increase of PO activity when catHP1b alone was incubated with 
hemolymph. When catHP1a or catHP1b, M. luteus, and control hemolymph were incubated 
together, PO activity was as high as catHP1a or catHP1b alone was incubated with hemolymph, 
indicating that there was no additive effect of either catHP1a or catHP1b and M. luteus on 
enhancement of PO activity. 
 
M. sexta proHP6 cleavage in plasma by catHP1a and catHP1b 
We used immunoblot analysis to investigate which endogenous serine proteinase(s) can 
be activated by catHP1a in M. sexta plasma with various antibodies against hemolymph serine 
proteinases (Jiang et al., 2005). There was no major difference in HP2, HP5, HP9, HP12-19, 
HP21, HP22, HP25, PAP-2 and PAP-3 precursor levels (data not shown). On the other hand, the 
cleavage of proHP6, proHP8 and proPAP-1 were observed (Fig. 24A). Proteolytic activation of 
proHP6 is predicted to resulting in decrease intensity of a band corresponding to HP6 zymogen 
and the appearance of a band corresponding to the HP6 carboxyl-terminal catalytic chain (our 
antisera to HP6 does not react well with the light chain). ProHP6 zymogen band was detected in 
plasma, and the intensity of this band decreased while a new band corresponding to the carboxyl-
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terminal catalytic chain appeared after catHP1a was added into the plasma. After catHP1a 
treatment, the intensity of proHP8 zymogen band detected in plasma decreased, but no clip 
domain band or catalytic domain band was detected. ProPAP-1 zymogen band and clip domain 
band were observed in plasma before catHP1a addition (our antisera to PAP-1 did not react well 
with its catalytic heavy chain, Wang et al., 2008). The zymogen band disappeared and the 
intensity of the clip domain band increased after catHP1a was added into plasma. According to 
the previous study (An et al., 2009), HP6 activates proHP8 and proPAP-1. Therefore, the 
proteolytic cleavages of proHP8 and proPAP-1 may be caused by the activation of proHP6 after 
catHP1a was added into hemolymph. We propose the hypothesis that the activation of proHP6 
may be related to HP1. 
To further observe the cleavage of proHP6 in plasma, naïve and induced hemolymph 
samples were used, and catHP1a or catHP1b were added into plasma. The 37 kDa proHP6 
zymogen band was detected in both naïve and induced plasma, and this band disappeared after 
plasma was treated with bacteria as was reported previously (An et al., 2009), or after catHP1a or 
catHP1b was added into plasma (Fig 24B and C). The disappearance of the proHP6 zymogen 
correlated with the appearance of a higher molecular weight band not detected in the hemolymph 
alone sample. This band is likely a covalent complex of HP6 catalytic chain with a serpin present 
in plasma. The appearance of serpin-proteinase complexes is a strong evidence that HP6 was 
indeed activated. The addition of recombinant proHP6 to plasma to increase it concentration led 
to increase in intensity of the zymogen band detected by immunoblot analysis. After treating 
proHP6-supplemented plasma with bacteria or catHP1a/b, a putative HP6-serpin complex 
appeared as well as an additional band at 30 kDa, representing the HP6 catalytic domain. Under 
non-reducing condition (SDS loading buffer without DTT or beta-mercaptoethonal), the active 
HP6 bands migrated as a series of bands around 37 kDa, indicating that the clip domain chain and 
catalytic chain remain attached by an interchain disulfide bond after cleavage. 
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In order to see if catHP1a or catHP1b was able to cleave proHP6 directly in vitro, 
catHP1a or catHP1b was incubated with proHP6 in the absence of plasma at 37°C for 2 h. Then 
the reaction mixture was subjected to immunoblotting using HP6 antibody. No cleavage of 
proHP6 was observed (result not shown). We further measured the amidase activity of catHP1a 
using artificial substrate, LDLHpNa. The activity was low (Fig. 25B), which might be the reason 
that catHP1a or catHP1b could not cleave proHP6 directly. 
 
CPC-induced M. sexta proHP1a, catHP1a, proHP1b and catHP1b amidase activities 
Insect proPO was reported to be activated by a cationic detergent, cetylpyridinium 
chloride (CPC) besides proteolytic cleavage (Hall et al., 1995). CPC was used to test if it can 
enhance the amidase activities of proHP1a. CPC concentration was optimized for proHP1a 
activation. The greatest enhancement occurred when proHP1a was incubated with 6 mM CPC in 
the reaction mixture (Fig. 25A). The result showed that proHP1a activation did not act in a CPC-
concentration-dependent manner, suggesting that the concentration of CPC is critical to enzyme 
activation and denaturation. ProHP1a had low activity when CPC concentrations were below 6 
mM, and the activity did not increase when CPC concentrations were higher than 6 mM, 
suggesting that CPC worked best at 6 mM for proHP1a activation. The activation caused by CPC 
occurred well below its critical micellar concentration (0.8 M) (Hall et al., 1995). 
Optimal amount of CPC (6 mM) was used to test if it can enhance the amidase activities 
of the four enzymes using another colorimetric substrate, LDLHpNa which mimicked the 
cleavage site of proHP6. ProHP1a, catHP1a and catHP1b had a greater increase in activity after 
CPC treatment, whereas proHP1b had a small increase in activity after incubation with CPC (Fig. 
25B and C). 
 
M. sexta proHP6 alternative cleavage by proHP1a in the presence of detergents 
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In Fig. 26A, immunoblot analysis using HP6 antibody showed that HP6 zymogen 
(proHP6) migrated at a molecular mass of 37 kDa. No cleaved band was detected when proHP6 
was incubated with proHP1a or CPC alone. A new 30 kDa band was observed when proHP6 was 
incubated with proHP1a and CPC, while the HP6 zymogen band disappeared. ProHP1a, proHP6, 
and proHP1a with CPC were used as negative controls. The positive control using plasma 
incubated with microbial elicitor was included as well. As described previously, in the positive 
control, the disappearance of the proHP6 zymogen correlated with the appearance of a faint 30 
kDa band and a higher molecular weight band not detected in the hemolymph alone sample. The 
novel cleaved band in Lane 6 migrated at the similar position as the one in Lane 8. Edman 
degradation showed that the sequence of the 30 kDa band in Lane 6 matches sequence at the N-
terminus of HP6 zymogen (proHP6-ΔC) (Table. 2), indicating that the hydrolysis did not occur at 
the activation site but within the catalytic domain. This was confirmed by immunoblot analysis 
under reducing and non-reducing conditions (Fig. 26B). If the hydrolysis occurs at the activation 
site, under non-reducing condition, the active HP6 migrated as a series of bands around 37 kDa 
(Fig. 25B and C), indicating that the clip domain chain and catalytic chain remain attached by an 
interchain disulfide bond after cleavage. However, we detected two bands in Lane 2 of Fig. 8B 
under non-reducing condition, suggesting that the cleavage site was in the catalytic domain. 
Various detergents were tested to see if it would help the cleavage of proHP6 by proHP1a. 
Different types of detergents were tested. CPC and CTAB are cationic detergents, SDS is anionic 
detergent, Triton-X114, Tween-20 and NP-40 are non-ionic detergent. Of all these various types 
of detergents, only cationic detergents, CPC and CTAB helped proHP1a to process proHP6 at the 
non-activation site (Fig. 26C), as the 30 kDa was not able to jump to the 37 kDa band under non-
reducing condition. 
 
M. sexta proHP6 alternative cleavage by proHP1a, proHP1b, catHP1a and catHP1b in the 
presence of CPC 
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We showed that in the presence of detergent CPC, proHP1a was able to process proHP6 
in an alternative way (Fig. 26). In order to investigate if other forms of HP1 could react with 
proHP6 in the same way, recombinant HP6 zymogen was incubated with proHP1a, proHP1b, 
catHP1a and catHP1b respectively in the presence of CPC. The cleavage of hemolymph proHP6 
in the presence of microbial elicitor was used as the control. The results showed that after HP6 
zymogen was incubated with proHP1a and CPC for 4 h, the HP6 zymogen was completed 
cleaved into the alternative cleavage band (proHP6-ΔC) (Fig. 27). The similar cleavage occured 
when proHP6 was incubated with catHP1b and CPC except that proHP6 was incompletely 
cleaved. Two bands appeared when HP6 zymogen was incubated with proHP1b and CPC, or with 
catHP1a and CPC. One cleaved band was corresponding to the band proHP6-ΔC (data not shown 
under non-reducing condition). But the other band was not identified. 
 
M. sexta hemolymph corrects HP6 activation by catHP1b 
We previously found that proHP6 can be activated in hemolymph by catHP1a or catHP1b 
in the absence of microbial elicitors (Fig. 24). However, when HP6 zymogen was incubated with 
catHP1a or catHP1b alone without hemolymph, the activation did not occur. When HP6 zymogen 
was incubated with catHP1a or catHP1b in the presence detergent CPC, proHP6 was processed in 
a different way. These results indicated that some hemolymph factor(s) in the hemolymph was 
important to correct HP6 activation. We reduced the amount of naïve plasma from one micro liter 
to one tenth micro liter in the reaction mixture of plasma, recombinant proHP6 and catHP1b. The 
activation of HP6 occurred when one half or one fourth micro liter was present, but the amount of 
active HP6 decreased as the amount of plasma reduced (Fig. 28). Under non-reducing condition, 
the active HP6 bands migrated to 37 kDa, indicating that the cleavage occurred between the clip 
domain and the catalytic domain. When the amount of plasma reduced to one tenth micro liter, no 




Effects of M. sexta hemolymph and CPC on the activation of HP6 
In order to study the addictive effects of hemolymph and CPC on the activation of 
proHP6, a series of diluted hemolymph were combined with proHP6 and catHP1b in the presence 
of three different concentrations of CPC. Results suggested that CPC at the concentration of 0.6 
mM works best for processing of HP6 in all dilutions of naïve or induced hemolymph (Fig. 29A 
and B). This CPC concentration (0.6 mM) is ten times lower than that used when proHP6 was 
incubated with catHP1b in the absence of hemolymph. However, since the reaction mixtures were 
not subjected to SDS-PAGE under non-reducing condition, it is not known whether the cleavage 
is between the clip domain and the catalytic domain. After the optimal CPC concentration (0.6 
mM) was determined, we combined proHP6, catHP1b, and CPC (0.6 mM) with a series of diluted 
hemolymph and separated the reaction mixtures under reducing and non-reducing conditions. The 
amount of active HP6 did not decrease significantly as the amount of plasma reduced (Fig. 29C), 
when compared to the results showed in Fig. 28, which might be due to the addition of CPC. 
When the amount of hemolymph reduced to one eighth micro liter, a significant amount of 
cleaved HP6 was not able to migrate back to 37 kDa (Fig. 29C, lane 6, -DTT), which means this 
cleavage site is different from other reaction samples in which the cleavage was between the clip 
domain and the catalytic domain. Only a very little of cleaved HP6 was not able to migrate back 
to 37 kDa (Fig. 29C, lane 5, -DTT), indicating that the HP6 cleaved band in lane 5 (+DTT) 
consisted of different cleavage products which coincidently migrated at the same position. These 
results suggested that hemolymph factor(s) is important for correct cleavage of proHP6 and CPC 
helps catHP1b process more HP6 zymogens. 
 
Inhibition of M. sexta HP1 activation 
To investigate the regulation of HP1, we tested if activation of proHP1 could be inhibited 
by some serpin(s) in M. sexta hemolymph. Previous study showed that HP1 was detected in the 
M. sexta serpin-4 and serpin-5 complex (Tong et al., 2005). However, the size of the HP1-serpin-
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4/5 complexes they purified was around 90 kDa which was larger than the predicted size of the 
complex consisting of the catalytic domain of HP1 and serpin-4/5. Therefore, we want to further 
characterize the 90 kDa complex of HP1. First, we tried to detect HP1-serpin complex in 
hemolymph. 0-35% AS fraction of hemolymph was incubated with microbial elicitor or 
recombinant serpin-4. No cleavage products were detected for HP1 after incubation of plasma 
with microbial elicitor, but a more intense band possibly representing HP1-serpin complex was 
detected by both HP1 and serpin-4 antibodies, when additional recombinant serpin-4 was added 
into plasma (Fig. 30), suggesting that active HP1 was inhibited by serpin-4. Less intense bands 
were observed in plasma alone, which indicated that HP1 possibly has been active without 
bacterial stimulation. 
 
Purification and identification of M. sexta HP1-serpin complex 
In Tong’s paper, he used immunoaffinity chromatography with serpin antibodies to isolate 
serpin-protease complexes and detected that HP1 was contained in both serpin-4-protease and 
serpin-5-protease complexes (Tong et al., 2005). In this study, we used immunoaffinity 
chromatography with HP1 antibody to isolate HP1-serpin complex and to further characterize the 
complex. According to the results shown in Fig. 30, microbial elicitor had little effect on complex 
formation. Thus, naïve hemolymph was not challenged by bacteria before purification. The 90 
kDa complex band was showed in Coomassie Blue stained gel and recognized by HP1, serpin-4 
and serpin-5 antibodies (Fig. 31), which was consistent with the previous results (Tong et al., 
2005). Other plasma proteins that co-purified with the complex were not recognized by HP1 
antibody. One band around 75kDa was recognized by serpin-4 antibody, but not HP1 or serpin-5 
antibodies. This band probably was the complex formed by serpin-4 with other protease that co-
purified with serpin-4. 
 
Identification of HP1 and serpins in M. sexta HP1-serpin complex 
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To identify the components in the complex, peptide mass fingerprint analysis was used. 
Masses of tryptic peptides derived from the 90kDa band matched well with those of the predicted 
tryptic peptides of serpin-4 and serpin-5. The experimental peptide masses of the 90kDa complex 
covered 34% of the sequence of serpin-4 (Fig. 34) and 31% of the sequence of serpin-5 (Fig. 35).  
Masses of tryptic peptides derived from the 90 kDa complex band matched well with 
those of the predicted tryptic peptides of HP1 as well, including peptides present only in isoform 
a or b (Fig. 32 and 33), indicating that both forms of HP1 are present in plasma and can form 
HP1-serpin complex. The experimental peptide masses of the complex covered 21% of the 
sequence of HP1a (Fig. 32) and 12% of the sequence of HP1b (Fig. 33). Surprisingly, peptides of 
HP1a (INQAQNR) and HP1b (ISQAQNR and GCGLSTRPQGR) in the linker region which is 
located between clip domain and catalytic domain were detected by mass fingerprint analysis. In 
SDS-PAGE of a protease-serpin complex, it is expected that the catalytic domain of the 
proteinase will remain connected to the serpin through a covalent bond, and the clip domain is 
released under reducing condition due to reduction of the disulfide bond that links the clip and 
protease domains. According to Tong’s results, only the tryptic peptides in the catalytic domain 
of HP1 were detected. Amino-terminal sequencing of the complex containing HP1 and serpin-4 
or serpin-5 yielded the N-terminal sequences of serpin-4 and serpin-5, but failed to detect 
sequence of HP1, perhaps due to blocking of the amino terminus of HP1 (Tong et al., 2005). The 
detection of the peptides in the linker region of a proteinase formed in a proteinase-serpin 
complex is uncommon. Since such peptides were observed in both isoform a and b of HP1, the 
results were meaningful. 
 
Discussion 
During the last decade, an increasing number of studies have investigated the serine 
proteinase cascade involved in immune responses in invertebrates, such as the proPO activation 
pathway and Toll immune pathway. The genetic studies of the Drosophila immune response have 
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elucidated the role of several serine proteinases in the activation of the Toll receptor. In M. sexta, 
the large moth, more than 20 serine proteinases cDNAs have been isolated from fat body and 
hemocytes (Jiang et al., 2005). Only a few of these hemolymph proteinases have been studied 
functionally. M. sexta HP6, an ortholog of Drosophila Persephone, functions in proPO activation 
leading to melaniztion, and spätzle activation leading to antimicrobial peptides synthesis (An et 
al., 2009). HP6 was found to be activated in hemolymph in the absence of microbial elicitor, 
indicating the existence of an endogenous activating proteinase. However, such proteinase has not 
yet been identified. 
HP1b cDNA sequence was recently found. HP1a and HP1b are highly similar in amino 
acid sequence (Fig. 20). We produced recombinant HP1 zymogen forms, proHP1a and proHP1b, 
and the catalytic domains of HP1, catHP1a and catHP1b. These purified proteins were used as 
reagents for in vitro experiments to examine their proteolytic activity and for in vivo experiments 
in the complex protein mixture present in hemolymph. 
Addition of proHP1a or proHP1b to plasma resulted in activation of proPO, but no 
addictive effect of proenzymes and M. luteus on increase of PO activity (Fig. 22). A dramatic 
increase of PO activity was observed when catHP1a alone was added into naïve hemolymph, 
suggesting that catHP1s are active or partially active enzymes that can directly or indirectly 
cleave unknown proteinase(s) in hemolymph to trigger proPO activation without microbial 
elicitors. All available antibodies against hemolymph proteinases were used to investigate which 
endogenous proteinase(s) can be activated by catHP1a in M. sexta plasma. The cleavages of 
proHP6, proHP8 and proPAP-1 were observed after catHP1a alone was incubated with plasma 
(Fig. 24A). ProHP8 and proPAP-1 were reported to be activated by HP6 (An et al., 2009). 
Therefore, our results indicate that such proteolytic cleavage of proHP6 is related to HP1 and is 
physiologically functional.  
No cleavage of proHP6 occurred when proHP6 was incubated directly with catHP1a or 
catHP1b in vitro, which is possibly due to low amidase activity of catHP1s. Insect proPO was 
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reported to be activated by CPC besides proteolytic cleavage (Hall et al., 1995). An increase of 
proHP1a amidase activity was observed after addition of CPC (Fig. 25), which may due to the 
exposure of the active site of proHP1a in the presence of the detergent. Surprisingly, the cleavage 
of proHP6 by proHP1a in the presence of CPC did not occur at the activation site but within the 
catalytic domain (Fig. 26), which is confirmed by N-terminal sequencing (Table. 2). This also 
happened in Drosophila serine proteinase Grass (Kellenberger et al., 2011). Since the endogenous 
activator of Grass in Drosophila is unknown, Grass zymogen was submitted to proteolysis by 
bovine and porcine pancreatic trypsin. Their result showed that the cleavag specifically occurred 
within catalytic domain, not at the activation site 
Results showed that when proHP6 was incubated with catHP1a or catHP1b in the 
presence of very low amount of hemolymph and absence of CPC, proHP6 was cleaved at its 
activation site (Fig. 28), indicating that some hemolymph factor(s) is contributed to the cleavage 
of proHP6 at its correct activation site. M. sexta proPO activation requires both PAP-1 and SPHs 
(Yu et al., 2003). In order to identify such factor(s), we tried to add SPHs into the reaction 
mixture including proHP6, proHP1a and CPC. The cleavage site was not corrected (data not 
shown). Then a few recognition proteins, such as GNBP, PGRP1 or βGRP2 were tried. They did 
not work either (data not shown). So far, such hemolymph factors have not been identified. An 
alternative cleavage was observed in Drosophila Persephone, the ortholog of M. sexta HP6. They 
incubated immunoprecipitated Persephone collected from the hemolymph of unchallenged wide-
type flies with purified preparations of fungal virulence factor 1 (PR1), a fungal protease. This 
digestion produced a 33 kDa and a 28 kDa band (Gottar et al., 2006). The 28 kDa band has the 
similar molecular weight to the predicted Persephone catalytic domain and may correspond to the 
active form of Persephone, and the 33 kDa was unidentified. The over-expression of Persephone 
can also lead to the appearance of the 33 kDa band. Interestingly, the B. mori clip-domain 
protease BAEEase is processed first into a 33 kDa band, and second, into a 29.5 kDa band, the 
latter processing event being essential for activation (Jane et al., 2006). They found that the 
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cleavage site of the 33 kDa band is located in the linkage region before the activation site. It is not 
known that if all such alternative cleavages occurred in M. sexta HP6, Drosophila Persephone 
and B. mori BAEEase have physiological function. 
Kellenberger et al. (2011) has established a modified classification of the clip-SPs into 
three classes based on the phylogenetic analysis by Jiang and Kanost (2000). Members of Group 
1 are predicted to have one helix between Cys3 and Cys4 in the clip domain and one helix 
centered on a cysteine of the linker. Group 2 contains two helices between Cys3 and Cys4. The 
Group 1 clip domains contain 8-16 residues between Cys3 and Cys4, whereas Group 2 clip 
domains have a longer sequence of 22-26 residues in this region. The clip domains that are 
devoid of any helical secondary structure form Group 3. According to their analysis, Group 3 
contains only inactive clip-SPHs (Kellenberger et al., 2011). Members of Group 1 are in 
penultimate position, suggesting that they are enzymes upstream in the pathways having terminal 
proteinases as their substrates. Group 2 are terminal clip-SPs known to activate spätzle or proPO. 
The terminal proteinases all have a basic residue, Arg or Lys, at their activation site, whereas the 
penultimate proteinases instead have Leu (M. sexta HP21, Drosophila snake), His (M. sexta HP6, 
Drosophila Persephone), or Ser (Drosophila Spirit) at this position, indicating that proteinases of 
quite different specificity are required as activating enzymes for Group1 and 2. Both M. sexta 
HP6 and HP1 fall into Group 1 displaying the classical clip-SP cysteine organization consisting 
of Clip (6 Cys) + linker (1 Cys) + SP (7 Cys). According to the classification analysis of the clip 
domains and our results, it is possible that HP1 activates HP6 with the help of other factor(s) in 
M. sexta hemolymph. 
The HP1-serpin complex was isolated using immunoaffinity chromatography with HP1 
antibody. Three peptides in the linker region of HP1a (INQAQNR) and HP1b (ISQAQNR and 
GCGLSTRPQGR) were detected by MS. The three peptides were not detected (Tong et al., 2005). 
Furthermore, we found that catHP1a or catHP1b failed to form complex with either serpin-4 or 
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serpin-5 in vitro (data not shown). According to these results, we propose that HP1 may form 










1    GTTTGGTAAAATGATTTTTGTGTTTCTTCTTTTGCTGGTGTCTGTGTGTGCAGAAAAAGGAGATTACTCCGAACTGCAGCACCCAGCATG 
            -14 M  I  F  V  F  L  L  L  L  V  S  V  C  A  E  K  G  D  Y  S  E  L  Q  H  P  A  W 
91   GGAAGACATTACAGAAGAAGGAGGCATGCACATCGGAGGCGGCAGGTCTAAACGATTCATTCAACTAAACCCCAATCTGGGAAATGTCGC 
14     E  D  I  T  E  E  G  G  M  H  I  G  G  G  R  S  K  R  F  I  Q  L  N  P  N  L  G  N  V  A 
181  CTACCAAGCTTGCACACTCCCGAACGGCAAGCAAGGCCACTGCCGCCACCTGCGCTTCTGCATCCAGGACGATTTCAAACAGGACTTCGT 
44     Y  Q  A  C  T  L  P  N  G  K  Q  G  H  C  R  H  L  R  F  C  I  Q  D  D  F  K  Q  D  F  V 
271  TAAATTCATGAATTACATTTGTGTTATACAAGGCCGGTCAATGGGCGCGTGCTGCCCGGATGACACGACAGTAGGAGGTCCAGAGGGTTT 
74     K  F  M  N  Y  I  C  V  I  Q  G  R  S  M  G  A  C  C  P  D  D  T  T  V  G  G  P  E  G  L 
361  GGCTGGAGAACTGCCGGCAACCGCGCCTCAGGAAGGAGAAGACGAGACTCTGATAAAGATAAGCCAAGCACAGAATAGAGGTTGTGGTCT 
104    A  G  E  L  P  A  T* A  P  Q  E  G  E  D  E  T  L  I  K  I  S  Q  A  Q  N  R  G  C  G  L 
451  AAGCACGCGACCCCAAGGCAGAGTATTCGACTCCCGCCCAGCAAACCCTCGGGAGTGGCCGTGGATGGCTTCCATCACACCTGAAGGCTA 
134    S  T  R  P  Q  G  R ║V  F  D  S  R  P  A  N  P  R  E  W  P  W  M  A  S  I  T  P  E  G  Y 
541  CGAGCGGTACTGCGGCGGAGTGCTGATCACAGAGCGGCATGTCCTCACAGCAGCTCATTGCACTGACAAGTTTGAGGCGAATGAACTATA 
164    E  R  Y  C  G  G  V  L  I  T  E  R  H  V  L  T  A  A  H※ C  T  D  K  F  E  A  N  E  L  Y 
631  CGTCCGGCTTGGAGAATATGACTTCAAGCGGACCAACGACACTCGCTCCTACAACTTCAGGGTGGTGGAGAAGGTCCAACACTTTGACTT 
194    V  R  L  G  E  Y  D  F  K  R  T  N# D  T  R  S  Y  N  F  R  V  V  E  K  V  Q  H  F  D  F 
721  TGAGACACTGAACTACCATCACGACATCGCCATACTGAAGCTGGACAAGCCTGCTACCTTCAACACTTACGTGTGGCCGATATGTCTGCC 
224    E  T  L  N  Y  H  H  D※I  A  I  L  K  L  D  K  P  A  T  F  N  T  Y  V  W  P  I  C  L  P 
811  GCCGCCTGGATTGAGTATCGAGAATGAAACTGTCACCGTCATTGGTTGGGGCACTCAATCGTTCGGTGGGCCGGATAGCCACATCCTTTT 
254    P  P  G  L  S  I  E  N# E  T  V  T  V  I  G  W  G  T  Q  S  F  G  G  P  D  S  H  I  L  L 
901  GGAAGTGTCGTTCCCAATTTGGACTCACGAGAAGTGCATCGAGGCGCACACCAACTCTATATTTGACGAGAATTATTGCGCCGCGGGACT 
284    E  V  S  F  P  I  W  T  H  E  K  C  I  E  A  H  T  N  S  I  F  D  E  N  Y  C  A  A  G  L 
991  CGAGGGAGGCAGGGATGCTTGTCAGCACGACAGTGGCGGCCCGCTGATGTATCAAATGCCAAGCGGCCGGTGGGCAGTGGTGGGCATCGT 
314    E  G  G  R  D@ A  C  Q  H  D  S※G  G  P  L  M  Y  Q  M  P  S  G  R  W  A  V  V  G  I  V 
1081 GTCCTGGGGCGTCGGCTGTGGGGACCCCAGCCATCCCGGGATATACACGCGCGTCGACAAATACCTCGGATGGATCATGGAGAATGCACG 
344    S  W  G@ V  G  C  G  D  P  S  H  P  G@ I  Y  T  R  V  D  K  Y  L  G  W  I  M  E  N  A  R 
1171 GTTTTAGAAAAACCCATTTCAACGTTAACTGCAACTCGATAACTTGTTGAAAATGAAAAGAATTTTTGTTCGTTTTTTTTTCACAGTTTA 
374    F  *  
1261 CATTTCCGATATAAATTTAAATTTAATATTTTTATGGGTTTAAAATGCTGAATAAATTTATTTTTAAATGCAAAAAAAAAAAAAAAAAA 1349 
 
 
Figure 19. Nucleotide and deduced amino acid sequence of M. sexta HP1b. The one-letter 
code for amino acid residue is shown below the nucleotide sequence and aligned with the second 
nucleotide of the corresponding codon. Numbers on the left are assigned to nucleotide residues 
and amino acid residues, including negative numbers for residues in the signal peptides which are 
underlined. Putative N-linked glycosylation sites are marked with # after the Asn residues. 
Putative O-linked glycosylation sites are marked with * after the Thr residues. The predicted 
proteolytic cleavage site is marked by ║. The catalytic triad residues are marked by ※. The 
residues that make the primary substrate-specificity pocket are marked by @. The putative 













Ms HP1a   MIFVFLLLLVSVCSEKGDYSELQHPAWEDIIEEGGMHIGGGRSKRFIQLNPNQGNVAYQA 
Ms HP1b   MIFVFLLLLVSVCAEKGDYSELQHPAWEDITEEGGMHIGGGRSKRFIQLNPNLGNVAYQA 
          *************:**************** ********************* ******* 
 
Ms HP1a   CTLPSGKQGHCRHLRFCIQEDFKQDFVKFMNYVCVIQGQSMGVCCPEDTTVGGPEGLAGD 
Ms HP1b   CTLPNGKQGHCRHLRFCIQDDFKQDFVKFMNYICVIQGRSMGACCPDDTTVGGPEGLAGE 
          ****.**************:************:*****:***.***:************: 
 
Ms HP1a   LPATAPQEGEDETLLKINQAQNRGCGLSTRAQGR║VFGSRPANPREWPWMASITPEGFEQY 
Ms HP1b   LPATAPQEGEDETLIKISQAQNRGCGLSTRPQGR║VFDSRPANPREWPWMASITPEGYERY 
          **************:**.************.*** **.*******************:*:* 
 
Ms HP1a   CGGVLITDRHVLTAAHCTRRWEANELYVRLGEYDFKRTNDTRSYNFRVVEKVQHVDFEIS 
Ms HP1b   CGGVLITERHVLTAAHCTDKFEANELYVRLGEYDFKRTNDTRSYNFRVVEKVQHFDFETL 
          *******:********** ::*********************************.***   
 
Ms HP1a   NYHHDIAILKLDKPAIFNTYVWPICLPPPGLSIENETVTVIGWGTQWYGGPHSHVLMEVS 
Ms HP1b   NYHHDIAILKLDKPATFNTYVWPICLPPPGLSIENETVTVIGWGTQSFGGPDSHILLEVS 
          *************** ****************************** :***.**:*:*** 
 
Ms HP1a   FPIWTHQNCIEVHTNSIFDESICAGGHEGGRDACQGDSGGPLMYQMPSGRWAVVGIVSWG 
Ms HP1b   FPIWTHEKCIEAHTNSIFDENYCAAGLEGGRDACQHDSGGPLMYQMPSGRWAVVGIVSWG 
          ******::***.********. **.* ******** ************************ 
 
Ms HP1a   VRCGEPNHPGIYTRVDKYIGWIMENARF 
Ms HP1b   VGCGDPSHPGIYTRVDKYLGWIMENARF 
          * **:*.***********:********* 
 
Figure 20. Sequence alignment of M. sexta HP1a with HP1b. The amino acid sequences of M. 
sexta HP1a and HP1b are aligned. The signal peptide sequences are underlined. The predicted 
proteolytic cleavage sites are indicated by “║”. “*” indicates positions which have an identical 
residue. “:” indicates positions which have strong conserved residues. “.” indicates positions 
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Figure 21. Purification of M. sexta proHP1a, proHP1b, catHP1a and catHP1b from the 
baculovirus-infected insect cells. Purified proteins were analyzed on 10% SDS-PAGE and 
Coomassie Blue staining. A, proHP1a (200 ng/μl, 6 μl); B, proHP1b (100 ng/μl, 2 μl); C, catHP1a 
(100 ng/μl, 5 μl); D, catHP1b (100 ng/μl, 3 μl). Positions and sizes of marker proteins are 





























plasma          +           +          +          +                  plasma        +          +          +         + 
M.luteus                     +                       +                 M. luteus                  +                     + 
proHP1a                                +           +                 proHP1b                              +         + 
 
Figure 22. Roles of proHP1a and proHP1b in M. sexta proPO activation. Naïve hemolymph 
(1 μl), M. luteus (1 μg/μl, 1 μl), and proHP1a/b (100 ng/μl, 1 μl) were incubated in the buffer (8 
μl, 20 mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-20) at room temperature for 30 min. 
PO activity (mean ± S.D., n = 3) was measured using dopamine as a substrate. Control reactions 





















plasma       +          +          +          +                 plasma       +          +          +         + 
M.luteus                 +                      +                 M. luteus                 +                     + 
catHP1a                              +         +                 catHP1b                              +         + 
 
Figure 23. Roles of catHP1a and catHP1b in M. sexta proPO activation. Naïve hemolymph (1 
μl), M. luteus (1 μg/μl, 1 μl), and catHP1a/b (50 ng/μl, 1 μl) were incubated in the buffer (8 μl, 20 
mM Tris-HCl pH 8.0, 1 mM CaCl2, 0.001% Tween-20) at room temperature for 30 min. PO 
86 
 
activity (mean ± S.D., n = 3) was measured using dopamine as a substrate. Control reactions were 
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naive plasma    +      +               naive plasma   +      +                naive plasma  +      + 
catHP1a            +                       catHP1a           +                        catHP1a          + 
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HP6 catalytic domain 
naive plasma     +    +    +    +    +     +    +       +   +    +    +   +    +   + 
M. luteus                   +    +                                      +    + 
proHP6                           +                  +    +                  +                +   + 
catHP1a                                +            +                               +         + 





























HP6 catalytic domain 
induced plasma +    +    +    +    +    +    +       +   +    +    +   +    +   + 
M. luteus                   +    +                                      +    + 
proHP6                           +                 +    +                  +                +   + 
catHP1a                                +           +                               +         + 
catHP1b                                       +          +                              +         + 
 
Figure 24. Cleavage of M. sexta proHP6 in plasma by catHP1a and catHP1b. A, Naive 
plasma (1 μl) was incubated with catHP1a (50 ng/μl, 1 μl) in the buffer (8 μl, 20 mM Tris-HCl 
pH 7.0, 20 mM NaCl) at room temperature for 30 min; B, Purified proHP6 (100 ng/μl, 1 μl) was 
incubated in the buffer (7 μl, 20 mM Tris-HCl pH 7.0, 20 mM NaCl) at room temperature for 30 
min with purified catHP1a (50 ng/μl, 1 μl) or catHP1b (50 ng/μl, 1 μl) and naive plasma (1 μl) (B) 
or induced plasma (1 μl) (C) in the presence of microbial elicitor, M. luteus (1 μg/μl, 1 μl). The 
reaction mixture were subjected to 10% SDS-PAGE followed by immunoblot analysis using HP6, 
HP8 and PAP-1 antiserum. The sizes and positions of molecular weight standards are indicated 
on the left (A) or in the middle (B and C). Bands representing HP6 zymogen, a cleavage product 
corresponding to its catalytic domain, and a putative HP6-serpin complex are marked by arrows. 

























proHP1a        +     +     +     +     +     +     + 







































proHP1a                        +             +                      catHP1a                        +              + 







































proHP1b                        +             +                      catHP1b                      +              + 
CPC                +                            +                      CPC              +                             + 
 
Figure 25. CPC-induced M. sexta proHP1a, catHP1a, proHP1b and catHP1b amidase 
activities. A, Optimization of the CPC concentration in the activation of proHP1a using an 
artificial substrate, IEARpNa. Purified recombinant proHP1a (250 ng/μl, 2 μl) was incubated with 
various concentrations of cetylpyridinium chloride (CPC, 1 μl) in the buffer (10 μl, 20 mM Tris-
HCl pH 7.0, 20 mM NaCl) at room temperature for 5 min. The residual amidase activity (mean ± 
S.D., n = 3) was then measured using an artificial substrate, IEARpNa (100 μM, 150 μl); B, CPC-
mediated enhancement of proHP1a and catHP1a residual amidase activities using substrate, 
LDLHpNa. C, CPC-mediated enhancement of proHP1b and catHP1b residual amidase activities 
using substrate, LDLHpNa. Purified recombinant proHP1a (250 ng/μl, 2 μl), catHP1a (150 ng/μl, 
2 μl), proHP1a (250 ng/μl, 2 μl) or catHP1a (150 ng/μl, 2 μl) was incubated with 6 mM CPC (1 
μl) respectively in the buffer (10 μl, 20 mM Tris-HCl pH 7.0, 20 mM NaCl) at room temperature 
for 5 min. The residual amidase activity (mean ± S.D., n = 3) was then measured using an 
artificial substrate, LDLHpNa (100 μM, 150 μl). CPC, proHP1a, catHP1a, proHP1b or catHP1b 














Table 3. Amino-terminal sequencing by automated Edman degradation of cleaved HP6 
Cycle # Amino acids detected (pmoles) 
1 E (3.45)  G (1.05)  A (0.96) 
2 N (2.14) 
3 V (2.90)  P (0.34) 
4 G (1.16) 
5 D (1.44) 
 
Purified recombinant proHP6 (150 ng/μl, 2 μl) (An et al., 2009) was incubated with proHP1a 
(300 ng/μl, 2 μl) in the presence of 6 mM CPC (1 μl) in the buffer (10 μl, 20 mM Tris-HCl pH 
7.0, 20 mM NaCl) at 37°C for 4 h. The reaction mixture was separated on 10% SDS-PAGE. The 
protein was then transferred to a polyvinylidene difluoride (PVDF) membrane and stained with 
Coomassie Blue. The 30 kDa polypeptide corresponding to the cleaved HP6 was subjected to 










































HP6 zymogen HP6 zymogen 
HP6 catalytic domain 
proHP6-ΔC 
                         proHP1a      +   +                +    + 
                         proHP6                    +    +   +    + 
CPC (6 mM)            +           +         + 
                 naive plasma                                                +    + 






























proHP1a        +     +              +    +        +     +              +    + 
                         proHP6        +     +    +    +                  +     +    +   +    





























HP6 zymogen HP6 zymogen 
proHP6-ΔC 
proHP6-ΔC
proHP1a      +    +    +     +    +     +     +         +      +    +     +     +     +     + 
proHP6        +    +    +     +    +     +     +         +      +    +     +     +     +     + 
CPC (0.6 mM)      +                                                  + 
CPC (6 mM)                +                                                    + 
CTAB (6 mM)                   +                                                    + 
SDS (6 mM)                              +                                                    + 
T-X114 (6 mM)                               +                                                     + 
Tween-20 (6 mM)                                   +                                                     + 
NP-40 (6 mM)                                                +                                                     + 
 
Figure 26. Alternative cleavage of M. sexta proHP6 by proHP1a in the presence of 
detergents. A, Cleavage of proHP6 by proHP1a in the presence of CPC. B, Cleavage of proHP6 
by proHP1a in the presence of CPC under reducing (+DTT) and non-reducing (-DTT) conditions. 
C, Cleavage of proHP6 by proHP1a in the presence of various detergents under reducing (+DTT) 
and non-reducing (-DTT) conditions. Purified proHP6 (100 ng/μl, 1 μl) was incubated with 
proHP1a (200 ng/μl, 1 μl) in the presence of detergents (6 mM, 1 μl) in the buffer (7 μl, 20 mM 
Tris-HCl pH 7.0, 20 mM NaCl) at 37°C for 4 h. Naive plasma (1 μl) was incubated with the 
microbial elicitor, M. luteus (1 μg/μl, 1 μl) in the same buffer (7 μl) at room temperature for 30 
min. This reaction was used as the control; CPC: cetylpyridinium chloride; CTAB: 
cetyltrimethylammonium bromide; SDS: sodium dodecyl sulfate; T-X114: Triton-X114; Tween-
20: polysorbate-20; NP-40: nonyl phenoxypolyethoxylethanol. All the reaction mixtures were 
subjected to 10% SDS-PAGE followed by immunoblot analysis using HP6 antiserum. The sizes 
and positions of molecular weight standards are indicated on the left (A and B) or in the middle 
(C). Bands representing HP6 zymogen, HP6 catalytic domain, an alternative cleavage product 
(proHP6-ΔC), and a putative HP6-serpin complex are marked by arrows. The nonspecific 































HP6 zymogen from hemolymph recombinant HP6 zymogen 
band not identified 
HP6 catalytic domain 
proHP6-ΔC 
naïve plasma       + 
M. luteus              + 
proHP6                +       +      +       +       + 
proHP1a                       + 
proHP1b                               + 
catHP1a                                          + 
catHP1b                                                   + 
CPC (6mM)                  +      +       +       + 
 
Figure 27. HP6 alternative cleavage by M. sexta proHP1a, proHP1b, catHP1a and catHP1b 
in the presence of CPC. Purified proHP6 (100 ng/μl, 1 μl) was incubated with proHP1a (200 
ng/μl, 1 μl), proHP1b (200 ng/μl, 1 μl), catHP1a (100 ng/μl, 1 μl) or catHP1b (100 ng/μl, 1 μl) 
respectively in the presence of CPC (6 mM, 1 μl) in the buffer (7 μl, 20 mM Tris-HCl pH 7.0, 20 
mM NaCl) at 37°C for 4 h (Lane 2-5). Control reaction was naive plasma (2 μl) incubated with 
proHP6 (100 ng/μl, 1 μl) in the presence of microbial elicitor, M. luteus (1 μg/μl, 1 μl) in the 
same buffer (6 μl) at room temperature for 30 min (Lane 1). All the reaction mixtures were 
subjected to 10% SDS-PAGE followed by immunoblot analysis using HP6 antiserum. The sizes 
and positions of molecular weight standards are indicated on the right. Bands representing HP6 
zymogen, HP6 catalytic domain, an alternative cleavage product (proHP6-ΔC), an unknown band 































HP6 zymogen HP6 zymogen
HP6 catalytic domain 
naïve plasma (1μl)        +   +   +    +                          +    +   +   + 
naïve plasma (1/2μl)                           +                                            + 
naïve plasma (1/4μl)                                +                                              + 
naïve plasma (1/10μl)                                    +                                              + 
M. luteus                              +   +                                      +   + 
proHP6                                     +    +   +   +   +                     +    +    +     +    + 
catHP1b                                          +   +   +   +                           +    +     +    + 
 
Figure 28. M. sexta HP6 activation by catHP1b in the presence of diluted hemolymph. 
Purified proHP6 (100 ng/μl, 1 μl) was incubated with catHP1b (50 ng/μl, 1 μl) in the presence of 
a series of diluted plasma in the buffer (7 μl, 20 mM Tris-HCl pH 7.0, 20 mM NaCl) at room 
temperature for 30 min. Control reactions were plasma alone or naive plasma (1 μl) incubated 
with the microbial elicitor, M. luteus (1 μg/μl, 1 μl) in the same buffer (8 μl) at room temperature 
for 30 min. All the reaction mixtures were subjected to 10% SDS-PAGE under reducing (+DTT) 
and non-reducing (-DTT) conditions followed by immunoblot analysis using HP6 antiserum. The 
sizes and positions of molecular weight standards are indicated in the middle. Bands representing 





























HP6 cleaved band 
induced plasma (1μl)              + 
M. luteus                            +    + 
naïve plasma (1μl)            +   
naïve plasma (1/2μl)                     +  +  +  + 
naïve plasma (1/4μl)                                          +  +   +   + 
naïve plasma (1/8μl)                                                              +   +   +   + 
proHP6                              +    +    +  +  +  +      +  +   +   +   +   +   +   + 
catHP1b                                         +   +  +  +     +   +   +   +  +   +   +   + 
CPC (0.6mM)                                     +                   +                  + 
CPC (6mM)                                            +                    +                  + 























HP6 cleaved band 
naïve plasma (1μl)         +   
M. luteus                         +    + 
induced plasma (1μl)           + 
induced plasma (1/2μl)               +   +   +   + 
induced plasma (1/4μl)                                      +   +   +   + 
induced plasma (1/8μl)                                                           +   +   +   + 
proHP6                           +    +     +   +   +   +     +    +   +  +   +   +   +   + 
catHP1b                                       +   +   +   +    +    +   +   +   +   +   +   + 
CPC (0.6mM)                                    +                     +                   + 
CPC (6mM)                                            +                     +                   + 



























HP6 cleaved band 
proHP6-ΔC
M. luteus                        +                                             + 
naïve plasma (1μl)       +    +    +                                 +    +     + 
naïve plasma (1/2μl)                        +                                             + 
naïve plasma (1/4μl)                               +                                             + 
naïve plasma (1/8μl)                                     +                                              + 
proHP6                         +    +    +     +     +    +             +    +     +    +    +     + 
catHP1b                              +    +     +     +    +                   +     +    +    +     + 
CPC (0.6mM)                           +     +     +    +                          +    +    +     + 
 
Figure 29. Effects of M. sexta hemolymph and CPC on the activation of proHP6. Process of 
proHP6 by catHP1b in the presence of different conentrations of CPC and a series of diluted 
naive hemolymph (A) or induced hemolymph (B); Purified proHP6 (100 ng/μl, 1 μl) was 
incubated with catHP1b (50 ng/μl, 1 μl) in the presence of a series of diluted plasma in the buffer 
(7 μl, 20 mM Tris-HCl pH 7.0, 20 mM NaCl) at room temperature for 30 min. Control reactions 
was induced plasma (1 μl) incubated with proHP6 (100 ng/μl, 1 μl) in the presence of microbial 
elicitor, M. luteus (1 μg/μl, 1 μl) in the same buffer (8 μl) at room temperature for 15 min. C, 
Process of proHP6 by catHP1b in the presence of a series of diluted naive hemolymph and CPC 
(0.6 mM). Same protocol decribed above except for CPC concentration. All the reaction mixtures 
were subjected to 10% SDS-PAGE under reducing (+DTT) and non-reducing (-DTT) conditions 
followed by immunoblot analysis using HP6 antiserum. The sizes and positions of molecular 
weight standards are indicated in the middle. Bands representing HP6 zymogen, an alternative 
























HP1 Ab Serpin-4 Ab
CH (35% A. S.)   +     +     +           +    +    + 
                          M. luteus            +                        + 
                           serpin-4                   +                        + 
 
Figure 30. Inhibition of M. sexta HP1 activation by serpin-4. 10 μl of induced hemolymph 
were mixed with 100% saturated ammonium sulfate (5.5 μl, pH 7.0). The ammonium sulfate 
(A.S.) was adjusted to 35% saturation, and centrifuged to separate precipitate from the 
supernatant. The pellet was saved and re-dissolved into the buffer (10 μl, 20 mM Tris-HCl, pH 
7.5). 35% ammonium sulfate precipitated fraction of control hemolymph was incubated with 
recombinant serpin-4 (100 ng/μl, 2 μl) (Tong et al., 2005) in the presence of M. luteus (1 μg/μl, 1 
μl) at room temperature for 30 min. The reaction mixtures were separated by 10% SDS-PAGE 
and immunoblot analysis was performed using HP1 and serpin-4 antibodies. The sizes and 
positions of molecular weight standards are indicated on the left. Bands representing proHP1, 




















                                                                                        
 
Figure 31. Purification and identification of M. sexta HP1-serpin complex from plasma. 
Elution Franction #2 (12 μl) of immunoaffinity purification was subjected to 10% SDS-PAGE 
and detected by Coomassie Blue staining or immunoblotting. A, Coomassie Blue stained gel; B, 
immunoblotting using HP1 antibody; C, immunoblotting using serpin-4 antibody; D, 
immunoblotting using serpin-5 antibody. . The sizes and positions of molecular weight standards 
are indicated on the left. Bands representing proHP1, serpin-4, serpin-5 and complex (HP1-90) 
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1   MIFVFLLLLV SVCSEKGDYS ELQHPAWEDI IEEGGMHIGG GRSKRFIQLN PNQGNVAYQA 





INQA QNRGCGLSTR AQGR  VFGSRP ANPREWPWMA SITPEGFEQY                        
                      1,2,3                   4,5 
 
181 CGGVLITDRH VLTAAHCTRR WEANELYVRL GEYDFKRTND TRSYNFRVVE KVQHVDFEIS  
 
         6      7,8         9,10     11-16 
 
241 NYHHDIAILK LDKPAIFNTY VWPICLPPPG LSIENETVTV IGWGTQWYGG PHSHVLMEVS 
301 FPIWTHQNCI EVHTNSIFDE SICAGGHEGG RDACQGDSGG PLMYQMPSGR WAVVGIVSWG  
 
                                              17,18 
 
361 VRCGEPNHPG IYTRVDKYIG WIMENARF 
 







Matched M. sexta HP1a Peptide Peptide # Measured Mass 
(MH+) from 
HP1-90 





1 842.44 137-143 842.91  
2 842.44 137-143 842.91  
3 842.44 137-143 842.91  
4 1099.59 155-164 1100.25  
5 1099.59 155-164 1100.25  
6 772.45 183-189 772.90  
7 1107.58 190-199 1108.28 ① 
8 1107.58 190-199 1108.28 ① 
9 1178.57 201-209 1179.30  
10 1178.57 201-209 1179.30  
11 870.41 210-216 870.96  
12 1026.51 210-217 1027.14  
13 1026.51 210-217 1027.14  
14 1026.51 210-217 1027.14  
15 1026.51 210-217 1027.14  
16 1026.51 210-217 1027.14  
17 1968.83 332-350 1970.18 ①, ②, ② 
18 1968.83 332-350 1970.18 ①, ②, ② 
19 1342.63 363-374 1343.48 ① 
20 1342.63 363-374 1343.48 ① 
21 1342.63 363-374 1343.48 ① 
22 1342.63 363-374 1343.48 ① 
 
Figure 32. Identification of M. sexta HP1a in HP1-serpin complex by MALDI-TOF mass 
spectrometry. The mass spectral analysis was performed as described in Materials and Methods. 
A, The amino acid sequence of M. sexta HP1a. In the sequence, the signal peptide is underlined. 
The predicted cleavage site between the clip domain and catalytic domain is indicated by a 
vertical arrow. Trypsin cleavage sites are double-underlined. The tryptic peptides for which the 
matching masses were found from mass spectral analysis are indicated with a vertical line 
(starting point) and an arrow (ending point). The numbers underneath indicate the matching 
masses listed in B. B, The measured monoisotopic (MH ) masses from HP1-90 and their 
corresponding matching peptides from HP1a. The peptides with putative residue modifications 
are indicated. 
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1   MIFVFLLLLV SVCAEKGDYS ELQHPAWEDI TEEGGMHIGG GRSKRFIQLN PNLGNVAYQA  
A 
61  CTLPNGKQGH CRHLRFCIQD DFKQDFVKFM NYICVIQGRS MGACCPDDTT VGGPEGLAGE  
121 LPATAPQEGE DETLIKISQA QNRGCGLSTR PQGR  VFDSRP ANPREWPWMA SITPEGYERY  
 
                        1         2             3 
 
181 CGGVLITERH VLTAAHCTDK FEANELYVRL GEYDFKRTND TRSYNFRVVE KVQHFDFETL  
 
                              4      5-10 
 
241 NYHHDIAILK LDKPATFNTY VWPICLPPPG LSIENETVTV IGWGTQSFGG PDSHILLEVS 
301 FPIWTHEKCI EAHTNSIFDE NYCAAGLEGG RDACQHDSGG PLMYQMPSGR WAVVGIVSWG 






Matched M. sexta HP1b Peptide Peptide # Measured Mass 
(MH+) from 
HP1-90 





1 815.42 137-143 815.88  
2 1130.58 144-154 1131.27 ① 
3 1157.59 155-164 1158.28  
4 1139.56 201-209 1140.26  
5 870.41 210-216 870.96  
6 1026.51 210-217 1027.14  
7 1026.51 210-217 1027.14  
8 1026.51 210-217 1027.14  
9 1026.51 210-217 1027.14  
10 1026.51 210-217 1027.14  
 
Figure 33. Identification of M. sexta HP1b in HP1-serpin complex by MALDI-TOF mass 
spectrometry. The mass spectral analysis was performed as described in Materials and Methods. 
A, The amino acid sequence of M. sexta HP1b. In the sequence, the signal peptide is underlined. 
The predicted cleavage site between the clip domain and catalytic domain is indicated by a 
vertical arrow. Trypsin cleavage sites are double-underlined. The tryptic peptides for which the 
matching masses were found from mass spectral analysis are indicated with a vertical line 
(starting point) and an arrow (ending point). The numbers underneath indicate the matching 
masses listed in B. B, The measured monoisotopic (MH ) masses from HP1-90 and their 
corresponding matching peptides from HP1b. The peptides with putative residue modifications 
are indicated. 
+






1   MKCVLVIVLC IVSCYCDDLP AKVRNGLTEK IGNFSIELLY HTSKSQPENQ NLVLSPITVW 
61  TALAVISEGA TGNTRR
102 
 
EINH ALRITNRNKN VTRANYREIS NWLVVKTKTV ELAKINAIFV  
 
                      1-4                                 5       6,7, 
 
121 DQQRLPQEDF IAIAKEIYDT NMVPLKFEES DVAADVINRQ ISNVTHGRIK NIVNSESFKE  
 
     8      9,10       11,12        13,14                     15-21 
 
181 SKMILTSALY FKAQWTVPFN ASSTTKMPFH DSHGKKIGEV NMMYNRQTYP FANMRQLQAR  
 
         22,23                     24-31      32,33     34-37 
 
240 VIELPYGSEN RLSMIIMLPN PGVSVEDMFL NFKTFTLDNF FEEMRLSSEE FGDDEIDCFL  
 
       38,39 
 
301 PRFKIEADLD MSEVLQNAMG IQALFDQNKA MLPYMARTPM YVSKVLHKAE IEVTEEGTVA  
 
                                    40,41    42-44 
 





















1 1007.56 76-83 1008.15  
2 1007.56 76-83 1008.15  
3 851.46 77-83 851.96  
4 851.46 77-83 851.96  
5 888.53 107-114 889.06  
6 1202.64 115-124 1203.36  
7 1202.64 115-124 1203.36  
8 1202.64 115-124 1203.36  
9 1243.68 116-135 1244.45  
10 1243.68 116-135 1244.45  
11 1321.65 136-146 1322.54 ② 
12 1321.65 136-146 1322.54 ② 
13 1447.70 147-159 1448.55  
14 1447.70 147-159 1448.55  
15 1277.70 169-179 1278.47  
16 1277.70 169-179 1278.47  
17 1277.70 169-179 1278.47  
18 1621.87 169-182 1622.84  
19 1036.52 171-179 1037.14  
20 1380.69 171-182 1381.51  
21 1380.69 171-182 1381.51  
22 1185.64 183-192 1186.47 ② 
23 1185.64 183-192 1186.47 ② 
24 1080.47 207-215 1081.21 ② 
25 1080.47 207-215 1081.21 ② 
26 1080.47 207-215 1081.21 ② 
27 1080.47 207-215 1081.21 ② 
28 1208.56 207-216 1209.39 ② 
29 1208.56 207-216 1208.56 ② 
30 1208.56 207-216 1208.56 ② 
31 1208.56 207-216 1208.56 ② 
32 1225.55 217-226 1226.43 ②, ② 
33 1255.55 217-226 1226.43 ②, ② 
34 1138.53 227-235 1139.34 ②, ③ 
35 1138.53 227-235 1139.34 ② 
36 1138.53 227-235 1139.34 ② 
37 1138.53 227-235 1139.34 ②, ③ 
38 1275.65 241-251 1276.41  
39 1275.65 241-251 1276.41  
40 921.47 330-337 922.11 ② 
41 921.47 330-337 922.11 ② 
42 824.41 338-344 824.99 ② 
43 824.41 338-344 824.99 ② 
44 824.41 338-344 824.99 ② 
 
Figure 34. Identification of M. sexta serpin-4 in HP1-serpin complex by MALDI-TOF mass 
spectrometry. The mass spectral analysis was performed as described in Materials and Methods. 
A, The amino acid sequence of M. sexta serpin-4. In the sequence, the signal peptide is 
underlined. Trypsin cleavage sites are double-underlined. The tryptic peptides for which the 
matching masses were found from mass spectral analysis are indicated with a vertical line 
(starting point) and an arrow (ending point). The numbers underneath indicate the matching 
masses listed in B. B, The measured monoisotopic (MH ) masses from HP1-90 and their 
corresponding matching peptides from serpin-4. The peptides with putative residue modifications 
are indicated.
+











1   MMMKCAIFVL FFGACYCDVD FYERPRNFSI ELLYHTQLQT GGHVVISPFG IWTLMTGIAL 
61  GATGNSYKQL SRAFILPK
104 
 
NP DTLTEGYKSL TNVVLDPSSN AVALTSKNFV FLDNDFNVYP  
 
                          1-3 
 
121 DFRLRLQKDF SAAIKVLDFG DPNSARIANT YIEKSGGRVS NVLQSDDFQE SRMLLTNVIS  
 
            4-6         7,8       9-12            13-16         17,18 
 
181 FKGLWATPFN KSDTVLEPFY NENKEVIGSV NMMYQKAQIP FSNIRDLKAF AIELPYGDTK  
 
                    19,20        21,22        23              24-26 
 
241 KYSMLIFLPH PNTKIDDMYK NLAVISLKDV FKKLQTDAEY FGLEDIDVKI PRFHISTNLV  
 
                   27-29   30-33 
 
301 LNKPLNDMGV YDIFQPDLAS FQRVSKDNIF VSAIVHKADI EVTEAGTVAS AATTASFADR 

















1 1136.54 79-88 1137.21  
2 1136.54 79-88 1137.21  
3 1136.54 79-88 1137.21  
4 1119.63 126-135 1120.31  
5 1119.63 126-135 1120.31  
6 750.39 129-135 750.85  
7 1189.57 136-146 1190.28  
8 1189.57 136-146 1190.28  
9 950.51 147-154 951.09  
10 950.51 147-154 951.09  
11 950.51 147-154 951.09  
12 950.51 147-154 951.09  
13 1622.76 159-172 1623.70  
14 1622.76 159-172 1623.70  
15 1622.76 159-172 1623.70  
16 1622.76 159-172 1623.70  
17 1164.65 173-182 1165.46  
18 1164.65 173-182 1165.46  
19 1554.72 192-204 1555.66  
20 1554.72 192-204 1555.66  
21 1397.66 205-216 1398.66 ②, ② 
22 1397.66 205-216 1398.66 ②, ② 
23 1044.57 217-225 1045.21  
24 1323.67 229-240 1324.50  
25 1323.67 229-240 1324.50  
26 1451.77 229-241 1452.67  
27 783.34 255-260 783.89 ② 
28 783.34 255-260 783.89 ② 
29 783.34 255-260 783.89 ② 
30 856.54 261-268 857.06  
31 856.54 261-268 857.06  
32 856.54 261-268 857.06  
33 856.54 261-268 857.06  
 
Figure 35. Identification of M. sexta serpin-5 in HP1-serpin complex by MALDI-TOF mass 
spectrometry. The mass spectral analysis was performed as described in Materials and Methods. 
A, The amino acid sequence of M. sexta serpin-5. In the sequence, the signal peptide is 
underlined. Trypsin cleavage sites are double-underlined. The tryptic peptides for which the 
matching masses were found from mass spectral analysis are indicated with a vertical line 
(starting point) and an arrow (ending point). The numbers underneath indicate the matching 
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masses listed in B. B, The measured monoisotopic (MH ) masses from HP1-90 and their 
corresponding matching peptides from serpin-5. The peptides with putative residue modifications 
are indicated. 
+








Melanization (prophenoloxidase-activating) is a major innate defense system in many 
invertebrates. It involves production of highly toxic and reactive compounds around the 
wounding or infection. The prophenoloxidase-activating pathway includes an extracellular serine 
proteinase cascade with similarities to blood clotting system and complement system of 
vertebrates. The recognition of microbial surface components by pattern recognition proteins 
triggers the activation of the serine proteinase cascade, leading to conversion of inactive 
prophenoloxidase (proPO) to active phenoloxidase (PO). Inhibitory regulation of the proteinases 
by serine proteinase inhibitors (serpins) is important for ensuring a localized defense response. 
In this study, a new immune responsive serpin from M. sexta was investigated. Serpin-8 
mRNA and protein levels increased significantly after immune challenge. The amino acid 
sequence of serpin-8 is similar to Drosophila serpin Necrotic. Both of them have an N-terminal 
extension and a Leu at the predicted P1 site. The serpin-8 core domain (serpin-8-ΔN) was 
expressed using baculovirus/insect cell system. Serpin-8-ΔN has a specificity being able to inhibit 
elastase- and chymotrypsin-like proteinases and formed inhibitory complexes with chymotrypsin, 
Cathepsin G, and elastase. Addition of recombinant serpin-8-ΔN to M. sexta plasma suppressed 
proPO activation. Serpin-8-ΔN inhibits one of the serine proteinases (HP19) in proPO activating 
pathway by forming inhibitory complex with its catalytic domain. Serpin-8-HP14 inhibitory 
complex was detected in M. sexta hemolymph and serpin-8-ΔN formed complex 
108 
 
with A. gambiae HP14 catalytic domain. All of our results indicate that serpin-8-ΔN acts as a 
serine proteinase inhibitor with the specificity to inhibitor elastase- and chymotrypsin-like 
proteinases. M. sexta HP19 and HP14 are highly possible physiological targets of serpin-8.  
Chapter IV reports the expression, purification and functional study of one clip domain 
serine proteinase in M. sexta. Two HP1 isoforms are present in M. sexta hemolymph. The two 
proteins share 90% amino acid sequence similarity. Recombinant HP1 zymogen forms, proHP1a 
and proHP1b, and catalytic domains, catHP1a and catHP1b were produced using 
baculovirus/insect cell system. Addition of zymogens or catalytic domains of HP1 into plasma 
resulted in proPO activation. Proteolytic cleavages of proHP6 and following proteolysis of 
proHP8 and proPAP-1 caused by HP6 activation were observed, when catHP1a alone was added 
into plasma. ProHP6 cleavage occurred within the catalytic domain when proHP6 was incubated 
with proHP1a in the presence of detergent. Some hemolymph factor(s) may contribute to the 
cleavage of proHP6 at its correct activation site, although the identity of such factor(s) is not yet 
known. HP1 was found to be regulated by M. sexta serpin-4 and serpin-5, and the inhibitory 






An, C., Ishibashi, J., Ragan, E.J., Jiang, H. and Kanost, M.R. (2009) (2009)Functions of Manduca 
sexta hemolymph proteinases HP6 and HP8 in two innate immune pathways. J. Biol. 
Chem. 284, 19716–19726. 
An, C., Hiromasa, Y., Zhang, X., Lovell, S. and Michel, K. (2012) Biochemical Characterization 
of Anopheles gambiae SRPN6, a Malaria Parasite Invasion Marker in Mosquitoes. PLoS 
ONE. 7, e48689 
Ashida, M. and Brey, P.T. (1997) Recent advances on the research of the insect prophenoloxidase 
cascade. Molecular Mechanisms of Immune Responses in Insects. Chapman and Hall, 
London, 135-172. 
Beatty, K., Bieth, J. and Travis, J. (1979) Kinetics of association of serpin proteinases with native 
and oxidized α-1-proteinase inhibitor andα-1-antichymotrypsin. J. Biol. Chem. 255, 3931–
3934. 
Bidochka, M.J., Leder, R.J., Robert, D.W. (1997) Induction of novel proteins in Manduca sexta 
and Blaberus giganteusas a response to fungal challenge. J. Invertebr. Pathol. 70, 184-189. 
Bohn, H., Barwig, B. (1984) Hemolymph clotting in the cockroach Leucophaea maderae 
(Blattaria) Influence of ions and inhibitors; isolation of the plasma coagulogen. J. Comp. 
Physiol. 154, 457-467.
Boman, H.G. (1991) Antibacterial peptides: Key components needed in immunity. Cell. 65, 205-
207.  
Boman, H.G. (1994) Cecropins: antibacterial peptides from insects and pigs. In Phylogenetic 
Perspectives in Immunity: The Insect Host Defense. 3–17. 
110 
 
Brey, P.T., Lee, W.J., Yamakawa, M., Koizumi, Y., Perrot, S., François, M. and Ashida, M. 
(1993) Role of the integument in insect immunity: epicuticular abrasion and induction of 
cecropin synthesis in cuticular epithelial cells. Proc. Natl. Acad. Sci. USA. 90, 6275-6279. 
Buchon, N. and Lee, B.K. (2009) A single modular serine protease integrates signals from 
pattern-recognition receptors upstream of the Drosophila Toll pathway. Proc. Natl. Acad. 
Sci. USA. 106, 12442-12447. 
Cerenius, L., Lee B.L. and Soderhall, K. (2008) The proPO-system: pros and cons for its role in 
invertebrate immunity. Trends. Immunol. 29, 263-271. 
Christen, J.M., Hiromasa, Y., An, C. and Kanost. M.R. (2012) Identification of plasma proteinase 
complexes with serpin-3 in Manduca sexta. Insect. Biochem. Mol. Biol. 42, 946–955. 
Coleman, S., Drahm, B., Petersen, G., Stolorov, J. and Kraus, K. (1995) A Drosophila male 
accessory gland protein that is a member of the serpin superfamily of proteinase inhibitors 
is transferred to females during mating. Insect. Biochem. Mol. Biol. 25, 203–207. 
Cornet, B., Bonmatin, J.M., Hetru, C., Hoffmann, J.A., Ptak, M. and Vovelle, F. (1995) Refined 
three-dimensional solution structure of insect defensin A. Structure. 3, 435–448. 
Decker, H. (2007) Similar enzyme activation and catalysis in hemocyanins and tyrosinases. Gene. 
398, 183-191. 
De Gregorio, E., Han, S.J., Lee, W.J., and Brey, P.T. (2002) An immune-responsive serpin 
regulates the melanization cascade in Drosophila. Dev. Cell. 3, 581–592. 
Dimarcq, J.L., Hoffmann, D., Meister, M., Bulet, P., Lanot, R., Reichhart, J.M. and Hoffmann, 
J.A. (1994) Characterization and transcriptional profiles of a Drosophila gene encoding an 
insect defensin. Eur. J. Biochem. 221, 209–221. 
Dunn, P.E. and Drake, D. (1983) Fate of bacteria injected into naïve and immunized larvae of the 
tobacco hornworm, Manduca sexta. J. Invertebr. Pathol. 41, 77-85. 
111 
 
Dushay, M. S., Asling, B. and Hultmark, D. (1996) Origins of immunity: Relish, a compound 
Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl Acad. Sci. USA. 93, 
10343–10347. 
Dushay, M.S. (2009) Insect hemolymph clotting. Cell. Mol. Life. Sci. 66, 2643-2650. 
Evans C.J., Hartenstein, V. and Banerjee, U. (2003) Thicker than blood: conserved mechanisms 
in Drosophila and vertebrate hemotopoiesis. Dev. Cell. 5, 673-690. 
Fehlbaum, P., Bulet, P., Michaut, L., Lagueux, M., Broekaert, W.F., Hetru, C. and Hoffmann J.A. 
(1994) Insect immunity: septic injury of Drosophila induces the synthesis of a potent 
antifungal peptide with sequence homology to plant antifungal peptides of special 
interest. J. Biol. Chem. 269, 33159–33163. 
Gettins, P.G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751–4804. 
Gillespie, J.P. and Kanost, M.R. (1997) Biological mediators of insect immunity. Ann. Rev. of. 
Immunol. 42, 611-643. 
Gorman, M.J., Wang, Y., Jiang, H. and Kanost, M.R. (2007) Manduca sexta hemolymph 
proteinase 21 activates prophenoloxidase-activating proteinase 3 in an insect innate 
immune response proteinase cascade. J. Biol. Chem. 282, 11742–11749. 
Gottar, M., Gobert, V., Michel, T., Belvin, M., Duyk, G., Hoffmann, J.A., Ferrandon, D., and 
Royet, J. (2002) The Drosophila immune response against Gram-negative bacteria is 
mediated by a peptidoglycan recognition protein. Nature. 416, 640-644. 
Gottar, M., Gobert, V., Matskevich, A.A., Reichhart, J.M., Wang, C. and Ferrandon, D. (2006) 
Dual detection of fungal infections in Drosophila through recognition of microbial 
structures and sensing of virulence factors. Cell. 127, 1425-1437. 
Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor 
Laboratory, Cold Spring Harbor, NY. 
Hetru, C. Bulet, P., Cociancich, S., Dimarcq, J.L., Hoffmann, D., Hoffmann, J.A. (1994) 
Antibacterial peptides/polypeptides in the insect host defense: a comparison with 
112 
 
vertebrate antibacterial peptides/polypeptides. In Phylogenetic Perspectives in Immunity: 
The Insect Host Defense, 43–65. 
Hoffman, J.A. (1995) Innate immunity of insects. Curr. Opin. Immunol. 7, 4-10. 
Hoffman, J.A., Reichhart, J.M., Hetru. C. (1996) Innate immunity in higher insects. Curr. Opin. 
Immunol. 8, 8-13. 
Hoffmann, J.A. and Reichhart, J.M. (2002) Drosophila innate immunity: an evolutionary 
perspective. Nat. Immunol. 3, 121-126. 
Hoffman, JA. (2003). The immune response of Drosophila. Nat. 426, 33-38. 
Huang, R., Lu, Z., Dai, H. and Jiang, H. (2007) The solution structure of clip domains from 
Manduca sexta prophenoloxidase activating proteinase-2. Biochem. 46, 11431-11439. 
Hultmark, D. (1993). Immune reactions in Drosophila and other insects: a model for innate 
immunity. Trends. Genet. 9, 178-183. 
Irving, J.A., Pike, R.N., Lesk, A.M. and Whisstock, J.C. (2000) Phylogeny of the serpin 
superfamily: implications of patterns of amino acid conservation for structure and 
function. Genome. Res. 10, 1845–1864. 
Iwanaga, S. (1993b) The limulus clotting reaction. Curr. Opin. Immunol. 5, 74-82. 
Iwanaga, S. and Lee, B.K. (2005) Recent advances in the innate immunity of invertebrate 
animals. J. Biochem. Mol. Biol. 38, 128-150. 
Janeway, C.J. (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold 
Spring Harbor, Symp. Quant. Biol. 54, 1-13. 
Jang, I.H., Chosa, N., Kim, S.H., Nam, H.J., Lemaitre, B., Ochiai, M. and Lee, W.J. (2006) A 
spätzle-processing enzyme requires for Toll signaling activation in Drosophila innate 
immunity. Dev. Cell. 10, 45-55. 
Jang, I.H., Nam H.J. and Lee, W.J. (2008) Clip-domain serine proteases in Drosophila innate 
immunity. J. Biochem. Mol.Biol. 41, 102-107. 
113 
 
Jiang, H., Wang, Y., Huang, Y., Mulnix, A.B., Kadel, J., Cole, K., and Kanost, M.R. (1996) 
Organization of serpin gene-1 from Manduca sexta: evolution of a family of alternate 
exons encoding the reactive site loop. J. Biol. Chem. 271, 28017-28023. 
Jiang H., Wang, Y., Ma, C. and Kanost M.R. (1997) Subunit composition of pro-phenoloxidase 
from Manduca sexta: molecular cloning of subunit proPO-P1. Insect. Biochem. Mol. Biol. 
27, 835-850. 
Jiang, H. and Kanost, M.R. (1997a) Characterization and functional analysis of 12 naturally 
occurring reactive site variants of serpin-1 from Manduca sexta. J. Biol.Chem 272, 1082-
1087. 
Jiang, H., Wang, Y. and Kanost, M.R. (1998) (1998) Pro-phenol oxidase activating proteinase 
from an insect, Manduca sexta: A bacteria-inducible protein similar to Drosophila easter. 
Proc. Natl Acad. Sci. USA. 95, 12220–12225. 
Jiang, H. and Kanost, M. R. (2000) The Clip-domain family of serine proteinases in    arthropods. 
Insect. Biochem. Mol. Biol. 30, 95-105. 
Jiang, H., Wang, Y., Yu, X.Q. and Kanost, M.R. (2003) Prophenoloxidase-activating proteinase-2 
from hemolymph of Manduca sexta. J. Biol.Chem 278, 3552-3561. 
Jiang, H., Wang, Y., Yu, X.Q. Zhu, Y. and Kanost, M.R. (2003) Prophenoloxidase-activating 
proteinase-3 (PAP-3) from Manduca sexta hemolymph: a clip-domain serine proteinase 
regulated by serpin-1J and serine proteinase homologs. Insect. Biochem. Mol. Biol. 33, 
1049-1060. 
Jiang, H., Ma, C. Lu, Z. and Kanost, M.R. (2004) β-1,3-glucan-recognition protein-2 (βGRP-2) 
from Manduca sexta, an acute-phase protein that binds β-1,3-glucan and lipoteichoic acid 
to aggregate fungi and bacteria. Insect. Biochem. Mol. Biol. 34, 89-100. 
Jiang, H., Wang, Y., Gu, Y., Guo, X. and Kanost, M.R. (2005) Molecular identification of a bevy 




Ji C., Wang, Y., Guo, X., Hartson S. and Jiang, H. (2004) A pattern recognition serine proteinase 
triggers the prophenoloxidase activation cascade in the Tobacco Hornworm, Manduca 
sexta. J. Biol. Chem. 279, 34101-34106. 
Jung, S.H., Evans, C.J., Uemura, C. and Banerjee, U. (2005) The Drosophila lymph gland as a 
developmental model of hemotopoiesis. Development. 132, 2521-2533. 
Kan, H., Kim, C., Kwon, H. and Lee, B.L. (2008) Molecular control of phenoloxidase-induced 
melanin systhesis in an insect. J. Biol. Chem. 283, 25316-25323. 
Kang, D., Liu, G., Lundstrom, A., Gelius, E. & Steiner, H. (1998) A peptidoglycan recognition 
protein in innate immunity conserved from insects to humans. Proc. Natl Acad. Sci. USA. 
95, 10078–10082. 
Kanost, M. R. (1999) Serine proteinase inhibitors in arthropod immunity. Devel.    Comp. 
Immunol. 23, 291-301. 
Kanost, M. R., Jiang, HB., Yu, XQ. (2004) Innate immune responses of a lepidopteran insect, 
Manduca sexta. Immunol. Rev. 198, 97-105. 
Kaufmann, S. (2008) Immunology’s foundation: the 100-year anniversary of the Nobel Prize to 
Paul Ehrlich and Elie Metchnikoff. Nat. Immunol. 9, 705-712. 
Kellenberger, C., Leone, P., Coguet, L., Jouenne, T., Reichhart, J.M. and Roussel, A. (2011) 
Structure-function analysis of grass clip serine protease involved in Drosophila Toll 
pathway activation. J. Biol. Chem. 286, 12300–12307. 
Kim, T., Kim, Y.J., (2005) Overview of innate immunity in Drosophila. J. Biochem. Mol. Biol. 
38, 121-127. 
Kimbrell, DA., Beutler, B. (2001) The evolution and genetics of innate immunity. Nat. Rev. 2, 
256-267. 
Kruger, O., Ladewig, J., Koster, K. and Ragg, H. (2002) Widespread occurrence of serpin genes 




Ladendorff, N.E. and Konast, M.R. (1990) Isolation and characterization of bacteria-induced 
protein P4 from hemolymph of Manduca sexta. Arch. Insect. Biochem. Physiol. 15, 33-
41. 
Lee, S.Y., Moon, H.J., Kurata, S., Natori, S. and Lee, B.L. (1995) Purification and cDNA cloning 
of an antifungal protein from the hemolymph of Holotrichia diomphalia larvae. Biol. 
Pharm. Bull. 18, 1049–1052. 
Lee, W.J., Lee, J.D., Kravchenko, V.V., Ulevitch, R.J., and Brey, P.T. (1996) Purification and 
molecular cloning of an inducible gram-negative bacteria-binding protein from the 
silkworm, Bombyx mori. Proc. Natl. Acad. Sci. USA. 93, 7888-7893. 
Lee, S.Y., Kwon, T.H., Hyun, J.H., Choi, J.S., Kawabata, S.I., Iwanaga, S. and Lee, B.L. (1998) 
In vitro activation of pro-phenol-oxidase by two kinds of pro-phenol-oxidase-activating 
factors isolated from hemolymph of coleopteran, Holotrichia diomphalia larvae. Eur. J. 
Biochem. 254, 50-57. 
Lee, K.Y., Horodyski, F.M., Valaitis, A.P. and Denlinger, D.L. (2002) Molecular characterization 
of the insect immune protein hemolin and its high induction during embryonic diapause in 
the gypsy moth, Lymantria dispar. Insect. Biochem. Mol. Biol. 32, 1457-1467. 
Lee, M.H., Osaki, T., Lee, J.Y. and Lee, B.L. (2004) Peptidoglycan recognition proteins involved 
in 1,3-β-D-glucan-dependent prophenoloxidase activation system of insect. J. Biol. Chem. 
279, 3218-3227. 
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. and Hoffmann, J. A. (1996) The 
dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal 
response in Drosophila adults. Cell. 86, 973–983.  
Lemaitre, B., Hoffmann, JA. (2007) The host defense of Drsophila melanogaster. Annu. Rev. 
Immunol. 25, 697-743.  
LeMosy, E.K., Hong, C.C. and Hashimoto, C. (1999) Signal transduction by a protease cascade. 
Trends. Cell. Biol. 9, 102-107 
116 
 
Leulier, F., Rodriguez, A., Khush, R.S., Abrams, J.M. and Lemaitre, B. (2000) The Drosophila 
caspase Dredd is requires to resist gram-negative baterial infection. EMBO. J. 1, 353-358. 
Levashina, E.A., Langley, E., Green, C., Gubb, D., Ashburner, M., Hoffmann, J.A. and 
Reichhart, J.M. (1999) Constitutive activation of toll-mediated antifungal defense in 
serpin-deficient Drosophila. Science. 285, 1917–1919. 
Li, Y., Wang, Y., Jiang, H. and Deng, J. (2009) Crystal structure of Manduca sexta 
prophenoloxidase provides insights into the mechanism of type 3 copper enzymes. Proc. 
Natl Acad. Sci. USA. 106, 17002–17006. 
Ling, E. and Yu, X.Q. (2005) Prophenoloxidase binds to the surface of hemocytes and is involved 
in hemocyte melanization in Manduca sexta. Insect. Biochem. Mol. Biol. 35, 1356–1366. 
Ligoxygakis, P., Pelte, N., Jiang, H., Hoffmann, J.A. and Reichhart, J.M. (2002) A serpin mutant 
links Toll activation to melanization in the host defence of Drosophila. EMBO J. 21, 
6330–6337. 
Liu, C., Xu, Z., Gupta, D., and Dziarski, R. (2001) Peptidoglycan recognition proteins: a novel 
family of four human innate immunity pattern recognition molecules. J. Biol. Chem. 276, 
34686-34694. 
Lowenberger, C., Bulet, P., Charlet, M., Hetru, C., Hodgeman, B., Christensen, B.M. and 
Hoffmann, J.A. (1995) Insect Immunity isolation of three novel inducible antibacterial 
defensins from the vector mosquito, Aedes aegypti. Insect. Biochem. Mol. Biol. 25, 867–
873.  
Lu Z. and Jiang H. (2008) Expression of Manduca sexta serine proteinase homolog precursors in 
insect cells and their proteolytic activation. Insec. Biochem. Mol. Biol. 38, 89-98. 
Ma, C. and kanost, M.R. (2000) A β-1,3-glucan-recognition protein from an insect, Manduca 
sexta, agglutinates microorganisms and activates the prophenoloxidase cascade. J. Biol. 
Chem. 275, 7505-7514. 
117 
 
Meister, M. (2004) Blood cells of Drosophila: cell lineages and role in host defense. Curr. Opin. 
Immunol. 16, 10-15. 
Michel, T., Reichhart, J.M., Hoffmann, J.A., and Royet, J. (2001) Drosophila Toll is activated by 
Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature. 
414, 756-759. 
Morishma, I., Horiba, T., Iketani, M., Nishioka, E., Horiba, T., Iketani, M., Nishioka, E. and 
Yamano, Y. (1995) Parallel induction of cecropin and lysozyme in larvae of the silkworm 
Bombyx mori. Dev. Comp. Immunol. 19, 357-363. 
Ochiai, M. and Ashida, M. (1999) A pattern recognition protein for peptidoglycan: cloning the 
cDNA and the gene of the silk worm, Bombyx mori. J. Biol. Chem. 274, 11854-11858. 
Osaki, T., Omotezako, M., Nagayama, R., Hirata, M., Iwanaga, S., Kasahara, J., Hattori, J., Ito, I., 
Sugiyama, H. and Kawabata, S. (1999) Horseshoe crab hemocyte-derived antimicrobial 
polypeptides, tachystatins, with sequence similarity to spider neurotoxins. J. Biol. Chem. 
274, 26172-26178. 
Park, J., Kim, C., Kim, J. and Lee, B.L. (2007) Clustering of peptidoglycan recognition protein-
SA is required for sensing lysine-type peptidoglycan in insects. Proc. Natl. Acad. Sci. 
USA. 104, 6602-6607. 
Pelte, N., Robertson, A.S., Zou, Z., Reichhart, J.M. and Gubb, D. (2006) Immune challenge 
induces N-terminal cleavage of the Drosophila serpin Necrotic. Insect. Biochem. Mol. 
Biol. 36, 37–46. 
Perona, J.J. and Craik, C.S. (1995) Structural basis of substrate specificity in the serine proteases. 
Protein Sci. 4, 337-360. 
Piao, S., Kim, S., Kim, J.H., Park, J.W., Lee, B.L. and Ha, N.C. (2007) Crystal structure of the 




Ramet, M., Manfruelli, P., Pearson, A., Mathey-Prevot, B., and Ezekowitz, R.A. (2002) 
Functional genomic analysis of phagocytosis and identification of a Drosophila receptor 
for E. coli. Nature. 416, 644-648. 
Rasmuson, T. and Boman, H.G. (1979) Purification and some properties of immune protein P4 
from hemolymph of Hyalophora cecropia pupae. Insect. Biochem. 9, 259-264. 
Ragan, E.J., An, C., Yang, C.T. and Kanost, M.R. (2010) Analysis of Mutually Exclusive 
Alternatively Spliced Serpin-1 Isoforms and Identification of Serpin-1 Proteinase 
Complexes in Manduca sexta Hemolymph. J. Biol. Chem. 285, 29642–29650. 
Rizki, T.M. and Rizki, R.M. (1984). The cellular defense system of Drosophila melanogaster. 
Plenum New York, USA. 579-604.  
Rizki, T.M. (1985) Genetics of a Drosophila phenoloxidase. Mol. Gen. Genet. 201, 7–13. 
Robertson, A.S., Belorgey, D., Lilley, K.S., Lomas, D.A., Gubb, D. and Dafforn, T.R. (2003) 
Characterization of the necrotic protein that regulates the Toll-mediated immune response 
in Drosophila. J. Biol. Chem. 278, 6175-6180. 
Shi, L., Li, B. and Paskewitz, S.M. (2006) Cloning and characterization of a putative inhibitor of 
melanization from Anopheles gambiae. Insect. Mol. Biol. 15, 313–320. 
Shrestha, S. and Kim, Y. (2008) Eicosanoids mediate prophenoloxidase release from 
ooenocytoids in the beet armyworm Spodoptera exigua. Insect. Biochem. Mol. Biol. 38, 
99–112. 
Skinner, W., Dennis,P, Li, J., Summerfelt, R., Carney, R. and Quistad, G. (1991) Isolation and 
identification of paralytic peptides from hemolymph of the lepidopteran insects Manduca 
sexta, Spodoptera exigua, and Heliothis virescens. J. Biol. Chem. 266, 12873-12877. 
Söderhäll, K. and Smith, V.J. (1983) Separation of the haemocyte populations of Carcinus 
maenas and other marine decapods, and prophenoloxidase distribution. Dev. Comp. 
Immunol. 7, 229–239. 
119 
 
Söderhäll, K., Corenius, L. and Johansson, M. (1996) The prophenoloxidase activating system in 
invertebrates. New Directions in Invertebrate Immunology. 229-254.  
Sondergaard, L. (1993) Homology between the mammalian liver and the Drosophila fat body. 
Trends. Genet. 9, 193. 
Soukup, S.F., Culi, J. and Gubb, D. (2009) Uptake of the Necrotic Serpin in Drosophila 
melanogaster via the Lipophorin Receptor-1. PLOS. 5, 1-13. 
Steiner, H. (2004) Peptidoglycan recognition proteins: on and off switches for innate immunity. 
Immunol. Rev. 198, 83–96. 
Strand, M.R., Pech, L.L. (1995) Immunological basis for compatibility in parasitoid-host 
relationships. Annu. Rev. Entomol. 40, 31-56.
Su, X.D., Gastinel, I.N., Vaughn, D.E., Faye, I., Poon, P. and Bjorkman, P.J. (1998) Crystal 
structure of hemolin: A horseshoe shape with implications for homophilic adhesion. 
Science. 281, 991-995. 
Takehana, A. (2002) Overexpression of a pattern-recognition receptor, peptidoglycan-recognition 
protein-LE, activates imd/relish-mediated antibacterial defense and the prophenoloxidase 
cascade in Drosophila larvae. Proc. Natl. Acad. Sci. USA. 99, 13705-13710. 
Tong, Y., Jiang, H. and Kanost, M.R. (2005) Identification of plasma proteases inhibited by 
Manduca sexta Serpin-4 and Serpin-5 and their association with components of the 
prophenoloxidase activation pathway. J. Biol. Chem. 280, 14932-14942. 
Tzou, P, Ohresser, S., Ferrandon, D., Capovilla, M. and Reichhart J.M. (2000) Tissue-specific 
inducible expression of antimicrobial peptide genes in Drosophila surface epithelia. 
Immunity. 13, 737-748. 
Vilmos, P. and Kurucz, E. (1998) Insect immunity: evolutionary roots of the mammalian innate 
immune system. Immunol. Letters. 62, 59-66.  
120 
 
Wang, Y., Jiang, H. and Kanost, M.R. (1999) Biological activity of Manduca sexta paralytic and 
plasmatocyte spreading peptide and primary structure of its hemolymph precursor. Insect. 
Biochem. Mol. Biol. 29, 1075-1086. 
Wang, Y., Jiang, H. and Kanost, M.R. (2001) Expression and purification of Manduca sexta 
prophenoloxidase-activating proteinase precursor (proPAP) from Baculovirus-infected 
insect cells. Protein Expression and Purification. 23, 328-337. 
Wang, Y., Jiang, H. (2006) Interaction of β-1,3-Glucan with its recognition protein activates 
hemolymph proteinase 14, an initiation enzyme of the prophenoloxidase activation system 
in Manduca sexta. J. Biol. Chem. 281, 9271-9278. 
Wang, Y. and Jiang, H. (2007) Reconstitution of a branch of the Manduca sexta 
prophenoloxidase activation cascade in vitro Snake-like hemolymph proteinase 21 (HP21) 
cleaved by HP14 activates prophenoloxidase-activating proteinase-2 precursor. Insect. 
Biochem. Mol. Biol. 37, 1015-1025. 
Wang Y. and Jiang, H. (2008) (2008)A positive feedback mechanism in the Manduca sexta 
prophenoloxidase activation system. Insect. Biochem. Mol. Biol. 38, 763-769. 
Wang, Y., Sumathipala, N., Rayaprolu, S. and Jiang, H. (2011) Recognition of microbial 
molecular patterns and stimulation of prophenoloxidase activation byβ-1,3-glucanase-
related protein in Manduca sexta larval plasma. Insect. Biochem. Mol. Biol. 41, 322-331.  
Waterhouse, R.M. (2007) Evolutionary dynamics of immune-related genes and pathways in 
disease-vector mosquitoes. Science. 316, 1738-1743. 
Weis, W.I., Taylor, M.E. and Drickarner, K. (1998) The C-type lectin superfamily in the immune 
system. Immunol. Rev. 163, 19-34. 
Ye, S., Cech, A.L., Belmares, R., Bergstrom, R.C., Tong, Y., Corey, D.R., Kanost, M.R. and 
Goldsmith, E.J. (2001) The structure of a Michaelis serpin-protease complex. Nat. Struct. 
Biol. 8, 979-983. 
121 
 
Yoshida, H., Kinoshita, K. and Ashida, M. (1996) Purification of a peptidoglycan recognition 
protein from hemolymph of the silkworm, Bombyx mori. J. Biol. Chem. 271, 13854-
13860. 
Yu, X.Q., Gan, H. and Kanost, M.R. (1999) Immulectin, an inducible C-type lectin from an 
insect, Manduca sexta, stimulates activation of plasma prophenol oxidase. Insect. 
Biochem. Mol. Biol. 29, 585-597. 
Yu, X.Q. and Kanost, M.R. (2000) Immunlectin-2, a lipopolysaccharide-specific lectin from an 
insect, Manduca sexta, is induced in response to Gram-negative bacteria. J. Biol. Chem. 
275, 37373-37381. 
Yu, X.Q., Zhu, Y., Ma, C., Fabrick, J.A. and Kanost, M.R. (2002) Pattern recognition proteins in 
Manduca sexta plasma. Insect. Biochem. Mol. Biol. 32, 1287-1293. 
Yu, X.Q., Jiang, H., Wang, Y. and Kanost, M.R. (2003) Nonproteolytic serine proteinase 
homologs are involved in prophenoloxidase activation in the tobacco hornworm, Manduca 
sexta. Insect. Biochem. Mol. Biol. 33, 197–208.  
Zhang, S., Gunaratna, R.T., Zhang, X., Najar, F., Wang, Y, Roe, B. and Jiang, H. (2011) 
Pyrosequencing-based expression profiling and identification of differentially regulated 
genes from Manduca sexta, a leipidopteran model insect. Insect. Biochem. Mol. Biol. 41, 
733–746. 
Zhao, P., Li J., Wang, Y. and Jiang, H. (2007) Broad-spectrum antimicrobial activity of 
the reactive compounds generated in vitro by Manduca sexta phenoloxidase. 
Insect. Biochem. Mol. Biol. 37, 952–959. 
Zhu, Y., Wang, Y., Gorman, M. J., Jiang, H. and Kanost, M. R. (2003) Manduca sexta serpin-3 
regulates prophenoloxidase activation in response to infection by inhibiting 
prophenoloxidase-activating proteinases. J. Biol. Chem. 278, 46556-46564. 
122 
 
Zou, Z. and Jiang, H. (2005) Manduca sexta serpin-6 regulates immune serine proteinases PAP-3 
and HP8: cDNA cloning, protein expression, inhibition kinetics, and functional 
elucidations. J. Biol. Chem. 280, 14341-14348. 
Zou, Z., Lopez, D.L., Kanost, M.R., Evans, J.D. and Jiang, H. (2006) Comparative analysis of 
serine protease-related genes in the honey bee genome: possible involvement in 


















clone in T 
vector) 
Bacmid Transfection Expression
catHP1 +j586/-j587 704 26.63 HP1-1 HP1-
2,3,4,5 
Yes dectected 
catHP2 +j588/-j589 740 27.23 HP2-1 HP2-1,2 Yes  
catHP5 +j590/-j591 782 28.55 HP5-1 HP5-1,2 Yes  
catHP6 +j592/-j500 743 27.00 HP6-
1(partial 
digestion) 
   






catHP9 +j594/-j502 797 28.44 HP9-3 HP9-
1,2,3,4 
Yes  
catHP12n +j595/-j596 839 30.93 HP12n-4 HP12n-
1,2,3,4 
Yes  
catHP13 +j597/-j516 746 27.64 HP13-2 HP13-1,2 Yes  
124 
 
catHP15 +j598/-j504 824 30.40 HP15-1 HP15-
1,2,3 
Yes dectected 
catHP16 +j599/-j600 776 28.38 HP16-1 HP16-
1,2,3,4 
Yes  
catHP17 +j638/-j505 770 28.64 HP17-1 HP17-1 Yes  
catHP18 +j639/-j454 752 27.27 HP18-1 HP18-
1,2,3,4 
Yes  
catHP19 +j640/-j641 761 28.49 HP19-1 HP19-
1,2,3 
Yes dectected 
proHP20 +j642/-j643 932 34.21 proHP20-5 proHP20-
1,2,3 
Yes dectected 
catHP21 +j644/-j540 743 27.64 HP21-2 HP21-
1,2,3 
Yes  






catHP23 +j647/-j648 818 30.69 HP23-2 HP23-
1,2,3 
Yes dectected 
catHP25 +j649/-j577 909 32.82 HP25-2 HP25-1,2 Yes dectected 












Candidate for the Degree of 
 
Doctor of Philosophy 
 
Thesis:    ROLES OF MANDUCA SEXTA SERPIN-8 AND HEMOLYMPH 
PROTEINASE-1 IN THE PROPHENOLOXIDASE ACTIVATION SYSTEM 
 
 






Completed the requirements for the Doctor of Philosophy in Entomology at 
Oklahoma State University, Stillwater, Oklahoma in December, 2012. 
 
Completed the requirements for the Master of Science in Microbial and 
Biochemical Pharmacy at East China University of Science and Technology, 
Shanghai, China in 2007. 
  
Completed the requirements for the Bachelor of Science in Food Science and 
Engineering at East China University of Science and Technology, Shanghai, 
China in 2004. 
 
Experience:   
 
Graduate Research Assistant at Oklahoma State University from 2007-2012 
Graduate Research Assistant at East China University of Science and 
Technology from 2004-2007 
 
 
 
 
 
 
